<!DOCTYPE html><html lang="en" class="bg-surface-base antialiased"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, interactive-widget=resizes-content"/><link rel="stylesheet" href="/_next/static/css/62c4caba71dfda84.css" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/eb3d87f98fe1565f.css" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/1b5e561215938d4d.css" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/0227d069a630d414.css" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/f87fff2ab93d05a7.css" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4" href="/_next/static/chunks/webpack-e121ed42680f327e.js"/><script src="/_next/static/chunks/78a669d9-e7993486b22c4915.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/40c4a5a7-abdabb07419d1cfc.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/2230-f7c87dc9fa57c408.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/main-app-536d4b8fca62396a.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/63f0ec43-8ee6a76d70472249.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/7670-7326298c9856172b.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/282-691fffb366e24ca5.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/7515-336759ef5dad2b52.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/927-34e2a6da3e15e26b.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/5855-243eeca8f0e4cabd.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/4393-1c8dff25ec904469.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/2225-454cf9f44775e7ce.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/7618-43536a8fb0dd3bfe.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/7720-3a1e7e411adba2d3.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/7086-1f1c4891d766e04f.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/app/global-error-4d07d20223cd4b4c.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/8208b75a-a48e5a4507a0de91.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/5497-ab85ef3ea59dd353.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/6281-c6e84786dade3614.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/2660-d983a7f287e89f18.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/5002-9735c25beda556ba.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/3655-6717081f7512305a.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/8945-e4e3cf487f5e27c7.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/9214-a10614844a67ba31.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/4789-2080f6497f78b5b6.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/app/layout-226f2bd71acf9f9e.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/24cf1b50-159cca90b09285e0.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/9ffa21ba-c069766d809bd4c7.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/600-9a9fcafaaa6c1c4c.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/5448-2a3cfd853d899c9a.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/8-8ca70ca619d8e099.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/app/error-4a29e9399afba038.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><script src="/_next/static/chunks/app/not-found-dd95690acf732f18.js" async="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script><meta name="next-size-adjust" content=""/><title>Grokipedia</title><meta name="description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><link rel="icon" type="image/x-icon" href="/favicon.ico" sizes="48x48"/><link rel="icon" href="/images/icon-dark.png" media="(prefers-color-scheme: light)" type="image/png"/><link rel="icon" href="/images/icon-light.png" media="(prefers-color-scheme: dark)" type="image/png"/><link rel="apple-touch-icon" href="/icon-192x192.png"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><meta property="og:title" content="Grokipedia"/><meta property="og:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta property="og:url" content="https://grokipedia.com"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="website"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Grokipedia"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Grokipedia"/><meta name="twitter:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><title>Cystatin C</title><meta name="description" content="Cystatin C or cystatin 3 (formerly gamma trace, post-gamma-globulin, or neuroendocrine basic polypeptide), a protein encoded by the CST3 gene, is mainly used as a biomarker of kidney function.[95] It has been investigated for its role in predicting new-onset or deteriorating cardiovascular disease. It has also been implicated in brain disorders involving amyloid (a specific type of protein deposition), such as Alzheimer&#x27;s disease. In humans, all cells with a nucleus (cell core containing the..."/><meta name="author" content="system"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="keywords" content="CysC, Cystatin-C"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><link rel="canonical" href="https://grokipedia.com/page/Cystatin_C"/><meta property="og:title" content="Cystatin C"/><meta property="og:description" content="Cystatin C or cystatin 3 (formerly gamma trace, post-gamma-globulin, or neuroendocrine basic polypeptide), a protein encoded by the CST3 gene, is mainly used as a biomarker of kidney function.[95] It has been investigated for its role in predicting new-onset or deteriorating cardiovascular disease. It has also been implicated in brain disorders involving amyloid (a specific type of protein deposition), such as Alzheimer&#x27;s disease. In humans, all cells with a nucleus (cell core containing the..."/><meta property="og:url" content="https://grokipedia.com/page/Cystatin_C"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Cystatin C"/><meta property="og:type" content="article"/><meta property="article:modified_time" content="1970-01-21T09:19:13.828Z"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Cystatin C"/><meta name="twitter:description" content="Cystatin C or cystatin 3 (formerly gamma trace, post-gamma-globulin, or neuroendocrine basic polypeptide), a protein encoded by the CST3 gene, is mainly used as a biomarker of kidney function.[95] It has been investigated for its role in predicting new-onset or deteriorating cardiovascular disease. It has also been implicated in brain disorders involving amyloid (a specific type of protein deposition), such as Alzheimer&#x27;s disease. In humans, all cells with a nucleus (cell core containing the..."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><link rel="icon" href="/favicon.ico" type="image/x-icon" sizes="16x16"/><meta name="sentry-trace" content="93c13b5af1b07a50ea4f1710a2930972-da8172950c71a4b6-1"/><meta name="baggage" content="sentry-environment=production,sentry-public_key=5f2258f71198ee26a355127af230c3a6,sentry-trace_id=93c13b5af1b07a50ea4f1710a2930972,sentry-org_id=4508179396558848,sentry-transaction=GET%20%2Fpage%2F%5Bslug%5D,sentry-sampled=true,sentry-sample_rand=0.2295892769951049,sentry-sample_rate=1"/><script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule="" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4"></script></head><body class="flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b"><div hidden=""><!--$--><!--/$--></div><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">((a,b,c,d,e,f,g,h)=>{let i=document.documentElement,j=["light","dark"];function k(b){var c;(Array.isArray(a)?a:[a]).forEach(a=>{let c="class"===a,d=c&&f?e.map(a=>f[a]||a):e;c?(i.classList.remove(...d),i.classList.add(f&&f[b]?f[b]:b)):i.setAttribute(a,b)}),c=b,h&&j.includes(c)&&(i.style.colorScheme=c)}if(d)k(d);else try{let a=localStorage.getItem(b)||c,d=g&&"system"===a?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":a;k(d)}catch(a){}})("class","theme","dark",null,["light","dark"],null,true,true)</script><header class="h-16 bg-surface-base fixed top-0 z-50 w-full"><div class="hidden h-full grid-cols-[1fr_3fr_1fr] items-center gap-4 !py-0 md:grid max-w-full py-6 px-4 w-full mx-auto"><div class="-ml-2 justify-self-start"><a class="cursor-pointer" href="/"><svg width="200" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="mx-auto flex w-full"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full px-3 shadow-none sm:w-80 focus-visible:z-1 mx-auto h-full w-full rounded-full bg-surface-l1" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div><div class="flex items-center gap-2 justify-self-end"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0" type="button" id="radix-_R_7apfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button></div></div><div class="flex h-full items-center md:hidden justify-between max-w-full py-6 px-4 w-full mx-auto pt-8"><div class="flex items-center"><div class="-ml-2"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button" aria-label="Toggle table of contents"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-list h-6 w-6"><path d="M3 12h.01"></path><path d="M3 18h.01"></path><path d="M3 6h.01"></path><path d="M8 12h13"></path><path d="M8 18h13"></path><path d="M8 6h13"></path></svg></button></div><a class="cursor-pointer" href="/"><svg width="160" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="flex items-center gap-1"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0 [&amp;_svg]:!w-5" type="button" id="radix-_R_aipfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-search h-5 w-5"><circle cx="11" cy="11" r="8"></circle><path d="m21 21-4.3-4.3"></path></svg></button></div></div></header><div class="bg-surface-base fixed right-0 top-16 z-50 h-[calc(100vh-4rem)] w-full transform border-l transition-transform duration-300 ease-in-out sm:w-1/2 md:hidden translate-x-full"><div class="flex flex-col gap-4 p-4"><div class="flex flex-row gap-2"><button class="focus-visible:ring-ring inline-flex items-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full shadow-none sm:w-80 h-10 w-full justify-start rounded-full bg-surface-l1 px-4" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div></div></div><div><div class="min-[1350px]:grid min-[1350px]:grid-cols-[1fr_3fr_1fr]"><nav class="bg-surface-base hidden h-[calc(100vh-4rem)] overflow-y-auto px-6 pb-32 min-[1350px]:sticky min-[1350px]:top-16 min-[1350px]:block scrollbar-none [-ms-overflow-style:none] [scrollbar-width:none] [&amp;::-webkit-scrollbar]:hidden [overscroll-behavior:contain] pt-8"><ul class="space-y-2 text-sm"><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#cystatin-c" class="transition-opacity hover:opacity-100 opacity-50">Cystatin C</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#role-in-medicine" class="transition-opacity hover:opacity-100 opacity-50">Role in Medicine</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#kidney-function" class="transition-opacity hover:opacity-100 opacity-50">Kidney function</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#death-and-cardiovascular-disease" class="transition-opacity hover:opacity-100 opacity-50">Death and cardiovascular disease</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#proposed-shrunken-pore-syndrome" class="transition-opacity hover:opacity-100 opacity-50">Proposed shrunken pore syndrome</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#neurologic-disorders" class="transition-opacity hover:opacity-100 opacity-50">Neurologic disorders</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#other-roles" class="transition-opacity hover:opacity-100 opacity-50">Other roles</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#laboratory-measurement" class="transition-opacity hover:opacity-100 opacity-50">Laboratory measurement</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#molecular-biology" class="transition-opacity hover:opacity-100 opacity-50">Molecular biology</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#history" class="transition-opacity hover:opacity-100 opacity-50">History</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#references" class="transition-opacity hover:opacity-100 opacity-50">References</a></li></ul></nav><div class="relative top-16 pb-32 pt-8 px-4 md:px-8"><div class="mx-auto max-w-[850px]"><button data-state="closed" type="button" class="flex items-center"><div class="text-fg-tertiary mb-2 flex cursor-help items-center gap-2 text-sm"><span class="inline-flex items-center justify-center p-0 m-0" data-namespace="@xai/icons" data-slot="icon" style="height:16px;width:16px"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 33 33" aria-hidden="true" class="" focusable="false" style="fill:currentColor;height:16px;width:16px"><path fill="currentColor" d="m13.237 21.04 11.082-8.19c.543-.4 1.32-.244 1.578.38 1.363 3.288.754 7.241-1.957 9.955-2.71 2.714-6.482 3.31-9.93 1.954l-3.765 1.745c5.401 3.697 11.96 2.782 16.059-1.324 3.251-3.255 4.258-7.692 3.317-11.693l.008.009c-1.365-5.878.336-8.227 3.82-13.031q.123-.17.247-.345l-4.585 4.59v-.014L13.234 21.044M10.95 23.031c-3.877-3.707-3.208-9.446.1-12.755 2.446-2.449 6.454-3.448 9.952-1.979L24.76 6.56c-.677-.49-1.545-1.017-2.54-1.387A12.465 12.465 0 0 0 8.675 7.901c-3.519 3.523-4.625 8.94-2.725 13.561 1.42 3.454-.907 5.898-3.251 8.364-.83.874-1.664 1.749-2.335 2.674l10.583-9.466"></path></svg></span><span>Fact-checked by Grok<!-- --> <!-- -->4 days ago</span></div></button><article class="text-[16px]"><h1 id="cystatin-c" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Cystatin C<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Cystatin C</strong> or <strong>cystatin 3</strong> (formerly <strong>gamma trace</strong>, post-gamma-globulin, or neuroendocrine basic polypeptide), a protein encoded by the <strong>CST3</strong> gene, is mainly used as a biomarker of kidney function.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> It has been investigated for its role in predicting new-onset or deteriorating cardiovascular disease. It has also been implicated in brain disorders involving amyloid (a specific type of protein deposition), such as Alzheimer&#x27;s disease. In humans, all cells with a nucleus (cell core containing the DNA) produce cystatin C as a chain of 120 amino acids. It is found in virtually all tissues and body fluids. It is a potent inhibitor of lysosomal proteinases (enzymes from a special subunit of the cell that break down proteins) and one of the most important extracellular inhibitors of cysteine proteases (it prevents the breakdown of proteins outside the cell by a specific type of protein-degrading enzymes). The 2024 KDIGO guidelines recommend its use alongside creatinine for improved glomerular filtration rate estimation in certain clinical scenarios, such as obesity or malignancy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Cystatin C belongs to the type 2 cystatin gene family.</span>
<h1 id="role-in-medicine" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Role in Medicine<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<h3 id="kidney-function" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Kidney function<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Glomerular filtration rate</span> (GFR), a marker of kidney health, is most accurately measured by injecting compounds such as <span class="inline text-[1em] leading-7">inulin</span>, <span class="inline text-[1em] leading-7">radioisotopes</span> such as 51chromium-<span class="inline text-[1em] leading-7">EDTA</span>, 125I-iothalamate, 99mTc-<span class="inline text-[1em] leading-7">DTPA</span> or <span class="inline text-[1em] leading-7">radiocontrast agents</span> such as <span class="inline text-[1em] leading-7">iohexol</span>, but these techniques are complicated, costly, time-consuming and have potential side-effects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_82abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> <span class="inline text-[1em] leading-7">Creatinine</span> is the most widely used <span class="inline text-[1em] leading-7">biomarker</span> of kidney function. It is inaccurate at detecting mild renal impairment, and levels can vary with muscle mass but not with protein intake. Urea levels might change with protein intake.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> Formulas such as the Cockcroft and Gault formula and the MDRD formula (see <span class="inline text-[1em] leading-7">Renal function</span>) try to adjust for these variables.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Cystatin C has a low <span class="inline text-[1em] leading-7">molecular weight</span> (approximately 13.3 <span class="inline text-[1em] leading-7">kilodaltons</span>), and it is removed from the bloodstream by <span class="inline text-[1em] leading-7">glomerular filtration</span> in the kidneys. If kidney function and glomerular filtration rate decline, the blood levels of cystatin C rise. <span class="inline text-[1em] leading-7">Cross-sectional studies</span> (based on a single point in time) suggest that serum levels of cystatin C are a more precise test of kidney function (as represented by the <span class="inline text-[1em] leading-7">glomerular filtration rate</span>, GFR) than serum creatinine levels.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_62qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> <span class="inline text-[1em] leading-7">Longitudinal studies</span> (following cystatin C over time) are sparse, but some show promising results.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_92qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> Although studies are somewhat divergent, most studies find that cystatin C levels are less dependent on age, gender, ethnicity, diet, and muscle mass compared to creatinine,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aiqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup> and that cystatin C is equal or superior to the other available biomarkers in a range of different patient populations, including diabetic patients, in <span class="inline text-[1em] leading-7">chronic kidney disease</span> (CKD), and after kidney transplant.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup> It has been suggested that cystatin C might predict the risk of developing CKD, thereby signaling a state of &#x27;preclinical&#x27; kidney dysfunction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup> Additionally, the age-related rise in serum cystatin C is a powerful predictor of adverse age-related health outcomes, including all-cause mortality, death from cardiovascular disease, <span class="inline text-[1em] leading-7">multimorbidity</span>, and declining physical and cognitive function.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> The 2014 UK&#x27;s <span class="inline text-[1em] leading-7">National Institute for Health and Care Excellence</span> (NICE) guideline (CG182) for the assessment and management of CKD in adults concluded that using serum cystatin C to estimate GFR is more specific for important disease outcomes than use of serum creatinine, and may reduce overdiagnosis in patients with a borderline diagnosis, reducing unnecessary appointments, patient worries, and the overall burden of CKD in the population.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup> The updated NICE guideline (NG203, 2021; last reviewed 2025) does not address cystatin C. More recent international guidelines, such as the KDIGO 2024 Clinical Practice Guideline for CKD, recommend using creatinine-based eGFR but adding cystatin C when available for improved accuracy, particularly in combination (eGFRcr-cys), to strengthen risk assessment.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_j2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Studies have also investigated cystatin C as a marker of kidney function in the adjustment of medication dosages.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_13abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1jabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Cystatin C levels have been reported to be altered in patients with cancer,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_13qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_23qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup> (even subtle) thyroid dysfunction<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_33qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_43qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup> and glucocorticoid therapy in some<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_53qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> but not all<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup> situations. Other reports have found that levels are influenced by <span class="inline text-[1em] leading-7">cigarette smoking</span> and levels of <span class="inline text-[1em] leading-7">C-reactive protein</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup> However, inflammation does not cause an increase in the production of cystatin C, since elective surgical procedures, producing a strong inflammatory response in patients, do not change the plasma concentration of cystatin C. Levels seem to be increased in <span class="inline text-[1em] leading-7">HIV</span> infection, which might or might not reflect actual renal dysfunction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bjqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cjqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[31]</sup> The role of cystatin C to monitor GFR during pregnancy remains controversial.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_djqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[33]</sup> Like creatinine, the elimination of cystatin C via routes other than the kidney increases with worsening GFR.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[34]</sup></span>
<h3 id="death-and-cardiovascular-disease" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Death and cardiovascular disease<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Kidney dysfunction increases the risk of death and cardiovascular disease.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_14qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[35]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[36]</sup> Several studies have found that increased levels of cystatin C are associated with the risk of death, several types of cardiovascular disease (including <span class="inline text-[1em] leading-7">myocardial infarction</span>, <span class="inline text-[1em] leading-7">stroke</span>, <span class="inline text-[1em] leading-7">heart failure</span>, <span class="inline text-[1em] leading-7">peripheral arterial disease</span> and <span class="inline text-[1em] leading-7">metabolic syndrome</span>) and healthy aging. Some studies have found cystatin C to be better in this regard than serum creatinine or creatinine-based GFR equations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[37]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_84qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[38]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[39]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_94qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[40]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[41]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[42]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_akqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[44]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bkqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[45]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[46]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ckqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[47]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[48]</sup> Because the association of cystatin C with long term outcomes has appeared stronger than what could be expected for GFR, it has been hypothesized that cystatin C might also be linked to mortality in a way independent of kidney function.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[49]</sup> In keeping with its <span class="inline text-[1em] leading-7">housekeeping gene</span> properties, it has been suggested that cystatin C might be influenced by the <span class="inline text-[1em] leading-7">basal metabolic rate</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[50]</sup></span>
<h3 id="proposed-shrunken-pore-syndrome" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Proposed shrunken pore syndrome<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The glomerular sieving coefficients for 10â€“30 kDa plasma proteins in the human kidney are relatively high with coefficients between 0.9 and 0.07.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_15qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[51]</sup> These relatively high sieving coefficients, combined with the high production of ultrafiltrate in health, means that proteins less than or equal to 30 kDa in plasma normally are mainly cleared by the kidneys and at least 85% of the clearance of cystatin C occurs in the kidney.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_25qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[52]</sup> If the pores of the glomerular membrane shrink, the filtration of bigger molecules, e.g. cystatin C, will decrease, whereas the filtration of small molecules, like water and creatinine, will be less affected. In this case, cystatin C-based estimates of GFR, eGFRcystatin C, will be lower than creatinine-based estimates eGFRcreatinine, so that a hypothesized condition, named <span class="inline text-[1em] leading-7">shrunken pore syndrome</span>, is identified by a low eGFRcystatin C/eGFRcreatinine-ratio.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_45qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[53]</sup> This syndrome is associated with a very strong increase in mortality.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_55qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[54]</sup></span>
<h3 id="neurologic-disorders" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Neurologic disorders<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Mutations</span> in the cystatin 3 <span class="inline text-[1em] leading-7">gene</span> are responsible for the <span class="inline text-[1em] leading-7">Icelandic</span> type of <span class="inline text-[1em] leading-7">hereditary cerebral amyloid angiopathy</span>, a condition predisposing to <span class="inline text-[1em] leading-7">intracerebral haemorrhage</span>, <span class="inline text-[1em] leading-7">stroke</span> and <span class="inline text-[1em] leading-7">dementia</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[55]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_86qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[56]</sup> The condition is inherited in a <span class="inline text-[1em] leading-7">dominant fashion</span>. The monomeric cystatin C forms dimers and oligomers by domain swapping<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[57]</sup> and the structures of both the dimers<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[58]</sup> and oligomers<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[59]</sup> have been determined.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Since cystatin 3 also binds <span class="inline text-[1em] leading-7">amyloid Î²</span> and reduces its aggregation and deposition, it is a potential target in <span class="inline text-[1em] leading-7">Alzheimer&#x27;s disease</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_37abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[60]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[61]</sup> Although not all studies have confirmed this, the overall evidence is in favor of a role for CST3 as a susceptibility gene for Alzheimer&#x27;s disease.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[62]</sup> Cystatin C levels have been reported to be higher in subjects with Alzheimer&#x27;s disease.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[63]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The role of cystatin C in <span class="inline text-[1em] leading-7">multiple sclerosis</span> and other <span class="inline text-[1em] leading-7">demyelinating diseases</span> (characterized by a loss of the myelin nerve sheath) remains controversial.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_37qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[64]</sup></span>
<h3 id="other-roles" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Other roles<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Cystatin C levels are decreased in <span class="inline text-[1em] leading-7">atherosclerotic</span> (so-called &#x27;hardening&#x27; of the arteries) and <span class="inline text-[1em] leading-7">aneurysmal</span> (saccular bulging) lesions of the <span class="inline text-[1em] leading-7">aorta</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_48qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[65]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4oqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[66]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_58qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[67]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5oqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[68]</sup> Genetic and prognostic studies also suggest a role for cystatin C.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6oqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[69]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_78qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[70]</sup> Breakdown of parts of the vessel wall in these conditions is thought to result from an imbalance between proteinases (<span class="inline text-[1em] leading-7">cysteine proteases</span> and <span class="inline text-[1em] leading-7">matrix metalloproteinases</span>, increased) and their inhibitors (such as cystatin C, decreased).</span>
<span class="mb-4 block break-words text-[1em] leading-7">A few studies have looked at the role of cystatin C or the CST3 gene in <span class="inline text-[1em] leading-7">age-related macular degeneration</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_29abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[71]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[72]</sup> Cystatin C has also been investigated as a prognostic marker in several forms of cancer.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[73]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_49abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[74]</sup> Its role in <span class="inline text-[1em] leading-7">pre-eclampsia</span> remains to be confirmed.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_69abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[75]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[76]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_79abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[77]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[78]</sup></span>
<h2 id="laboratory-measurement" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Laboratory measurement<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Cystatin C can be measured in a random sample of serum using immunoassays such as nephelometry or particle-enhanced turbidimetry.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[79]</sup> It is more expensive than serum creatinine, typically costing $50â€“150 compared to $10â€“50 for the latter, which can be measured with a Jaffe reaction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[80]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[81]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Since 2010, cystatin C assays have been standardized using the International Federation of Clinical Chemistry (IFCC) reference material, improving comparability across laboratories.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[82]</sup> Cystatin C is incorporated into glomerular filtration rate (GFR) estimating equations, such as the CKD-EPI cystatin C equation (2021, race-free), recommended by KDIGO (2024) for confirming reduced eGFR when creatinine-based estimates are unreliable (e.g., in extremes of muscle mass).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[83]</sup> Chronic kidney disease (CKD) is diagnosed based on eGFR below 60 mL/min/1.73 mÂ² for â‰¥3 months, not direct cystatin C thresholds.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[84]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Reference values vary by age, sex, and population. Recent laboratory standards (e.g., Mayo Clinic, as of 2025) provide: for ages 18â€“49 years, 0.63â€“1.03 mg/L; for â‰¥50 years, 0.67â€“1.21 mg/L.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[79]</sup> Values are generally lower in females than males and increase with age beyond 50. In pediatric patients, normal values decrease until the first year of life and stabilize; creatinine levels rise until puberty and vary by gender, complicating interpretation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[85]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Historical data from NHANES III (1988â€“1994) reported a reference interval (1stâ€“99th percentile) of 0.57â€“1.12 mg/L overall, 0.55â€“1.18 mg/L for women, and 0.60â€“1.11 mg/L for men, with lower levels in non-Hispanic Blacks and Mexican Americans.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[86]</sup> Using an older threshold of 1.09 mg/L (99th percentile in young healthy adults), prevalence of elevated cystatin C was 9.6% in normal-weight U.S. adults, higher in overweight and obese individuals; in those aged â‰¥60 and â‰¥80 years, 41% and &gt;50% had elevated levels, respectively (based on 1988â€“1994 data).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[87]</sup></span>
<h2 id="molecular-biology" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Molecular biology<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active <span class="inline text-[1em] leading-7">cysteine protease inhibitors</span>, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and the <span class="inline text-[1em] leading-7">kininogens</span>. The type 2 cystatin proteins are a class of cysteine proteinase inhibitors found in a variety of human fluids and secretions, where they appear to provide protective functions. The cystatin <span class="inline text-[1em] leading-7">locus</span> on the short arm of <span class="inline text-[1em] leading-7">chromosome 20</span> contains the majority of the type 2 cystatin genes and <span class="inline text-[1em] leading-7">pseudogenes</span>.</span>
<span class="mb-4 block break-words text-[1em] leading-7">The CST3 gene is located in the cystatin locus and comprises 3 <span class="inline text-[1em] leading-7">exons</span> (coding regions, as opposed to <span class="inline text-[1em] leading-7">introns</span>, non-coding regions within a gene), spanning 4.3 <span class="inline text-[1em] leading-7">kilo-base pairs</span>. It encodes the most abundant extracellular inhibitor of cysteine proteases. It is found in high concentrations in biological fluids and is expressed in virtually all organs of the body (CST3 is a <span class="inline text-[1em] leading-7">housekeeping gene</span>). The highest levels are found in <span class="inline text-[1em] leading-7">semen</span>, followed by <span class="inline text-[1em] leading-7">breastmilk</span>, <span class="inline text-[1em] leading-7">tears</span> and <span class="inline text-[1em] leading-7">saliva</span>. The <span class="inline text-[1em] leading-7">hydrophobic</span> <span class="inline text-[1em] leading-7">leader sequence</span> indicates that the protein is normally secreted. There are three <span class="inline text-[1em] leading-7">polymorphisms</span> in the <span class="inline text-[1em] leading-7">promoter</span> region of the gene, resulting in two common variants.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ddabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[88]</sup> Several <span class="inline text-[1em] leading-7">single nucleotide polymorphisms</span> have been associated with altered cystatin C levels.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_fdabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[89]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Cystatin C is a non-<span class="inline text-[1em] leading-7">glycosylated</span>, <span class="inline text-[1em] leading-7">basic</span> protein (<span class="inline text-[1em] leading-7">isoelectric point</span> at <span class="inline text-[1em] leading-7">pH</span> 9.3). The <span class="inline text-[1em] leading-7">crystal structure</span> of cystatin C is characterized by a short <span class="inline text-[1em] leading-7">alpha helix</span> and a long alpha helix which lies across a large antiparallel, five-<span class="inline text-[1em] leading-7">stranded</span> <span class="inline text-[1em] leading-7">beta sheet</span>. Like other type 2 cystatins, it has two <span class="inline text-[1em] leading-7">disulfide bonds</span>. Around 50% of the molecules carry a <span class="inline text-[1em] leading-7">hydroxylated proline</span>. Cystatin C forms <span class="inline text-[1em] leading-7">dimers</span> (molecule pairs) by exchanging subdomains; in the paired state, each half is made up of the long alpha helix and one beta strand of one partner, and four beta strands of the other partner.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cdqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[90]</sup></span>
<h2 id="history" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">History<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Cystatin C was first described as &#x27;gamma-trace&#x27; in 1961 by J. Clausen as a trace protein in normal cerebrospinal fluid not found in serum.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[91]</sup> Grubb and LÃ¶fberg first reported its amino acid sequence in 1982.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> They noticed it was increased in patients with advanced kidney failure.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[92]</sup> In 1984, it was renamed cystatin C due to its similarity to other cystatin protease inhibitors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[93]</sup> It was first proposed as a measure of glomerular filtration rate by Grubb and coworkers in 1985.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[94]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5uqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[95]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A study reported in the July 5, 2012, issue of the New England Journal of Medicine found that equations using serum creatinine and cystatin C provided more accurate estimates of GFR than creatinine alone.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[96]</sup></span></article><div id="references" class="min-w-0 scroll-mt-8 overflow-hidden"><div class="text-[16px]"><h2 id="references" node="[object Object]" class="mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden">References</h2></div><ol class="columns-1 gap-x-12 [counter-reset:item] md:columns-2"><li id="95" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Grubb A, LÃ¶fberg H (May 1982). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC346341" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis&quot;</a>. <em>Proceedings of the National Academy of Sciences of the United States of America</em>. <strong>79</strong> (9): 3024â€“7. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/1982PNAS...79.3024G" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1982PNAS...79.3024G</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1073%2Fpnas.79.9.3024" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1073/pnas.79.9.3024</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC346341" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">346341</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/6283552" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6283552</a>.</span></div></li><li id="https://kdigo.org/guidelines/ckd-evaluation-and-management/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://kdigo.org/guidelines/ckd-evaluation-and-management/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://kdigo.org/guidelines/ckd-evaluation-and-management/</a></span></div></li><li id="6" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Zahran A, El-Husseini A, Shoker A (2007). <a href="https://www.karger.com/Article/PDF/000100907" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature review&quot;</a>. <em>American Journal of Nephrology</em>. <strong>27</strong> (2): 197â€“205. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1159%2F000100907" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1159/000100907</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17361076" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17361076</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:25523216" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">25523216</a>.</span></div></li><li id="7" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Roos JF, Doust J, Tett SE, Kirkpatrick CM (March 2007). &quot;Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children--a meta-analysis&quot;. <em>Clinical Biochemistry</em>. <strong>40</strong> (5â€“6): 383â€“91. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.clinbiochem.2006.10.026" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.clinbiochem.2006.10.026</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17316593" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17316593</a>.</span></div></li><li id="8" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">King AJ, Levey AS (May 1993). <a href="http://jasn.asnjournals.org/cgi/pmidlookup?view=long&amp;pmid=8329667" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Dietary protein and renal function&quot;</a>. <em>Journal of the American Society of Nephrology</em>. <strong>3</strong> (11): 1723â€“37. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1681%2FASN.V3111723" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1681/ASN.V3111723</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/8329667" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8329667</a>.</span></div></li><li id="9" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Dharnidharka VR, Kwon C, Stevens G (August 2002). &quot;Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis&quot;. <em>American Journal of Kidney Diseases</em>. <strong>40</strong> (2): 221â€“6. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1053%2Fajkd.2002.34487" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1053/ajkd.2002.34487</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12148093" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12148093</a>.</span></div></li><li id="10" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Premaratne E, MacIsaac RJ, Finch S, Panagiotopoulos S, Ekinci E, Jerums G (May 2008). <a href="http://care.diabetesjournals.org/cgi/pmidlookup?view=long&amp;pmid=18319326" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes&quot;</a>. <em>Diabetes Care</em>. <strong>31</strong> (5): 971â€“3. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.2337%2Fdc07-1588" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.2337/dc07-1588</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18319326" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18319326</a>.</span></div></li><li id="11" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Perkins BA, Nelson RG, Ostrander BE, Blouch KL, Krolewski AS, Myers BD, Warram JH (May 2005). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2429917" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study&quot;</a>. <em>Journal of the American Society of Nephrology</em>. <strong>16</strong> (5): 1404â€“12. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1681%2FASN.2004100854" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1681/ASN.2004100854</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2429917" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2429917</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15788478" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15788478</a>.</span></div></li><li id="12" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Corrao AM, Lisi G, Di Pasqua G, Guizzardi M, Marino N, Ballone E, Chiesa PL (January 2006). &quot;Serum cystatin C as a reliable marker of changes in glomerular filtration rate in children with urinary tract malformations&quot;. <em>The Journal of Urology</em>. <strong>175</strong> (1): 303â€“9. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2FS0022-5347%2805%2900015-7" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/S0022-5347(05)00015-7</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16406933" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16406933</a>.</span></div></li><li id="13" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Onopiuk A, Tokarzewicz A, Gorodkiewicz E (2015). &quot;Cystatin C: a kidney function biomarker&quot;. <em>Adv Clin Chem</em>. <strong>68</strong> : 57â€“69. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fbs.acc.2014.11.007" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/bs.acc.2014.11.007</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/25858868" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">25858868</a>.</span></div></li><li id="14" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Ferguson TW, Komenda P, Tangri N (May 2015). <a href="https://doi.org/10.1097%2FMNH.0000000000000115" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cystatin C as a biomarker for estimating glomerular filtration rate&quot;</a>. <em>Curr Opin Nephrol Hypertens</em>. <strong>24</strong> (3): 295â€“300. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1097%2FMNH.0000000000000115" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1097/MNH.0000000000000115</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/26066476" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">26066476</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:27385" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">27385</a>.</span></div></li><li id="15" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Porto JR, Gomes KB, Fernandes AP, Domingueti CP (January 1, 2017). <a href="http://www.rbac.org.br/artigos/cystatin-c-promising-biomarker-to-evaluate-renal-function/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cystatin C: a promising biomarker to evaluate renal function&quot;</a>. <em>Revista Brasileira de Analises Clinicas</em>. <strong>49</strong> (3). <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.21877%2F2448-3877.201600446" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.21877/2448-3877.201600446</a>. Retrieved 18 November 2020.</span></div></li><li id="16" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, et al. (August 2006). <a href="http://www.annals.org/cgi/pmidlookup?view=reprint&amp;pmid=16908914" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease&quot;</a>. <em>Annals of Internal Medicine</em>. <strong>145</strong> (4): 237â€“46. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.7326%2F0003-4819-145-4-200608150-00003" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.7326/0003-4819-145-4-200608150-00003</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16908914" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16908914</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:24679098" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">24679098</a>.</span></div></li><li id="17" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Justice JN, Ferrucci L, Newman AB, Aroda VR, Bahnson JL, Divers J, Espeland MA, Marcovina S, Pollak MN, Kritchevsky SB, Barzilai N, Kuchel GA (December 2018). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294728" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup&quot;</a>. <em><span class="inline text-[1em] leading-7">Geroscience</span></em>. <strong>40</strong> (5â€“6): 419â€“436. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1007%2Fs11357-018-0042-y" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1007/s11357-018-0042-y</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294728" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6294728</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/30151729" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">30151729</a>.</span></div></li><li id="18" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nice.org.uk/guidance/cg182/chapter/implementation-getting-started" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Chronic kidney disease in adults: assessment and management&quot;</a>. <em><span class="inline text-[1em] leading-7">National Institute for Health and Care Excellence</span> (NICE)</em>. 23 July 2014. Retrieved 18 November 2020.</span></div></li><li id="https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline-Executive-Summary.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline-Executive-Summary.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline-Executive-Summary.pdf</a></span></div></li><li id="19" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Hermida J, Tutor JC (June 2006). &quot;Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin&quot;. <em>Therapeutic Drug Monitoring</em>. <strong>28</strong> (3): 326â€“31. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1097%2F01.ftd.0000211805.89440.3d" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1097/01.ftd.0000211805.89440.3d</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16778715" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16778715</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:27219789" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">27219789</a>.</span></div></li><li id="20" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">SchÃ¼ck O, Teplan V, SibovÃ¡ J, StollovÃ¡ M (February 2004). &quot;Predicting the glomerular filtration rate from serum creatinine, serum cystatin C and the Cockcroft and Gault formula with regard to drug dosage adjustment&quot;. <em>International Journal of Clinical Pharmacology and Therapeutics</em>. <strong>42</strong> (2): 93â€“7. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.5414%2Fcpp42093" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.5414/cpp42093</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15180169" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15180169</a>.</span></div></li><li id="21" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">DemirtaÅŸ S, Akan O, Can M, Elmali E, Akan H (February 2006). &quot;Cystatin C can be affected by nonrenal factors: a preliminary study on leukemia&quot;. <em>Clinical Biochemistry</em>. <strong>39</strong> (2): 115â€“8. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.clinbiochem.2005.10.009" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.clinbiochem.2005.10.009</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16337174" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16337174</a>.</span></div></li><li id="22" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Nakai K, Kikuchi M, Fujimoto K, Kaneko Y, Omori S, Nakai K, Suwabe A (April 2008). &quot;Serum levels of cystatin C in patients with malignancy&quot;. <em>Clinical and Experimental Nephrology</em>. <strong>12</strong> (2): 132â€“139. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1007%2Fs10157-008-0043-8" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1007/s10157-008-0043-8</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18317874" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18317874</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:19326312" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">19326312</a>.</span></div></li><li id="23" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kos J, Stabuc B, Cimerman N, BrÃ¼nner N (December 1998). <a href="https://doi.org/10.1093%2Fclinchem%2F44.12.2556" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression&quot;</a>. <em>Clinical Chemistry</em>. <strong>44</strong> (12): 2556â€“7. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1093%2Fclinchem%2F44.12.2556" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1093/clinchem/44.12.2556</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9836733" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9836733</a>.</span></div></li><li id="24" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Fricker M, Wiesli P, BrÃ¤ndle M, Schwegler B, Schmid C (May 2003). <a href="https://doi.org/10.1046%2Fj.1523-1755.2003.00925.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Impact of thyroid dysfunction on serum cystatin C&quot;</a>. <em>Kidney International</em>. <strong>63</strong> (5): 1944â€“7. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1046%2Fj.1523-1755.2003.00925.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1046/j.1523-1755.2003.00925.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12675875" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12675875</a>.</span></div></li><li id="25" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Manetti L, Pardini E, Genovesi M, Campomori A, Grasso L, Morselli LL, et al. (April 2005). <a href="https://web.archive.org/web/20080608033357/http://www.kurtis.it/abs/index.cfm?id_articolo_numero=3109" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Thyroid function differently affects serum cystatin C and creatinine concentrations&quot;</a>. <em>Journal of Endocrinological Investigation</em>. <strong>28</strong> (4): 346â€“9. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1007%2Fbf03347201" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1007/bf03347201</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15966508" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15966508</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:26777752" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">26777752</a>. Archived from <a href="http://www.kurtis.it/abs/index.cfm?id_articolo_numero=3109" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 2008-06-08.</span></div></li><li id="26" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Wiesli P, Schwegler B, Spinas GA, Schmid C (December 2003). &quot;Serum cystatin C is sensitive to small changes in thyroid function&quot;. <em>Clinica Chimica Acta; International Journal of Clinical Chemistry</em>. <strong>338</strong> (1â€“2): 87â€“90. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.cccn.2003.07.022" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.cccn.2003.07.022</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/14637271" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">14637271</a>.</span></div></li><li id="27" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Risch L, Herklotz R, Blumberg A, Huber AR (November 2001). <a href="https://doi.org/10.1093%2Fclinchem%2F47.11.2055" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients&quot;</a>. <em>Clinical Chemistry</em>. <strong>47</strong> (11): 2055â€“9. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1093%2Fclinchem%2F47.11.2055" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1093/clinchem/47.11.2055</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11673383" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11673383</a>.</span></div></li><li id="28" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Cimerman N, Brguljan PM, Krasovec M, Suskovic S, Kos J (October 2000). &quot;Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients&quot;. <em>Clinica Chimica Acta; International Journal of Clinical Chemistry</em>. <strong>300</strong> (1â€“2): 83â€“95. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2FS0009-8981%2800%2900298-9" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/S0009-8981(00)00298-9</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/10958865" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10958865</a>.</span></div></li><li id="29" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">BÃ¶kenkamp A, van Wijk JA, Lentze MJ, Stoffel-Wagner B (July 2002). <a href="https://doi.org/10.1093%2Fclinchem%2F48.7.1123" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations&quot;</a>. <em>Clinical Chemistry</em>. <strong>48</strong> (7): 1123â€“6. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1093%2Fclinchem%2F48.7.1123" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1093/clinchem/48.7.1123</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12089191" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12089191</a>.</span></div></li><li id="30" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE (April 2004). <a href="https://doi.org/10.1111%2Fj.1523-1755.2004.00517.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement&quot;</a>. <em>Kidney International</em>. <strong>65</strong> (4): 1416â€“21. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fj.1523-1755.2004.00517.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/j.1523-1755.2004.00517.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15086483" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15086483</a>.</span></div></li><li id="31" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Odden MC, Scherzer R, Bacchetti P, Szczech LA, Sidney S, Grunfeld C, Shlipak MG (November 2007). <a href="https://archive.today/20080607214011/http://archinte.ama-assn.org/cgi/pmidlookup?view=long&amp;pmid=17998494" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study&quot;</a>. <em>Archives of Internal Medicine</em>. <strong>167</strong> (20): 2213â€“9. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1001%2Farchinte.167.20.2213" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1001/archinte.167.20.2213</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189482" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3189482</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17998494" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17998494</a>. Archived from <a href="http://archinte.ama-assn.org/cgi/pmidlookup?view=long&amp;pmid=17998494" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 2008-06-07.</span></div></li><li id="32" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">CollÃ© A, Tavera C, PrÃ©vot D, Leung-Tack J, Thomas Y, Manuel Y, et al. (1992). &quot;Cystatin C levels in sera of patients with human immunodeficiency virus infection. A new avidin-biotin ELISA assay for its measurement&quot;. <em>Journal of Immunoassay</em>. <strong>13</strong> (1): 47â€“60. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1080%2F15321819208019824" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1080/15321819208019824</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/1569212" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1569212</a>.</span></div></li><li id="33" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Jaroszewicz J, Wiercinska-Drapalo A, Lapinski TW, Prokopowicz D, Rogalska M, Parfieniuk A (2006). <a href="https://doi.org/10.1177%2F135965350601100502" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration&quot;</a>. <em>Antiviral Therapy</em>. <strong>11</strong> (5): 641â€“5. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1177%2F135965350601100502" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1177/135965350601100502</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16964834" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16964834</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:33722022" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">33722022</a>.</span></div></li><li id="34" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Strevens H, Wide-Swensson D, Torffvit O, Grubb A (2002). &quot;Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy&quot;. <em>Scandinavian Journal of Clinical and Laboratory Investigation</em>. <strong>62</strong> (2): 141â€“7. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1080%2F003655102753611771" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1080/003655102753611771</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12004930" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12004930</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:25382382" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">25382382</a>.</span></div></li><li id="35" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Akbari A, Lepage N, Keely E, Clark HD, Jaffey J, MacKinnon M, Filler G (May 2005). &quot;Cystatin-C and beta trace protein as markers of renal function in pregnancy&quot;. <em>BJOG</em>. <strong>112</strong> (5): 575â€“8. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fj.1471-0528.2004.00492.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/j.1471-0528.2004.00492.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15842279" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15842279</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:1851149" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1851149</a>.</span></div></li><li id="36" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">SjÃ¶strÃ¶m P, Tidman M, Jones I (2005). &quot;Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans&quot;. <em>Scandinavian Journal of Clinical and Laboratory Investigation</em>. <strong>65</strong> (2): 111â€“24. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1080%2F00365510510013523" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1080/00365510510013523</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16025834" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16025834</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:41336736" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">41336736</a>.</span></div></li><li id="37" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. (July 2006). <a href="http://jasn.asnjournals.org/cgi/pmidlookup?view=long&amp;pmid=16738019" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Chronic kidney disease and mortality risk: a systematic review&quot;</a>. <em>Journal of the American Society of Nephrology</em>. <strong>17</strong> (7): 2034â€“47. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1681%2FASN.2005101085" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1681/ASN.2005101085</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16738019" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16738019</a>.</span></div></li><li id="38" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (September 2004). <a href="https://doi.org/10.1056%2FNEJMoa041031" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization&quot;</a>. <em>The New England Journal of Medicine</em>. <strong>351</strong> (13): 1296â€“305. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1056%2FNEJMoa041031" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1056/NEJMoa041031</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15385656" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15385656</a>.</span></div></li><li id="39" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Zethelius B, Berglund L, SundstrÃ¶m J, Ingelsson E, Basu S, Larsson A, et al. (May 2008). <a href="https://doi.org/10.1056%2FNEJMoa0707064" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Use of multiple biomarkers to improve the prediction of death from cardiovascular causes&quot;</a>. <em>The New England Journal of Medicine</em>. <strong>358</strong> (20): 2107â€“16. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1056%2FNEJMoa0707064" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1056/NEJMoa0707064</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18480203" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18480203</a>.</span></div></li><li id="40" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. (May 2005). <a href="https://doi.org/10.1056%2FNEJMoa043161" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cystatin C and the risk of death and cardiovascular events among elderly persons&quot;</a>. <em>The New England Journal of Medicine</em>. <strong>352</strong> (20): 2049â€“60. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1056%2FNEJMoa043161" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1056/NEJMoa043161</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15901858" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15901858</a>.</span></div></li><li id="41" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Ix JH, Shlipak MG, Chertow GM, Whooley MA (January 2007). <a href="http://circ.ahajournals.org/cgi/pmidlookup?view=long&amp;pmid=17190862" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study&quot;</a>. <em>Circulation</em>. <strong>115</strong> (2): 173â€“9. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1161%2FCIRCULATIONAHA.106.644286" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1161/CIRCULATIONAHA.106.644286</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771187" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2771187</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17190862" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17190862</a>.</span></div></li><li id="42" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Deo R, Fyr CL, Fried LF, Newman AB, Harris TB, Angleman S, et al. (January 2008). &quot;Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study&quot;. <em>American Heart Journal</em>. <strong>155</strong> (1): 62â€“8. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.ahj.2007.08.012" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.ahj.2007.08.012</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18082491" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18082491</a>.</span></div></li><li id="43" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Koenig W, Twardella D, Brenner H, Rothenbacher D (February 2005). <a href="https://doi.org/10.1373%2Fclinchem.2004.041889" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate&quot;</a>. <em>Clinical Chemistry</em>. <strong>51</strong> (2): 321â€“7. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1373%2Fclinchem.2004.041889" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1373/clinchem.2004.041889</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15563478" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15563478</a>.</span></div></li><li id="44" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Jernberg T, Lindahl B, James S, Larsson A, Hansson LO, Wallentin L (October 2004). <a href="http://circ.ahajournals.org/cgi/pmidlookup?view=long&amp;pmid=15477399" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome&quot;</a>. <em>Circulation</em>. <strong>110</strong> (16): 2342â€“8. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1161%2F01.CIR.0000145166.44942.E0" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1161/01.CIR.0000145166.44942.E0</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15477399" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15477399</a>.</span></div></li><li id="45" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Luc G, Bard JM, Lesueur C, Arveiler D, Evans A, Amouyel P, et al. (April 2006). <a href="https://pure.qub.ac.uk/ws/files/496612/Plasma%20cystatin-C%20and%20development%20of%20coronary%20heart%20disease%20-%20The%20PRIME%20Study%20-%20Atherosclerosis%202006%20-%20Evans%20AE%20-%20(Yarnell%20JW,%20Kee%20F,%20members).pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Plasma cystatin-C and development of coronary heart disease: The PRIME Study&quot;</a> (PDF). <em>Atherosclerosis</em>. <strong>185</strong> (2): 375â€“80. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.atherosclerosis.2005.06.017" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.atherosclerosis.2005.06.017</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16046222" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16046222</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:40221090" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">40221090</a>.</span></div></li><li id="46" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Servais A, Giral P, Bernard M, Bruckert E, Deray G, Isnard Bagnis C (May 2008). &quot;Is serum cystatin-C a reliable marker for metabolic syndrome?&quot;. <em>The American Journal of Medicine</em>. <strong>121</strong> (5): 426â€“32. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.amjmed.2008.01.040" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.amjmed.2008.01.040</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18456039" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18456039</a>.</span></div></li><li id="47" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Menon V, Shlipak MG, Wang X, Coresh J, Greene T, Stevens L, et al. (July 2007). <a href="http://www.annals.org/cgi/pmidlookup?view=reprint&amp;pmid=17606957" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cystatin C as a risk factor for outcomes in chronic kidney disease&quot;</a>. <em>Annals of Internal Medicine</em>. <strong>147</strong> (1): 19â€“27. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.7326%2F0003-4819-147-1-200707030-00004" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.7326/0003-4819-147-1-200707030-00004</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17606957" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17606957</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:31964826" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">31964826</a>.</span></div></li><li id="48" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Sarnak MJ, Katz R, Fried LF, Siscovick D, Kestenbaum B, Seliger S, et al. (January 2008). <a href="https://archive.today/20080607214016/http://archinte.ama-assn.org/cgi/pmidlookup?view=long&amp;pmid=18227360" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cystatin C and aging success&quot;</a>. <em>Archives of Internal Medicine</em>. <strong>168</strong> (2): 147â€“53. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1001%2Farchinternmed.2007.40" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1001/archinternmed.2007.40</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871318" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2871318</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18227360" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18227360</a>. Archived from <a href="http://archinte.ama-assn.org/cgi/pmidlookup?view=long&amp;pmid=18227360" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 2008-06-07.</span></div></li><li id="49" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">DjoussÃ© L, Kurth T, Gaziano JM (January 2008). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2179893" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cystatin C and risk of heart failure in the Physicians&#x27; Health Study (PHS)&quot;</a>. <em>American Heart Journal</em>. <strong>155</strong> (1): 82â€“6. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.ahj.2007.08.023" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.ahj.2007.08.023</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2179893" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2179893</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18082494" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18082494</a>.</span></div></li><li id="50" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">O&#x27;Hare AM, Newman AB, Katz R, Fried LF, Stehman-Breen CO, Seliger SL, et al. (2005). <a href="https://doi.org/10.1001%2Farchinte.165.22.2666" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study&quot;</a>. <em>Archives of Internal Medicine</em>. <strong>165</strong> (22): 2666â€“70. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1001%2Farchinte.165.22.2666" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1001/archinte.165.22.2666</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16344426" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16344426</a>.</span></div></li><li id="51" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Stevens LA, Levey AS (May 2005). &quot;Chronic kidney disease in the elderly--how to assess risk&quot;. <em>The New England Journal of Medicine</em>. <strong>352</strong> (20): 2122â€“4. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1056%2FNEJMe058035" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1056/NEJMe058035</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15901867" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15901867</a>.</span></div></li><li id="52" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Delanaye P, Cavalier E, Krzesinski JM (February 2008). <a href="http://orbi.ulg.ac.be/handle/2268/4787" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cystatin C, renal function, and cardiovascular risk&quot;</a>. <em>Annals of Internal Medicine</em>. <strong>148</strong> (4): 323. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.7326%2F0003-4819-148-4-200802190-00023" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.7326/0003-4819-148-4-200802190-00023</a>. <span class="inline text-[1em] leading-7">hdl</span>:<a href="https://hdl.handle.net/2268%2F4787" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2268/4787</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18283218" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18283218</a>.</span></div></li><li id="53" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Norden AG, Lapsley M, Lee PJ, Pusey CD, Scheinman SJ, Tam FW, et al. (November 2001). <a href="https://doi.org/10.1046%2Fj.1523-1755.2001.00016.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Glomerular protein sieving and implications for renal failure in Fanconi syndrome&quot;</a>. <em>Kidney International</em>. <strong>60</strong> (5): 1885â€“92. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1046%2Fj.1523-1755.2001.00016.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1046/j.1523-1755.2001.00016.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11703607" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11703607</a>.</span></div></li><li id="54" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Tenstad O, Roald AB, Grubb A, Aukland K (August 1996). &quot;Renal handling of radiolabelled human cystatin C in the rat&quot;. <em>Scandinavian Journal of Clinical and Laboratory Investigation</em>. <strong>56</strong> (5): 409â€“14. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3109%2F00365519609088795" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3109/00365519609088795</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/8869663" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8869663</a>.</span></div></li><li id="55" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Grubb A, LindstrÃ¶m V, Jonsson M, BÃ¤ck SE, Ã…hlund T, Rippe B, Christensson A (July 2015). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487590" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: &#x27;Shrunken pore syndrome&#x27;&quot;</a>. <em>Scandinavian Journal of Clinical and Laboratory Investigation</em>. <strong>75</strong> (4): 333â€“40. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3109%2F00365513.2015.1025427" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3109/00365513.2015.1025427</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487590" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4487590</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/25919022" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">25919022</a>.</span></div></li><li id="56" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Grubb A (June 2020). <a href="https://doi.org/10.1016%2Fj.clinbiochem.2020.06.002" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options&quot;</a>. <em>Clinical Biochemistry</em>. Online ahead of print: 12â€“20. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.clinbiochem.2020.06.002" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.clinbiochem.2020.06.002</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/32544475" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">32544475</a>.</span></div></li><li id="57" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Levy E, Lopez-Otin C, Ghiso J, Geltner D, Frangione B (May 1989). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189307" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases&quot;</a>. <em>The Journal of Experimental Medicine</em>. <strong>169</strong> (5): 1771â€“8. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1084%2Fjem.169.5.1771" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1084/jem.169.5.1771</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189307" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2189307</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/2541223" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2541223</a>.</span></div></li><li id="58" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Levy E, Jaskolski M, Grubb A (January 2006). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095742" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal models&quot;</a>. <em>Brain Pathology</em>. <strong>16</strong> (1): 60â€“70. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fj.1750-3639.2006.tb00562.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/j.1750-3639.2006.tb00562.x</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095742" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8095742</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16612983" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16612983</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:21279341" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21279341</a>.</span></div></li><li id="59" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Janowski R, Kozak M, Janowska E, Grzonka Z, Grubb A, Abrahamson M, et al. (April 2001). <a href="https://lup.lub.lu.se/record/131360" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping&quot;</a>. <em>Nature Structural Biology</em>. <strong>8</strong> (4): 316â€“320. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2F86188" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/86188</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11276250" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11276250</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:28916747" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">28916747</a>.</span></div></li><li id="60" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Janowski R, Kozak M, Abrahamson M, Grubb A, Jaskolski M (Nov 2005). &quot;Glomerular protein sieving and implications for renal failure in Fanconi syndrome&quot;. <em>Proteins</em>. <strong>61</strong> (3): 570â€“578â€“92. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Fprot.20633" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/prot.20633</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16170782" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16170782</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:633348" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">633348</a>.</span></div></li><li id="61" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Chrabaszczewska M, Sieradzan AK, Rodziewicz-MotowidÅ‚o S, Grubb A, Dobson CM, Kunita JR, Kozak M (Aug 2020). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461555" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Structural characterization of covalently stabilized human cystatin C oligomers&quot;</a>. <em>International Journal of Molecular Sciences</em>. <strong>21</strong> (5860): 5860. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3390%2Fijms21165860" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3390/ijms21165860</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461555" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">7461555</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/32824145" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">32824145</a>.</span></div></li><li id="62" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Mi W, Pawlik M, Sastre M, Jung SS, Radvinsky DS, Klein AM, et al. (December 2007). &quot;Cystatin C inhibits amyloid-beta deposition in Alzheimer&#x27;s disease mouse models&quot;. <em>Nature Genetics</em>. <strong>39</strong> (12): 1440â€“2. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fng.2007.29" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/ng.2007.29</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18026100" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18026100</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:21332698" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21332698</a>.</span></div></li><li id="63" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kaeser SA, Herzig MC, Coomaraswamy J, Kilger E, Selenica ML, Winkler DT, et al. (December 2007). &quot;Cystatin C modulates cerebral beta-amyloidosis&quot;. <em>Nature Genetics</em>. <strong>39</strong> (12): 1437â€“9. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fng.2007.23" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/ng.2007.23</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18026102" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18026102</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:7001526" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">7001526</a>.</span></div></li><li id="64" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (January 2007). &quot;Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database&quot;. <em>Nature Genetics</em>. <strong>39</strong> (1): 17â€“23. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fng1934" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/ng1934</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17192785" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17192785</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:452851" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">452851</a>.</span></div></li><li id="65" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Chuo LJ, Sheu WH, Pai MC, Kuo YM (2007). <a href="https://www.karger.com/Article/PDF/000100021" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease&quot;</a>. <em>Dementia and Geriatric Cognitive Disorders</em>. <strong>23</strong> (4): 251â€“7. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1159%2F000100021" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1159/000100021</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17310123" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17310123</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:29689590" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">29689590</a>.</span></div></li><li id="66" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Del Boccio P, Pieragostino D, Lugaresi A, Di Ioia M, Pavone B, Travaglini D, et al. (August 2007). &quot;Cleavage of cystatin C is not associated with multiple sclerosis&quot;. <em>Annals of Neurology</em>. <strong>62</strong> (2): 201â€“4, discussion 205. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Fana.20968" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/ana.20968</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17006926" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17006926</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:10687960" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10687960</a>.</span></div></li><li id="67" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, et al. (November 1999). <a href="https://dash.harvard.edu/bitstream/handle/1/13506934/Cystatin%20C%20deficiency%20in%20human%20atherosclerosis.pdf?sequence=1" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cystatin C deficiency in human atherosclerosis and aortic aneurysms&quot;</a> (PDF). <em>The Journal of Clinical Investigation</em>. <strong>104</strong> (9): 1191â€“7. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1172%2FJCI7709" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1172/JCI7709</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC409823" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">409823</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/10545518" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10545518</a>.</span></div></li><li id="68" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Abisi S, Burnand KG, Waltham M, Humphries J, Taylor PR, Smith A (December 2007). <a href="https://doi.org/10.1016%2Fj.jvs.2007.08.015" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cysteine protease activity in the wall of abdominal aortic aneurysms&quot;</a>. <em>Journal of Vascular Surgery</em>. <strong>46</strong> (6): 1260â€“6. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.jvs.2007.08.015" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.jvs.2007.08.015</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18155003" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18155003</a>.</span></div></li><li id="69" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Abdul-Hussien H, Soekhoe RG, Weber E, von der ThÃ¼sen JH, Kleemann R, Mulder A, et al. (March 2007). <a href="http://ajp.amjpathol.org/cgi/pmidlookup?view=long&amp;pmid=17322367" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases&quot;</a>. <em>The American Journal of Pathology</em>. <strong>170</strong> (3): 809â€“17. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.2353%2Fajpath.2007.060522" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.2353/ajpath.2007.060522</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1864891" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1864891</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17322367" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17322367</a>.</span></div></li><li id="70" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Gacko M, Chyczewski L, Chrostek L (1999). &quot;Distribution, activity and concentration of cathepsin B and cystatin C in the wall of aortic aneurysm&quot;. <em>Polish Journal of Pathology</em>. <strong>50</strong> (2): 83â€“6. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/10481531" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10481531</a>.</span></div></li><li id="71" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Eriksson P, Jones KG, Brown LC, Greenhalgh RM, Hamsten A, Powell JT (January 2004). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439999" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Genetic approach to the role of cysteine proteases in the expansion of abdominal aortic aneurysms&quot;</a>. <em>The British Journal of Surgery</em>. <strong>91</strong> (1): 86â€“9. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Fbjs.4364" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/bjs.4364</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439999" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11439999</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/14716800" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">14716800</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:45363107" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">45363107</a>.</span></div></li><li id="72" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Lindholt JS, Erlandsen EJ, Henneberg EW (November 2001). <a href="https://doi.org/10.1046%2Fj.0007-1323.2001.01911.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms&quot;</a>. <em>The British Journal of Surgery</em>. <strong>88</strong> (11): 1472â€“5. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1046%2Fj.0007-1323.2001.01911.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1046/j.0007-1323.2001.01911.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11683743" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11683743</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:42364814" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">42364814</a>.</span></div></li><li id="73" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Zurdel J, Finckh U, Menzer G, Nitsch RM, Richard G (February 2002). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1771004" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;CST3 genotype associated with exudative age related macular degeneration&quot;</a>. <em>The British Journal of Ophthalmology</em>. <strong>86</strong> (2): 214â€“9. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1136%2Fbjo.86.2.214" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1136/bjo.86.2.214</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1771004" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1771004</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11815350" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11815350</a>.</span></div></li><li id="74" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Im E, Kazlauskas A (March 2007). &quot;The role of cathepsins in ocular physiology and pathology&quot;. <em>Experimental Eye Research</em>. <strong>84</strong> (3): 383â€“8. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.exer.2006.05.017" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.exer.2006.05.017</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16893541" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16893541</a>.</span></div></li><li id="75" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Strojan P, Oblak I, Svetic B, Smid L, Kos J (May 2004). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409457" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis&quot;</a>. <em>British Journal of Cancer</em>. <strong>90</strong> (10): 1961â€“8. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fsj.bjc.6601830" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/sj.bjc.6601830</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409457" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2409457</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15138478" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15138478</a>.</span></div></li><li id="76" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kos J, Krasovec M, Cimerman N, Nielsen HJ, Christensen IJ, BrÃ¼nner N (February 2000). <a href="http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=long&amp;pmid=10690531" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis&quot;</a>. <em>Clinical Cancer Research</em>. <strong>6</strong> (2): 505â€“11. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/10690531" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10690531</a>.</span></div></li><li id="77" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Strevens H, Wide-Swensson D, Grubb A, Hansen A, Horn T, Ingemarsson I, et al. (September 2003). <a href="https://doi.org/10.1111%2Fj.1471-0528.2003.02051.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies&quot;</a>. <em>BJOG</em>. <strong>110</strong> (9): 825â€“30. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fj.1471-0528.2003.02051.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/j.1471-0528.2003.02051.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/14511964" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">14511964</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:26686328" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">26686328</a>.</span></div></li><li id="78" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Franceschini N, Qiu C, Barrow DA, Williams MA (2008). &quot;Cystatin C and preeclampsia: a case control study&quot;. <em>Renal Failure</em>. <strong>30</strong> (1): 89â€“95. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1080%2F08860220701742229" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1080/08860220701742229</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18197549" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18197549</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:205592849" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">205592849</a>.</span></div></li><li id="79" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kristensen K, Wide-Swensson D, Schmidt C, Blirup-Jensen S, LindstrÃ¶m V, Strevens H, Grubb A (2007). <a href="https://doi.org/10.1080%2F00016340701318133" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cystatin C, beta-2-microglobulin and beta-trace protein in pre-eclampsia&quot;</a>. <em>Acta Obstetricia et Gynecologica Scandinavica</em>. <strong>86</strong> (8): 921â€“6. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1080%2F00016340701318133" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1080/00016340701318133</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17653875" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17653875</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:45055267" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">45055267</a>.</span></div></li><li id="80" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kristensen K, Larsson I, Hansson SR (March 2007). <a href="https://doi.org/10.1093%2Fmolehr%2Fgal111" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Increased cystatin C expression in the pre-eclamptic placenta&quot;</a>. <em>Molecular Human Reproduction</em>. <strong>13</strong> (3): 189â€“95. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1093%2Fmolehr%2Fgal111" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1093/molehr/gal111</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17227816" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17227816</a>.</span></div></li><li id="https://www.mayocliniclabs.com/test-catalog/overview/614154" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mayocliniclabs.com/test-catalog/overview/614154" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mayocliniclabs.com/test-catalog/overview/614154</a></span></div></li><li id="https://www.mdsave.com/procedures/creatinine-blood/d786f9c4" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mdsave.com/procedures/creatinine-blood/d786f9c4" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mdsave.com/procedures/creatinine-blood/d786f9c4</a></span></div></li><li id="https://www.findlabtest.com/lab-test/general-wellness/creatinine-labcorp-001370" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.findlabtest.com/lab-test/general-wellness/creatinine-labcorp-001370" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.findlabtest.com/lab-test/general-wellness/creatinine-labcorp-001370</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S246802492031785X" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S246802492031785X" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S246802492031785X</a></span></div></li><li id="https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf</a></span></div></li><li id="https://www.kidney.org/atoz/content/gfr" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.kidney.org/atoz/content/gfr" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.kidney.org/atoz/content/gfr</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK507821/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK507821/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK507821/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/18295054/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/18295054/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/18295054/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/18374694/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/18374694/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/18374694/</a></span></div></li><li id="92" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/gene?Db=gene&amp;Cmd=ShowDetailView&amp;TermToSearch=1471" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Entrez Gene: CST3 cystatin C (amyloid angiopathy and cerebral hemorrhage)&quot;</a>.</span></div></li><li id="93" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Hwang SJ, Yang Q, Meigs JB, Pearce EN, Fox CS (September 2007). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1995611" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;A genome-wide association for kidney function and endocrine-related traits in the NHLBI&#x27;s Framingham Heart Study&quot;</a>. <em>BMC Medical Genetics</em>. <strong>8</strong> (Suppl 1): S10. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1186%2F1471-2350-8-S1-S10" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1186/1471-2350-8-S1-S10</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1995611" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1995611</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17903292" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17903292</a>.</span></div></li><li id="94" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Janowski R, Kozak M, Jankowska E, Grzonka Z, Grubb A, Abrahamson M, Jaskolski M (April 2001). <a href="http://portal.research.lu.se/ws/files/4833049/624200.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping&quot;</a> (PDF). <em>Nature Structural Biology</em>. <strong>8</strong> (4): 316â€“20. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2F86188" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/86188</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11276250" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11276250</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:28916747" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">28916747</a>.</span></div></li><li id="https://doi.org/10.3181/00379727-107-26569" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://doi.org/10.3181/00379727-107-26569" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://doi.org/10.3181/00379727-107-26569</a></span></div></li><li id="96" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">LÃ¶fberg H, Grubb AO (November 1979). &quot;Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system&quot;. <em>Scandinavian Journal of Clinical and Laboratory Investigation</em>. <strong>39</strong> (7): 619â€“26. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3109%2F00365517909108866" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3109/00365517909108866</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/119302" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">119302</a>.</span></div></li><li id="https://doi.org/10.1016/0006-291X(84)91300-20" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://doi.org/10.1016/0006-291X(84)91300-20" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://doi.org/10.1016/0006-291X(84)91300-20</a></span></div></li><li id="97" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Grubb A, Simonsen O, Sturfelt G, Truedsson L, Thysell H (1985). &quot;Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate&quot;. <em>Acta Medica Scandinavica</em>. <strong>218</strong> (5): 499â€“503. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fj.0954-6820.1985.tb08880.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/j.0954-6820.1985.tb08880.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/3911736" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3911736</a>.</span></div></li><li id="98" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Simonsen O, Grubb A, Thysell H (April 1985). &quot;The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate&quot;. <em>Scandinavian Journal of Clinical and Laboratory Investigation</em>. <strong>45</strong> (2): 97â€“101. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3109%2F00365518509160980" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3109/00365518509160980</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/3923607" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3923607</a>.</span></div></li><li id="https://doi.org/10.1056/NEJMoa1114248" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://doi.org/10.1056/NEJMoa1114248" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://doi.org/10.1056/NEJMoa1114248</a></span></div></li></ol></div><div class="text-fg-secondary text-xs [&amp;_*]:mb-2"><hr class="border-border-l1 my-8 rounded-sm border-t"/>
<span class="mb-4 block break-words text-[1em] leading-7">The content is adapted from <a href="https://en.wikipedia.org/wiki/Cystatin_C" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Wikipedia</a>, licensed under Creative Commons Attribution-ShareAlike 4.0 License.</span></div></div></div><div class="hidden min-[1400px]:block"></div></div></div><!--$--><!--/$--><div role="region" aria-label="Notifications (F8)" tabindex="-1" style="pointer-events:none"><ol tabindex="-1" class="pointer-events-none fixed top-0 z-[100] flex max-h-screen w-full flex-col-reverse p-4 max-sm:left-0 sm:bottom-0 sm:right-0 sm:top-auto sm:max-w-[420px] sm:flex-col pl-16 pr-2 pt-16 sm:px-4"></ol></div><script type="application/json" id="server-client-data-experimentation">{"status":"uninitialized"}</script><script src="/_next/static/chunks/webpack-e121ed42680f327e.js" nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4" id="_R_" async=""></script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">(self.__next_f=self.__next_f||[]).push([0])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"1:\"$Sreact.fragment\"\n3:I[91363,[],\"\"]\n4:I[23775,[],\"\"]\n5:I[57654,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"PageHeaderProvider\"]\n6:I[17618,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"HeaderContent\"]\n7:I[25529,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"6751\",\"static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js\"],\"default\"]\n9:I[6666,[],\"OutletBoundary\"]\nb:I[80415,[],\"AsyncMetadataOutlet\"]\nd:I[6666,[],\"ViewportBoundary\"]\nf:I[6666,[],\"MetadataBoundary\"]\n10:\"$Sreact.suspense\"\n12:I[95909,[\"4219\",\"static/chunks/app/global-error-4d07d20223cd4b4c.js\"],\"default\"]\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"13:I[51498,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"ConstantsProvider\"]\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"14:I[91073,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"15:I[38642,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"16:I[99648,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"17:I[78825,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"18:I[8550,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MixpanelProvider\"]\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"19:I[12290,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MobileTocProvider\"]\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"1a:I[53947,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"NuqsAdapter\"]\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"1b:I[91873,[\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8039\",\"static/chunks/app/error-4a29e9399afba038.js\"],\"default\"]\n1c:I[5091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"4345\",\"static/chunks/app/not-found-dd95690acf732f18.js\"],\"default\"]\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"1d:I[16091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,":HL[\"/_next/static/media/1f2316909698f815.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/3d4419af2cf8609b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/4dec29efcaeb336c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/74452ea3ef0f9101.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/904ef0a86fe32a00.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/d886a03bcda7ad8f.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/e1447589d6f59c4b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/f5a90156f8995c8c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/css/62c4caba71dfda84.css\",\"style\",{\"nonce\":\"ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4\"}]\n:HL[\"/_next/static/css/eb3d87f98fe1565f.css\",\"style\",{\"nonce\":\"ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4\"}]\n:HL[\"/_next/static/css/1b5e561215938d4d.css\",\"style\",{\"nonce\":\"ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4\"}]\n:HL[\"/_next/static/css/0227d069a630d414.css\",\"style\",{\"nonce\":\"ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4\"}]\n:HL[\"/_next/static/css/f87fff2ab93d05a7.css\",\"style\",{\"nonce\":\"ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4\"}]\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"0:{\"P\":null,\"b\":\"BpM29AX4fmgcUxZ_6t0le\",\"p\":\"\",\"c\":[\"\",\"page\",\"Cystatin_C\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"page\",{\"children\":[[\"slug\",\"Cystatin_C\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/62c4caba71dfda84.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/eb3d87f98fe1565f.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4\"}],[\"$\",\"link\",\"2\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/1b5e561215938d4d.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4\"}],[\"$\",\"link\",\"3\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/0227d069a630d414.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4\"}]],\"$L2\"]}],{\"children\":[\"page\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"Cystatin_C\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L5\",null,{\"children\":[[\"$\",\"$L6\",null,{\"maxWidth\":\"full\",\"mobileOptions\":{\"right\":{\"showFixedIssues\":true,\"showThemeSwitcher\":true,\"showSearch\":true,\"showTableOfContents\":true}}}],[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L7\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$L8\",[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/f87fff2ab93d05a7.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4\"}]],[\"$\",\"$L9\",null,{\"children\":[\"$La\",[\"$\",\"$Lb\",null,{\"promise\":\"$@c\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$Ld\",null,{\"children\":\"$Le\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$Lf\",null,{\"children\":[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$10\",null,{\"fallback\":null,\"children\":\"$L11\"}]}]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$12\",[]],\"s\":false,\"S\":false}\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"2:[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"bg-surface-base antialiased\",\"suppressHydrationWarning\":true,\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"title\",null,{\"children\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"type\":\"image/x-icon\",\"href\":\"/favicon.ico\",\"sizes\":\"48x48\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-dark.png\",\"media\":\"(prefers-color-scheme: light)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-light.png\",\"media\":\"(prefers-color-scheme: dark)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"apple-touch-icon\",\"href\":\"/icon-192x192.png\"}],[\"$\",\"link\",null,{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\"}],[\"$\",\"meta\",null,{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",null,{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"meta\",null,{\"property\":\"og:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"property\":\"og:url\",\"content\":\"https://grokipedia.com\"}],[\"$\",\"meta\",null,{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:locale\",\"content\":\"en_US\"}],[\"$\",\"meta\",null,{\"property\":\"og:type\",\"content\":\"website\"}],[\"$\",\"meta\",null,{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:alt\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}]]}],[\"$\",\"body\",null,{\"className\":\"flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b\",\"children\":[[\"$\",\"$L13\",null,{\"children\":[\"$\",\"$L14\",null,{\"children\":[\"$\",\"$L15\",null,{\"defaultTheme\":\"dark\",\"nonce\":\"ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4\",\"children\":[\"$\",\"$L16\",null,{\"children\":[\"$\",\"$L17\",null,{\"children\":[\"$\",\"$L18\",null,{\"children\":[\"$\",\"$L19\",null,{\"children\":[\"$\",\"$L1a\",null,{\"children\":[[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$1b\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L1c\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}],[\"$\",\"$L1d\",null,{}]]}]}]}]}]}]}]}]}],[\"$\",\"script\",null,{\"type\":\"application/json\",\"id\":\"server-client-data-experimentation\",\"children\":\"{\\\"status\\\":\\\"uninitialized\\\"}\"}]]}]]}]\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"e:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1, interactive-widget=resizes-content\"}]]\na:null\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"1e:I[42712,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"HydrationBoundary\"]\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"21:I[6367,[],\"IconMark\"]\n1f:T4337,"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"# Cystatin C\n\n**Cystatin C** or **cystatin 3** (formerly **gamma trace**, post-gamma-globulin, or neuroendocrine basic polypeptide), a protein encoded by the **CST3** gene, is mainly used as a biomarker of kidney function.[95] It has been investigated for its role in predicting new-onset or deteriorating cardiovascular disease. It has also been implicated in brain disorders involving amyloid (a specific type of protein deposition), such as Alzheimer's disease. In humans, all cells with a nucleus (cell core containing the DNA) produce cystatin C as a chain of 120 amino acids. It is found in virtually all tissues and body fluids. It is a potent inhibitor of lysosomal proteinases (enzymes from a special subunit of the cell that break down proteins) and one of the most important extracellular inhibitors of cysteine proteases (it prevents the breakdown of proteins outside the cell by a specific type of protein-degrading enzymes). The 2024 KDIGO guidelines recommend its use alongside creatinine for improved glomerular filtration rate estimation in certain clinical scenarios, such as obesity or malignancy.[](https://kdigo.org/guidelines/ckd-evaluation-and-management/) Cystatin C belongs to the type 2 cystatin gene family.\n# Role in Medicine\n\n### Kidney function\n\n[Glomerular filtration rate](Renal_function \"Renal function\") (GFR), a marker of kidney health, is most accurately measured by injecting compounds such as [inulin](Inulin \"Inulin\"), [radioisotopes](Radioisotope \"Radioisotope\") such as 51chromium-[EDTA](EDTA \"EDTA\"), 125I-iothalamate, 99mTc-[DTPA](DTPA \"DTPA\") or [radiocontrast agents](Radiocontrast_agent \"Radiocontrast_agent\") such as [iohexol](Iohexol \"Iohexol\"), but these techniques are complicated, costly, time-consuming and have potential side-effects.[6][7] [Creatinine](Creatinine \"Creatinine\") is the most widely used [biomarker](Biomarker \"Biomarker\") of kidney function. It is inaccurate at detecting mild renal impairment, and levels can vary with muscle mass but not with protein intake. Urea levels might change with protein intake.[8] Formulas such as the Cockcroft and Gault formula and the MDRD formula (see [Renal function](Renal_function \"Renal function\")) try to adjust for these variables. \n\nCystatin C has a low [molecular weight](Molecular_weight \"Molecular weight\") (approximately 13.3 [kilodaltons](Kilodalton \"Kilodalton\")), and it is removed from the bloodstream by [glomerular filtration](Glomerular_filtration \"Glomerular filtration\") in the kidneys. If kidney function and glomerular filtration rate decline, the blood levels of cystatin C rise. [Cross-sectional studies](Cross-sectional_study \"Cross-sectional study\") (based on a single point in time) suggest that serum levels of cystatin C are a more precise test of kidney function (as represented by the [glomerular filtration rate](Glomerular_filtration_rate \"Glomerular filtration rate\"), GFR) than serum creatinine levels.[7][9] [Longitudinal studies](Longitudinal_study \"Longitudinal study\") (following cystatin C over time) are sparse, but some show promising results.[10][11][12] Although studies are somewhat divergent, most studies find that cystatin C levels are less dependent on age, gender, ethnicity, diet, and muscle mass compared to creatinine,[13][14] and that cystatin C is equal or superior to the other available biomarkers in a range of different patient populations, including diabetic patients, in [chronic kidney disease](Chronic_kidney_disease \"Chronic kidney disease\") (CKD), and after kidney transplant.[15] It has been suggested that cystatin C might predict the risk of developing CKD, thereby signaling a state of 'preclinical' kidney dysfunction.[16] Additionally, the age-related rise in serum cystatin C is a powerful predictor of adverse age-related health outcomes, including all-cause mortality, death from cardiovascular disease, [multimorbidity](Multimorbidity \"Multimorbidity\"), and declining physical and cognitive function.[17] The 2014 UK's [National Institute for Health and Care Excellence](National_Institute_for_Health_and_Care_Excellence \"National Institute for Health and Care Excellence\") (NICE) guideline (CG182) for the assessment and management of CKD in adults concluded that using serum cystatin C to estimate GFR is more specific for important disease outcomes than use of serum creatinine, and may reduce overdiagnosis in patients with a borderline diagnosis, reducing unnecessary appointments, patient worries, and the overall burden of CKD in the population.[18] The updated NICE guideline (NG203, 2021; last reviewed 2025) does not address cystatin C. More recent international guidelines, such as the KDIGO 2024 Clinical Practice Guideline for CKD, recommend using creatinine-based eGFR but adding cystatin C when available for improved accuracy, particularly in combination (eGFRcr-cys), to strengthen risk assessment.[](https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline-Executive-Summary.pdf)\n\nStudies have also investigated cystatin C as a marker of kidney function in the adjustment of medication dosages.[19][20]\n\nCystatin C levels have been reported to be altered in patients with cancer,[21][22][23] (even subtle) thyroid dysfunction[24][25][26] and glucocorticoid therapy in some[27][28] but not all[29] situations. Other reports have found that levels are influenced by [cigarette smoking](Cigarette_smoking \"Cigarette smoking\") and levels of [C-reactive protein](C-reactive_protein \"C-reactive protein\").[30] However, inflammation does not cause an increase in the production of cystatin C, since elective surgical procedures, producing a strong inflammatory response in patients, do not change the plasma concentration of cystatin C. Levels seem to be increased in [HIV](HIV \"HIV\") infection, which might or might not reflect actual renal dysfunction.[31][32][33] The role of cystatin C to monitor GFR during pregnancy remains controversial.[34][35] Like creatinine, the elimination of cystatin C via routes other than the kidney increases with worsening GFR.[36]\n\n### Death and cardiovascular disease\n\nKidney dysfunction increases the risk of death and cardiovascular disease.[37][38] Several studies have found that increased levels of cystatin C are associated with the risk of death, several types of cardiovascular disease (including [myocardial infarction](Myocardial_infarction \"Myocardial infarction\"), [stroke](Stroke \"Stroke\"), [heart failure](Heart_failure \"Heart failure\"), [peripheral arterial disease](Peripheral_arterial_disease \"Peripheral arterial disease\") and [metabolic syndrome](Metabolic_syndrome \"Metabolic syndrome\")) and healthy aging. Some studies have found cystatin C to be better in this regard than serum creatinine or creatinine-based GFR equations.[39][40][41][42][43][44][45][46][47][48][49][50] Because the association of cystatin C with long term outcomes has appeared stronger than what could be expected for GFR, it has been hypothesized that cystatin C might also be linked to mortality in a way independent of kidney function.[51] In keeping with its [housekeeping gene](Housekeeping_gene \"Housekeeping gene\") properties, it has been suggested that cystatin C might be influenced by the [basal metabolic rate](Basal_metabolic_rate \"Basal metabolic rate\").[52]\n\n### Proposed shrunken pore syndrome\n\nThe glomerular sieving coefficients for 10â€“30 kDa plasma proteins in the human kidney are relatively high with coefficients between 0.9 and 0.07.[53] These relatively high sieving coefficients, combined with the high production of ultrafiltrate in health, means that proteins less than or equal to 30 kDa in plasma normally are mainly cleared by the kidneys and at least 85% of the clearance of cystatin C occurs in the kidney.[54] If the pores of the glomerular membrane shrink, the filtration of bigger molecules, e.g. cystatin C, will decrease, whereas the filtration of small molecules, like water and creatinine, will be less affected. In this case, cystatin C-based estimates of GFR, eGFRcystatin C, will be lower than creatinine-based estimates eGFRcreatinine, so that a hypothesized condition, named [shrunken pore syndrome](Shrunken_pore_syndrome \"Shrunken pore syndrome\"), is identified by a low eGFRcystatin C/eGFRcreatinine-ratio.[55] This syndrome is associated with a very strong increase in mortality.[56]\n\n### Neurologic disorders\n\n[Mutations](Mutation \"Mutation\") in the cystatin 3 [gene](Gene \"Gene\") are responsible for the [Icelandic](Iceland \"Iceland\") type of [hereditary cerebral amyloid angiopathy](Hereditary_cystatin_C_amyloid_angiopathy \"Hereditary cystatin C amyloid angiopathy\"), a condition predisposing to [intracerebral haemorrhage](Intracerebral_haemorrhage \"Intracerebral haemorrhage\"), [stroke](Stroke \"Stroke\") and [dementia](Dementia \"Dementia\").[57][58] The condition is inherited in a [dominant fashion](Dominance_relationship \"Dominance relationship\"). The monomeric cystatin C forms dimers and oligomers by domain swapping[59] and the structures of both the dimers[60] and oligomers[61] have been determined. \n\nSince cystatin 3 also binds [amyloid Î²](Amyloid_%CE%B2 \"Amyloid Î²\") and reduces its aggregation and deposition, it is a potential target in [Alzheimer's disease](Alzheimer's_disease \"Alzheimer's disease\").[62][63] Although not all studies have confirmed this, the overall evidence is in favor of a role for CST3 as a susceptibility gene for Alzheimer's disease.[64] Cystatin C levels have been reported to be higher in subjects with Alzheimer's disease.[65]\n\nThe role of cystatin C in [multiple sclerosis](Multiple_sclerosis \"Multiple sclerosis\") and other [demyelinating diseases](Demyelinating_disease \"Demyelinating disease\") (characterized by a loss of the myelin nerve sheath) remains controversial.[66]\n\n### Other roles\n\nCystatin C levels are decreased in [atherosclerotic](Atherosclerosis \"Atherosclerosis\") (so-called 'hardening' of the arteries) and [aneurysmal](Aneurysm \"Aneurysm\") (saccular bulging) lesions of the [aorta](Aorta \"Aorta\").[67][68][69][70] Genetic and prognostic studies also suggest a role for cystatin C.[71][72] Breakdown of parts of the vessel wall in these conditions is thought to result from an imbalance between proteinases ([cysteine proteases](Cysteine_protease \"Cysteine protease\") and [matrix metalloproteinases](Matrix_metalloproteinase \"Matrix metalloproteinase\"), increased) and their inhibitors (such as cystatin C, decreased). \n\nA few studies have looked at the role of cystatin C or the CST3 gene in [age-related macular degeneration](Age-related_macular_degeneration \"Age-related macular degeneration\").[73][74] Cystatin C has also been investigated as a prognostic marker in several forms of cancer.[75][76] Its role in [pre-eclampsia](Pre-eclampsia \"Pre-eclampsia\") remains to be confirmed.[77][78][79][80]\n## Laboratory measurement\n\nCystatin C can be measured in a random sample of serum using immunoassays such as nephelometry or particle-enhanced turbidimetry.[](https://www.mayocliniclabs.com/test-catalog/overview/614154) It is more expensive than serum creatinine, typically costing $50â€“150 compared to $10â€“50 for the latter, which can be measured with a Jaffe reaction.[](https://www.mdsave.com/procedures/creatinine-blood/d786f9c4)[](https://www.findlabtest.com/lab-test/general-wellness/creatinine-labcorp-001370)\n\nSince 2010, cystatin C assays have been standardized using the International Federation of Clinical Chemistry (IFCC) reference material, improving comparability across laboratories.[](https://www.sciencedirect.com/science/article/pii/S246802492031785X) Cystatin C is incorporated into glomerular filtration rate (GFR) estimating equations, such as the CKD-EPI cystatin C equation (2021, race-free), recommended by KDIGO (2024) for confirming reduced eGFR when creatinine-based estimates are unreliable (e.g., in extremes of muscle mass).[](https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf) Chronic kidney disease (CKD) is diagnosed based on eGFR below 60 mL/min/1.73 mÂ² for â‰¥3 months, not direct cystatin C thresholds.[](https://www.kidney.org/atoz/content/gfr)\n\nReference values vary by age, sex, and population. Recent laboratory standards (e.g., Mayo Clinic, as of 2025) provide: for ages 18â€“49 years, 0.63â€“1.03 mg/L; for â‰¥50 years, 0.67â€“1.21 mg/L.[](https://www.mayocliniclabs.com/test-catalog/overview/614154) Values are generally lower in females than males and increase with age beyond 50. In pediatric patients, normal values decrease until the first year of life and stabilize; creatinine levels rise until puberty and vary by gender, complicating interpretation.[](https://www.ncbi.nlm.nih.gov/books/NBK507821/)\n\nHistorical data from NHANES III (1988â€“1994) reported a reference interval (1stâ€“99th percentile) of 0.57â€“1.12 mg/L overall, 0.55â€“1.18 mg/L for women, and 0.60â€“1.11 mg/L for men, with lower levels in non-Hispanic Blacks and Mexican Americans.[](https://pubmed.ncbi.nlm.nih.gov/18295054/) Using an older threshold of 1.09 mg/L (99th percentile in young healthy adults), prevalence of elevated cystatin C was 9.6% in normal-weight U.S. adults, higher in overweight and obese individuals; in those aged â‰¥60 and â‰¥80 years, 41% and \u003e50% had elevated levels, respectively (based on 1988â€“1994 data).[](https://pubmed.ncbi.nlm.nih.gov/18374694/)\n# Cystatin C\n\n## Molecular biology\n\nThe cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active [cysteine protease inhibitors](Cysteine_protease \"Cysteine protease\"), while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and the [kininogens](Kininogen \"Kininogen\"). The type 2 cystatin proteins are a class of cysteine proteinase inhibitors found in a variety of human fluids and secretions, where they appear to provide protective functions. The cystatin [locus](Gene_locus \"Gene locus\") on the short arm of [chromosome 20](Chromosome_20 \"Chromosome 20\") contains the majority of the type 2 cystatin genes and [pseudogenes](Pseudogene \"Pseudogene\"). \n\nThe CST3 gene is located in the cystatin locus and comprises 3 [exons](Exon \"Exon\") (coding regions, as opposed to [introns](Intron \"Intron\"), non-coding regions within a gene), spanning 4.3 [kilo-base pairs](Kilo-base_pair \"Kilo-base pair\"). It encodes the most abundant extracellular inhibitor of cysteine proteases. It is found in high concentrations in biological fluids and is expressed in virtually all organs of the body (CST3 is a [housekeeping gene](Housekeeping_gene \"Housekeeping gene\")). The highest levels are found in [semen](Semen \"Semen\"), followed by [breastmilk](Breastmilk \"Breastmilk\"), [tears](Tears \"Tears\") and [saliva](Saliva \"Saliva\"). The [hydrophobic](Hydrophobic \"Hydrophobic\") [leader sequence](Leader_sequence_\\(mRNA\\) \"Leader sequence \\(mRNA\\)\") indicates that the protein is normally secreted. There are three [polymorphisms](Polymorphism_\\(biology\\) \"Polymorphism \\(biology\\)\") in the [promoter](Promoter_\\(biology\\) \"Promoter \\(biology\\)\") region of the gene, resulting in two common variants.[92] Several [single nucleotide polymorphisms](Single_nucleotide_polymorphism \"Single nucleotide polymorphism\") have been associated with altered cystatin C levels.[93]\n\nCystatin C is a non-[glycosylated](Glycosylation \"Glycosylation\"), [basic](Base_\\(chemistry\\) \"Base \\(chemistry\\)\") protein ([isoelectric point](Isoelectric_point \"Isoelectric point\") at [pH](PH \"PH\") 9.3). The [crystal structure](Protein_structure \"Protein structure\") of cystatin C is characterized by a short [alpha helix](Alpha_helix \"Alpha helix\") and a long alpha helix which lies across a large antiparallel, five-[stranded](Beta_strand \"Beta strand\") [beta sheet](Beta_sheet \"Beta sheet\"). Like other type 2 cystatins, it has two [disulfide bonds](Disulfide_bond \"Disulfide bond\"). Around 50% of the molecules carry a [hydroxylated proline](Hydroxyproline \"Hydroxyproline\"). Cystatin C forms [dimers](Protein_dimer \"Protein dimer\") (molecule pairs) by exchanging subdomains; in the paired state, each half is made up of the long alpha helix and one beta strand of one partner, and four beta strands of the other partner.[94]\n## History\n\nCystatin C was first described as 'gamma-trace' in 1961 by J. Clausen as a trace protein in normal cerebrospinal fluid not found in serum.[](https://doi.org/10.3181/00379727-107-26569) Grubb and LÃ¶fberg first reported its amino acid sequence in 1982.[95] They noticed it was increased in patients with advanced kidney failure.[96] In 1984, it was renamed cystatin C due to its similarity to other cystatin protease inhibitors.[](https://doi.org/10.1016/0006-291X(84)91300-20) It was first proposed as a measure of glomerular filtration rate by Grubb and coworkers in 1985.[97][98]\n\nA study reported in the July 5, 2012, issue of the New England Journal of Medicine found that equations using serum creatinine and cystatin C provided more accurate estimates of GFR than creatinine alone.[](https://doi.org/10.1056/NEJMoa1114248)"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"8:[\"$\",\"$L1e\",null,{\"state\":{\"mutations\":[],\"queries\":[{\"dehydratedAt\":1761887278811,\"state\":{\"data\":{\"page\":{\"citations\":[{\"id\":\"1\",\"title\":\"_**a**_ _**b**_ _**c**_ [GRCh38: Ensembl release 89: ENSG00000101439](http://May2017.archive.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000101439) â€“ [Ensembl](Ensembl_genome_database_project \\\"Ensembl genome database project\\\"), May 2017\",\"description\":\"1. ^ _**a**_ _**b**_ _**c**_ [GRCh38: Ensembl release 89: ENSG00000101439](http://May2017.archive.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000101439) â€“ [Ensembl](Ensembl_genome_database_project \\\"Ensembl genome database project\\\"), May 2017\",\"url\":\"http://May2017.archive.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000101439\",\"favicon\":\"\"},{\"id\":\"2\",\"title\":\"_**a**_ _**b**_ _**c**_ [GRCm38: Ensembl release 89: ENSMUSG00000027447](http://May2017.archive.ensembl.org/Mus_musculus/Gene/Summary?db=core;g=ENSMUSG00000027447) â€“ [Ensembl](Ensembl_genome_database_project \\\"Ensembl genome database project\\\"), May 2017\",\"description\":\"2. ^ _**a**_ _**b**_ _**c**_ [GRCm38: Ensembl release 89: ENSMUSG00000027447](http://May2017.archive.ensembl.org/Mus_musculus/Gene/Summary?db=core;g=ENSMUSG00000027447) â€“ [Ensembl](Ensembl_genome_database_project \\\"Ensembl genome database project\\\"), May 2017\",\"url\":\"http://May2017.archive.ensembl.org/Mus_musculus/Gene/Summary?db=core;g=ENSMUSG00000027447\",\"favicon\":\"\"},{\"id\":\"3\",\"title\":\"** [\\\"Human PubMed Reference:\\\"](https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene\u0026cmd=Link\u0026LinkName=gene_pubmed\u0026from_uid=1471). _National Center for Biotechnology Information, U.S. National Library of Medicine_.\",\"description\":\"3. **^** [\\\"Human PubMed Reference:\\\"](https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene\u0026cmd=Link\u0026LinkName=gene_pubmed\u0026from_uid=1471). _National Center for Biotechnology Information, U.S. National Library of Medicine_.\",\"url\":\"https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene\u0026cmd=Link\u0026LinkName=gene_pubmed\u0026from_uid=1471\",\"favicon\":\"\"},{\"id\":\"4\",\"title\":\"** [\\\"Mouse PubMed Reference:\\\"](https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene\u0026cmd=Link\u0026LinkName=gene_pubmed\u0026from_uid=13010). _National Center for Biotechnology Information, U.S. National Library of Medicine_.\",\"description\":\"4. **^** [\\\"Mouse PubMed Reference:\\\"](https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene\u0026cmd=Link\u0026LinkName=gene_pubmed\u0026from_uid=13010). _National Center for Biotechnology Information, U.S. National Library of Medicine_.\",\"url\":\"https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene\u0026cmd=Link\u0026LinkName=gene_pubmed\u0026from_uid=13010\",\"favicon\":\"\"},{\"id\":\"5\",\"title\":\"** [\\\"Alzforum: AlzGene\\\"](https://web.archive.org/web/20041227020557/http://www.alzforum.org/res/com/gen/alzgene/geneoverview.asp?geneid=66). Archived from [the original](http://www.alzforum.org/res/com/gen/alzgene/geneoverview.asp?geneid=66) on 2004-12-27.\",\"description\":\"5. **^** [\\\"Alzforum: AlzGene\\\"](https://web.archive.org/web/20041227020557/http://www.alzforum.org/res/com/gen/alzgene/geneoverview.asp?geneid=66). Archived from [the original](http://www.alzforum.org/res/com/gen/alzgene/geneoverview.asp?geneid=66) on 2004-12-27.\",\"url\":\"https://web.archive.org/web/20041227020557/http://www.alzforum.org/res/com/gen/alzgene/geneoverview.asp?geneid=66\",\"favicon\":\"\"},{\"id\":\"6\",\"title\":\"** Zahran A, El-Husseini A, Shoker A (2007). [\\\"Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature review\\\"](https://www.karger.com/Article/PDF/000100907). _American Journal of Nephrology_. **27** (2): 197â€“205\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1159/000100907](https://doi.org/10.1159%2F000100907). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17361076](https://pubmed.ncbi.nlm.nih.gov/17361076). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [25523216](https://api.semanticscholar.org/CorpusID:25523216).\",\"description\":\"6. **^** Zahran A, El-Husseini A, Shoker A (2007). [\\\"Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature review\\\"](https://www.karger.com/Article/PDF/000100907). _American Journal of Nephrology_. **27** (2): 197â€“205\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1159/000100907](https://doi.org/10.1159%2F000100907). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17361076](https://pubmed.ncbi.nlm.nih.gov/17361076). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [25523216](https://api.semanticscholar.org/CorpusID:25523216).\",\"url\":\"https://www.karger.com/Article/PDF/000100907\",\"favicon\":\"\"},{\"id\":\"7\",\"title\":\"_**a**_ _**b**_ Roos JF, Doust J, Tett SE, Kirkpatrick CM (March 2007). \\\"Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children--a meta-analysis\\\". _Clinical Biochemistry_. **40** (5â€“6): 383â€“91\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.clinbiochem.2006.10.026](https://doi.org/10.1016%2Fj.clinbiochem.2006.10.026). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17316593](https://pubmed.ncbi.nlm.nih.gov/17316593).\",\"description\":\"7. ^ _**a**_ _**b**_ Roos JF, Doust J, Tett SE, Kirkpatrick CM (March 2007). \\\"Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children--a meta-analysis\\\". _Clinical Biochemistry_. **40** (5â€“6): 383â€“91\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.clinbiochem.2006.10.026](https://doi.org/10.1016%2Fj.clinbiochem.2006.10.026). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17316593](https://pubmed.ncbi.nlm.nih.gov/17316593).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"8\",\"title\":\"** King AJ, Levey AS (May 1993). [\\\"Dietary protein and renal function\\\"](http://jasn.asnjournals.org/cgi/pmidlookup?view=long\u0026pmid=8329667). _Journal of the American Society of Nephrology_. **3** (11): 1723â€“37\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1681/ASN.V3111723](https://doi.org/10.1681%2FASN.V3111723). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8329667](https://pubmed.ncbi.nlm.nih.gov/8329667).\",\"description\":\"8. **^** King AJ, Levey AS (May 1993). [\\\"Dietary protein and renal function\\\"](http://jasn.asnjournals.org/cgi/pmidlookup?view=long\u0026pmid=8329667). _Journal of the American Society of Nephrology_. **3** (11): 1723â€“37\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1681/ASN.V3111723](https://doi.org/10.1681%2FASN.V3111723). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8329667](https://pubmed.ncbi.nlm.nih.gov/8329667).\",\"url\":\"http://jasn.asnjournals.org/cgi/pmidlookup?view=long\u0026pmid=8329667\",\"favicon\":\"\"},{\"id\":\"9\",\"title\":\"** Dharnidharka VR, Kwon C, Stevens G (August 2002). \\\"Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis\\\". _American Journal of Kidney Diseases_. **40** (2): 221â€“6\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1053/ajkd.2002.34487](https://doi.org/10.1053%2Fajkd.2002.34487). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12148093](https://pubmed.ncbi.nlm.nih.gov/12148093).\",\"description\":\"9. **^** Dharnidharka VR, Kwon C, Stevens G (August 2002). \\\"Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis\\\". _American Journal of Kidney Diseases_. **40** (2): 221â€“6\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1053/ajkd.2002.34487](https://doi.org/10.1053%2Fajkd.2002.34487). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12148093](https://pubmed.ncbi.nlm.nih.gov/12148093).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"10\",\"title\":\"** Premaratne E, MacIsaac RJ, Finch S, Panagiotopoulos S, Ekinci E, Jerums G (May 2008). [\\\"Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes\\\"](http://care.diabetesjournals.org/cgi/pmidlookup?view=long\u0026pmid=18319326). _Diabetes Care_. **31** (5): 971â€“3\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2337/dc07-1588](https://doi.org/10.2337%2Fdc07-1588). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18319326](https://pubmed.ncbi.nlm.nih.gov/18319326).\",\"description\":\"10. **^** Premaratne E, MacIsaac RJ, Finch S, Panagiotopoulos S, Ekinci E, Jerums G (May 2008). [\\\"Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes\\\"](http://care.diabetesjournals.org/cgi/pmidlookup?view=long\u0026pmid=18319326). _Diabetes Care_. **31** (5): 971â€“3\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2337/dc07-1588](https://doi.org/10.2337%2Fdc07-1588). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18319326](https://pubmed.ncbi.nlm.nih.gov/18319326).\",\"url\":\"http://care.diabetesjournals.org/cgi/pmidlookup?view=long\u0026pmid=18319326\",\"favicon\":\"\"},{\"id\":\"11\",\"title\":\"** Perkins BA, Nelson RG, Ostrander BE, Blouch KL, Krolewski AS, Myers BD, Warram JH (May 2005). [\\\"Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2429917). _Journal of the American Society of Nephrology_. **16** (5): 1404â€“12\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1681/ASN.2004100854](https://doi.org/10.1681%2FASN.2004100854). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2429917](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2429917). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15788478](https://pubmed.ncbi.nlm.nih.gov/15788478).\",\"description\":\"11. **^** Perkins BA, Nelson RG, Ostrander BE, Blouch KL, Krolewski AS, Myers BD, Warram JH (May 2005). [\\\"Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2429917). _Journal of the American Society of Nephrology_. **16** (5): 1404â€“12\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1681/ASN.2004100854](https://doi.org/10.1681%2FASN.2004100854). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2429917](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2429917). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15788478](https://pubmed.ncbi.nlm.nih.gov/15788478).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2429917\",\"favicon\":\"\"},{\"id\":\"12\",\"title\":\"** Corrao AM, Lisi G, Di Pasqua G, Guizzardi M, Marino N, Ballone E, Chiesa PL (January 2006). \\\"Serum cystatin C as a reliable marker of changes in glomerular filtration rate in children with urinary tract malformations\\\". _The Journal of Urology_. **175** (1): 303â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0022-5347(05)00015-7](https://doi.org/10.1016%2FS0022-5347%2805%2900015-7). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16406933](https://pubmed.ncbi.nlm.nih.gov/16406933).\",\"description\":\"12. **^** Corrao AM, Lisi G, Di Pasqua G, Guizzardi M, Marino N, Ballone E, Chiesa PL (January 2006). \\\"Serum cystatin C as a reliable marker of changes in glomerular filtration rate in children with urinary tract malformations\\\". _The Journal of Urology_. **175** (1): 303â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0022-5347(05)00015-7](https://doi.org/10.1016%2FS0022-5347%2805%2900015-7). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16406933](https://pubmed.ncbi.nlm.nih.gov/16406933).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"13\",\"title\":\"** Onopiuk A, Tokarzewicz A, Gorodkiewicz E (2015). \\\"Cystatin C: a kidney function biomarker\\\". _Adv Clin Chem_. **68** : 57â€“69\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/bs.acc.2014.11.007](https://doi.org/10.1016%2Fbs.acc.2014.11.007). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25858868](https://pubmed.ncbi.nlm.nih.gov/25858868).\",\"description\":\"13. **^** Onopiuk A, Tokarzewicz A, Gorodkiewicz E (2015). \\\"Cystatin C: a kidney function biomarker\\\". _Adv Clin Chem_. **68** : 57â€“69\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/bs.acc.2014.11.007](https://doi.org/10.1016%2Fbs.acc.2014.11.007). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25858868](https://pubmed.ncbi.nlm.nih.gov/25858868).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"14\",\"title\":\"** Ferguson TW, Komenda P, Tangri N (May 2015). [\\\"Cystatin C as a biomarker for estimating glomerular filtration rate\\\"](https://doi.org/10.1097%2FMNH.0000000000000115). _Curr Opin Nephrol Hypertens_. **24** (3): 295â€“300\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1097/MNH.0000000000000115](https://doi.org/10.1097%2FMNH.0000000000000115). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26066476](https://pubmed.ncbi.nlm.nih.gov/26066476). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [27385](https://api.semanticscholar.org/CorpusID:27385).\",\"description\":\"14. **^** Ferguson TW, Komenda P, Tangri N (May 2015). [\\\"Cystatin C as a biomarker for estimating glomerular filtration rate\\\"](https://doi.org/10.1097%2FMNH.0000000000000115). _Curr Opin Nephrol Hypertens_. **24** (3): 295â€“300\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1097/MNH.0000000000000115](https://doi.org/10.1097%2FMNH.0000000000000115). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26066476](https://pubmed.ncbi.nlm.nih.gov/26066476). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [27385](https://api.semanticscholar.org/CorpusID:27385).\",\"url\":\"https://doi.org/10.1097%2FMNH.0000000000000115\",\"favicon\":\"\"},{\"id\":\"15\",\"title\":\"** Porto JR, Gomes KB, Fernandes AP, Domingueti CP (January 1, 2017). [\\\"Cystatin C: a promising biomarker to evaluate renal function\\\"](http://www.rbac.org.br/artigos/cystatin-c-promising-biomarker-to-evaluate-renal-function/). _Revista Brasileira de Analises Clinicas_. **49** (3). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.21877/2448-3877.201600446](https://doi.org/10.21877%2F2448-3877.201600446). Retrieved 18 November 2020.\",\"description\":\"15. **^** Porto JR, Gomes KB, Fernandes AP, Domingueti CP (January 1, 2017). [\\\"Cystatin C: a promising biomarker to evaluate renal function\\\"](http://www.rbac.org.br/artigos/cystatin-c-promising-biomarker-to-evaluate-renal-function/). _Revista Brasileira de Analises Clinicas_. **49** (3). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.21877/2448-3877.201600446](https://doi.org/10.21877%2F2448-3877.201600446). Retrieved 18 November 2020.\",\"url\":\"http://www.rbac.org.br/artigos/cystatin-c-promising-biomarker-to-evaluate-renal-function/\",\"favicon\":\"\"},{\"id\":\"16\",\"title\":\"** Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, et al. (August 2006). [\\\"Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease\\\"](http://www.annals.org/cgi/pmidlookup?view=reprint\u0026pmid=16908914). _Annals of Internal Medicine_. **145** (4): 237â€“46\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7326/0003-4819-145-4-200608150-00003](https://doi.org/10.7326%2F0003-4819-145-4-200608150-00003). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16908914](https://pubmed.ncbi.nlm.nih.gov/16908914). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [24679098](https://api.semanticscholar.org/CorpusID:24679098).\",\"description\":\"16. **^** Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, et al. (August 2006). [\\\"Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease\\\"](http://www.annals.org/cgi/pmidlookup?view=reprint\u0026pmid=16908914). _Annals of Internal Medicine_. **145** (4): 237â€“46\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7326/0003-4819-145-4-200608150-00003](https://doi.org/10.7326%2F0003-4819-145-4-200608150-00003). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16908914](https://pubmed.ncbi.nlm.nih.gov/16908914). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [24679098](https://api.semanticscholar.org/CorpusID:24679098).\",\"url\":\"http://www.annals.org/cgi/pmidlookup?view=reprint\u0026pmid=16908914\",\"favicon\":\"\"},{\"id\":\"17\",\"title\":\"** Justice JN, Ferrucci L, Newman AB, Aroda VR, Bahnson JL, Divers J, Espeland MA, Marcovina S, Pollak MN, Kritchevsky SB, Barzilai N, Kuchel GA (December 2018). [\\\"A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294728). _[Geroscience](Geroscience_\\\\(journal\\\\) \\\"Geroscience \\\\(journal\\\\)\\\")_. **40** (5â€“6): 419â€“436\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s11357-018-0042-y](https://doi.org/10.1007%2Fs11357-018-0042-y). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6294728](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294728). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30151729](https://pubmed.ncbi.nlm.nih.gov/30151729).\",\"description\":\"17. **^** Justice JN, Ferrucci L, Newman AB, Aroda VR, Bahnson JL, Divers J, Espeland MA, Marcovina S, Pollak MN, Kritchevsky SB, Barzilai N, Kuchel GA (December 2018). [\\\"A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294728). _[Geroscience](Geroscience_\\\\(journal\\\\) \\\"Geroscience \\\\(journal\\\\)\\\")_. **40** (5â€“6): 419â€“436\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s11357-018-0042-y](https://doi.org/10.1007%2Fs11357-018-0042-y). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6294728](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294728). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30151729](https://pubmed.ncbi.nlm.nih.gov/30151729).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294728\",\"favicon\":\"\"},{\"id\":\"18\",\"title\":\"** [\\\"Chronic kidney disease in adults: assessment and management\\\"](https://www.nice.org.uk/guidance/cg182/chapter/implementation-getting-started). _[National Institute for Health and Care Excellence](National_Institute_for_Health_and_Care_Excellence \\\"National Institute for Health and Care Excellence\\\") (NICE)_. 23 July 2014. Retrieved 18 November 2020.\",\"description\":\"18. **^** [\\\"Chronic kidney disease in adults: assessment and management\\\"](https://www.nice.org.uk/guidance/cg182/chapter/implementation-getting-started). _[National Institute for Health and Care Excellence](National_Institute_for_Health_and_Care_Excellence \\\"National Institute for Health and Care Excellence\\\") (NICE)_. 23 July 2014. Retrieved 18 November 2020.\",\"url\":\"https://www.nice.org.uk/guidance/cg182/chapter/implementation-getting-started\",\"favicon\":\"\"},{\"id\":\"19\",\"title\":\"** Hermida J, Tutor JC (June 2006). \\\"Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin\\\". _Therapeutic Drug Monitoring_. **28** (3): 326â€“31\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1097/01.ftd.0000211805.89440.3d](https://doi.org/10.1097%2F01.ftd.0000211805.89440.3d). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16778715](https://pubmed.ncbi.nlm.nih.gov/16778715). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [27219789](https://api.semanticscholar.org/CorpusID:27219789).\",\"description\":\"19. **^** Hermida J, Tutor JC (June 2006). \\\"Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin\\\". _Therapeutic Drug Monitoring_. **28** (3): 326â€“31\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1097/01.ftd.0000211805.89440.3d](https://doi.org/10.1097%2F01.ftd.0000211805.89440.3d). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16778715](https://pubmed.ncbi.nlm.nih.gov/16778715). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [27219789](https://api.semanticscholar.org/CorpusID:27219789).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"20\",\"title\":\"** SchÃ¼ck O, Teplan V, SibovÃ¡ J, StollovÃ¡ M (February 2004). \\\"Predicting the glomerular filtration rate from serum creatinine, serum cystatin C and the Cockcroft and Gault formula with regard to drug dosage adjustment\\\". _International Journal of Clinical Pharmacology and Therapeutics_. **42** (2): 93â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.5414/cpp42093](https://doi.org/10.5414%2Fcpp42093). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15180169](https://pubmed.ncbi.nlm.nih.gov/15180169).\",\"description\":\"20. **^** SchÃ¼ck O, Teplan V, SibovÃ¡ J, StollovÃ¡ M (February 2004). \\\"Predicting the glomerular filtration rate from serum creatinine, serum cystatin C and the Cockcroft and Gault formula with regard to drug dosage adjustment\\\". _International Journal of Clinical Pharmacology and Therapeutics_. **42** (2): 93â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.5414/cpp42093](https://doi.org/10.5414%2Fcpp42093). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15180169](https://pubmed.ncbi.nlm.nih.gov/15180169).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"21\",\"title\":\"** DemirtaÅŸ S, Akan O, Can M, Elmali E, Akan H (February 2006). \\\"Cystatin C can be affected by nonrenal factors: a preliminary study on leukemia\\\". _Clinical Biochemistry_. **39** (2): 115â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.clinbiochem.2005.10.009](https://doi.org/10.1016%2Fj.clinbiochem.2005.10.009). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16337174](https://pubmed.ncbi.nlm.nih.gov/16337174).\",\"description\":\"21. **^** DemirtaÅŸ S, Akan O, Can M, Elmali E, Akan H (February 2006). \\\"Cystatin C can be affected by nonrenal factors: a preliminary study on leukemia\\\". _Clinical Biochemistry_. **39** (2): 115â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.clinbiochem.2005.10.009](https://doi.org/10.1016%2Fj.clinbiochem.2005.10.009). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16337174](https://pubmed.ncbi.nlm.nih.gov/16337174).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"22\",\"title\":\"** Nakai K, Kikuchi M, Fujimoto K, Kaneko Y, Omori S, Nakai K, Suwabe A (April 2008). \\\"Serum levels of cystatin C in patients with malignancy\\\". _Clinical and Experimental Nephrology_. **12** (2): 132â€“139\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s10157-008-0043-8](https://doi.org/10.1007%2Fs10157-008-0043-8). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18317874](https://pubmed.ncbi.nlm.nih.gov/18317874). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [19326312](https://api.semanticscholar.org/CorpusID:19326312).\",\"description\":\"22. **^** Nakai K, Kikuchi M, Fujimoto K, Kaneko Y, Omori S, Nakai K, Suwabe A (April 2008). \\\"Serum levels of cystatin C in patients with malignancy\\\". _Clinical and Experimental Nephrology_. **12** (2): 132â€“139\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s10157-008-0043-8](https://doi.org/10.1007%2Fs10157-008-0043-8). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18317874](https://pubmed.ncbi.nlm.nih.gov/18317874). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [19326312](https://api.semanticscholar.org/CorpusID:19326312).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"23\",\"title\":\"** Kos J, Stabuc B, Cimerman N, BrÃ¼nner N (December 1998). [\\\"Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression\\\"](https://doi.org/10.1093%2Fclinchem%2F44.12.2556). _Clinical Chemistry_. **44** (12): 2556â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/clinchem/44.12.2556](https://doi.org/10.1093%2Fclinchem%2F44.12.2556). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9836733](https://pubmed.ncbi.nlm.nih.gov/9836733).\",\"description\":\"23. **^** Kos J, Stabuc B, Cimerman N, BrÃ¼nner N (December 1998). [\\\"Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression\\\"](https://doi.org/10.1093%2Fclinchem%2F44.12.2556). _Clinical Chemistry_. **44** (12): 2556â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/clinchem/44.12.2556](https://doi.org/10.1093%2Fclinchem%2F44.12.2556). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9836733](https://pubmed.ncbi.nlm.nih.gov/9836733).\",\"url\":\"https://doi.org/10.1093%2Fclinchem%2F44.12.2556\",\"favicon\":\"\"},{\"id\":\"24\",\"title\":\"** Fricker M, Wiesli P, BrÃ¤ndle M, Schwegler B, Schmid C (May 2003). [\\\"Impact of thyroid dysfunction on serum cystatin C\\\"](https://doi.org/10.1046%2Fj.1523-1755.2003.00925.x). _Kidney International_. **63** (5): 1944â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1046/j.1523-1755.2003.00925.x](https://doi.org/10.1046%2Fj.1523-1755.2003.00925.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12675875](https://pubmed.ncbi.nlm.nih.gov/12675875).\",\"description\":\"24. **^** Fricker M, Wiesli P, BrÃ¤ndle M, Schwegler B, Schmid C (May 2003). [\\\"Impact of thyroid dysfunction on serum cystatin C\\\"](https://doi.org/10.1046%2Fj.1523-1755.2003.00925.x). _Kidney International_. **63** (5): 1944â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1046/j.1523-1755.2003.00925.x](https://doi.org/10.1046%2Fj.1523-1755.2003.00925.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12675875](https://pubmed.ncbi.nlm.nih.gov/12675875).\",\"url\":\"https://doi.org/10.1046%2Fj.1523-1755.2003.00925.x\",\"favicon\":\"\"},{\"id\":\"25\",\"title\":\"** Manetti L, Pardini E, Genovesi M, Campomori A, Grasso L, Morselli LL, et al. (April 2005). [\\\"Thyroid function differently affects serum cystatin C and creatinine concentrations\\\"](https://web.archive.org/web/20080608033357/http://www.kurtis.it/abs/index.cfm?id_articolo_numero=3109). _Journal of Endocrinological Investigation_. **28** (4): 346â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/bf03347201](https://doi.org/10.1007%2Fbf03347201). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15966508](https://pubmed.ncbi.nlm.nih.gov/15966508). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [26777752](https://api.semanticscholar.org/CorpusID:26777752). Archived from [the original](http://www.kurtis.it/abs/index.cfm?id_articolo_numero=3109) on 2008-06-08.\",\"description\":\"25. **^** Manetti L, Pardini E, Genovesi M, Campomori A, Grasso L, Morselli LL, et al. (April 2005). [\\\"Thyroid function differently affects serum cystatin C and creatinine concentrations\\\"](https://web.archive.org/web/20080608033357/http://www.kurtis.it/abs/index.cfm?id_articolo_numero=3109). _Journal of Endocrinological Investigation_. **28** (4): 346â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/bf03347201](https://doi.org/10.1007%2Fbf03347201). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15966508](https://pubmed.ncbi.nlm.nih.gov/15966508). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [26777752](https://api.semanticscholar.org/CorpusID:26777752). Archived from [the original](http://www.kurtis.it/abs/index.cfm?id_articolo_numero=3109) on 2008-06-08.\",\"url\":\"https://web.archive.org/web/20080608033357/http://www.kurtis.it/abs/index.cfm?id_articolo_numero=3109\",\"favicon\":\"\"},{\"id\":\"26\",\"title\":\"** Wiesli P, Schwegler B, Spinas GA, Schmid C (December 2003). \\\"Serum cystatin C is sensitive to small changes in thyroid function\\\". _Clinica Chimica Acta; International Journal of Clinical Chemistry_. **338** (1â€“2): 87â€“90\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.cccn.2003.07.022](https://doi.org/10.1016%2Fj.cccn.2003.07.022). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [14637271](https://pubmed.ncbi.nlm.nih.gov/14637271).\",\"description\":\"26. **^** Wiesli P, Schwegler B, Spinas GA, Schmid C (December 2003). \\\"Serum cystatin C is sensitive to small changes in thyroid function\\\". _Clinica Chimica Acta; International Journal of Clinical Chemistry_. **338** (1â€“2): 87â€“90\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.cccn.2003.07.022](https://doi.org/10.1016%2Fj.cccn.2003.07.022). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [14637271](https://pubmed.ncbi.nlm.nih.gov/14637271).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"27\",\"title\":\"** Risch L, Herklotz R, Blumberg A, Huber AR (November 2001). [\\\"Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients\\\"](https://doi.org/10.1093%2Fclinchem%2F47.11.2055). _Clinical Chemistry_. **47** (11): 2055â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/clinchem/47.11.2055](https://doi.org/10.1093%2Fclinchem%2F47.11.2055). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11673383](https://pubmed.ncbi.nlm.nih.gov/11673383).\",\"description\":\"27. **^** Risch L, Herklotz R, Blumberg A, Huber AR (November 2001). [\\\"Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients\\\"](https://doi.org/10.1093%2Fclinchem%2F47.11.2055). _Clinical Chemistry_. **47** (11): 2055â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/clinchem/47.11.2055](https://doi.org/10.1093%2Fclinchem%2F47.11.2055). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11673383](https://pubmed.ncbi.nlm.nih.gov/11673383).\",\"url\":\"https://doi.org/10.1093%2Fclinchem%2F47.11.2055\",\"favicon\":\"\"},{\"id\":\"28\",\"title\":\"** Cimerman N, Brguljan PM, Krasovec M, Suskovic S, Kos J (October 2000). \\\"Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients\\\". _Clinica Chimica Acta; International Journal of Clinical Chemistry_. **300** (1â€“2): 83â€“95\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0009-8981(00)00298-9](https://doi.org/10.1016%2FS0009-8981%2800%2900298-9). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10958865](https://pubmed.ncbi.nlm.nih.gov/10958865).\",\"description\":\"28. **^** Cimerman N, Brguljan PM, Krasovec M, Suskovic S, Kos J (October 2000). \\\"Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients\\\". _Clinica Chimica Acta; International Journal of Clinical Chemistry_. **300** (1â€“2): 83â€“95\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0009-8981(00)00298-9](https://doi.org/10.1016%2FS0009-8981%2800%2900298-9). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10958865](https://pubmed.ncbi.nlm.nih.gov/10958865).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"29\",\"title\":\"** BÃ¶kenkamp A, van Wijk JA, Lentze MJ, Stoffel-Wagner B (July 2002). [\\\"Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations\\\"](https://doi.org/10.1093%2Fclinchem%2F48.7.1123). _Clinical Chemistry_. **48** (7): 1123â€“6\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/clinchem/48.7.1123](https://doi.org/10.1093%2Fclinchem%2F48.7.1123). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12089191](https://pubmed.ncbi.nlm.nih.gov/12089191).\",\"description\":\"29. **^** BÃ¶kenkamp A, van Wijk JA, Lentze MJ, Stoffel-Wagner B (July 2002). [\\\"Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations\\\"](https://doi.org/10.1093%2Fclinchem%2F48.7.1123). _Clinical Chemistry_. **48** (7): 1123â€“6\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/clinchem/48.7.1123](https://doi.org/10.1093%2Fclinchem%2F48.7.1123). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12089191](https://pubmed.ncbi.nlm.nih.gov/12089191).\",\"url\":\"https://doi.org/10.1093%2Fclinchem%2F48.7.1123\",\"favicon\":\"\"},{\"id\":\"30\",\"title\":\"** Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE (April 2004). [\\\"Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement\\\"](https://doi.org/10.1111%2Fj.1523-1755.2004.00517.x). _Kidney International_. **65** (4): 1416â€“21\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1523-1755.2004.00517.x](https://doi.org/10.1111%2Fj.1523-1755.2004.00517.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15086483](https://pubmed.ncbi.nlm.nih.gov/15086483).\",\"description\":\"30. **^** Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE (April 2004). [\\\"Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement\\\"](https://doi.org/10.1111%2Fj.1523-1755.2004.00517.x). _Kidney International_. **65** (4): 1416â€“21\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1523-1755.2004.00517.x](https://doi.org/10.1111%2Fj.1523-1755.2004.00517.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15086483](https://pubmed.ncbi.nlm.nih.gov/15086483).\",\"url\":\"https://doi.org/10.1111%2Fj.1523-1755.2004.00517.x\",\"favicon\":\"\"},{\"id\":\"31\",\"title\":\"** Odden MC, Scherzer R, Bacchetti P, Szczech LA, Sidney S, Grunfeld C, Shlipak MG (November 2007). [\\\"Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study\\\"](https://archive.today/20080607214011/http://archinte.ama-assn.org/cgi/pmidlookup?view=long\u0026pmid=17998494). _Archives of Internal Medicine_. **167** (20): 2213â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1001/archinte.167.20.2213](https://doi.org/10.1001%2Farchinte.167.20.2213). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3189482](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189482). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17998494](https://pubmed.ncbi.nlm.nih.gov/17998494). Archived from [the original](http://archinte.ama-assn.org/cgi/pmidlookup?view=long\u0026pmid=17998494) on 2008-06-07.\",\"description\":\"31. **^** Odden MC, Scherzer R, Bacchetti P, Szczech LA, Sidney S, Grunfeld C, Shlipak MG (November 2007). [\\\"Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study\\\"](https://archive.today/20080607214011/http://archinte.ama-assn.org/cgi/pmidlookup?view=long\u0026pmid=17998494). _Archives of Internal Medicine_. **167** (20): 2213â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1001/archinte.167.20.2213](https://doi.org/10.1001%2Farchinte.167.20.2213). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3189482](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189482). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17998494](https://pubmed.ncbi.nlm.nih.gov/17998494). Archived from [the original](http://archinte.ama-assn.org/cgi/pmidlookup?view=long\u0026pmid=17998494) on 2008-06-07.\",\"url\":\"https://archive.today/20080607214011/http://archinte.ama-assn.org/cgi/pmidlookup?view=long\u0026pmid=17998494\",\"favicon\":\"\"},{\"id\":\"32\",\"title\":\"** CollÃ© A, Tavera C, PrÃ©vot D, Leung-Tack J, Thomas Y, Manuel Y, et al. (1992). \\\"Cystatin C levels in sera of patients with human immunodeficiency virus infection. A new avidin-biotin ELISA assay for its measurement\\\". _Journal of Immunoassay_. **13** (1): 47â€“60\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1080/15321819208019824](https://doi.org/10.1080%2F15321819208019824). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [1569212](https://pubmed.ncbi.nlm.nih.gov/1569212).\",\"description\":\"32. **^** CollÃ© A, Tavera C, PrÃ©vot D, Leung-Tack J, Thomas Y, Manuel Y, et al. (1992). \\\"Cystatin C levels in sera of patients with human immunodeficiency virus infection. A new avidin-biotin ELISA assay for its measurement\\\". _Journal of Immunoassay_. **13** (1): 47â€“60\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1080/15321819208019824](https://doi.org/10.1080%2F15321819208019824). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [1569212](https://pubmed.ncbi.nlm.nih.gov/1569212).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"33\",\"title\":\"** Jaroszewicz J, Wiercinska-Drapalo A, Lapinski TW, Prokopowicz D, Rogalska M, Parfieniuk A (2006). [\\\"Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration\\\"](https://doi.org/10.1177%2F135965350601100502). _Antiviral Therapy_. **11** (5): 641â€“5\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1177/135965350601100502](https://doi.org/10.1177%2F135965350601100502). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16964834](https://pubmed.ncbi.nlm.nih.gov/16964834). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [33722022](https://api.semanticscholar.org/CorpusID:33722022).\",\"description\":\"33. **^** Jaroszewicz J, Wiercinska-Drapalo A, Lapinski TW, Prokopowicz D, Rogalska M, Parfieniuk A (2006). [\\\"Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration\\\"](https://doi.org/10.1177%2F135965350601100502). _Antiviral Therapy_. **11** (5): 641â€“5\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1177/135965350601100502](https://doi.org/10.1177%2F135965350601100502). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16964834](https://pubmed.ncbi.nlm.nih.gov/16964834). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [33722022](https://api.semanticscholar.org/CorpusID:33722022).\",\"url\":\"https://doi.org/10.1177%2F135965350601100502\",\"favicon\":\"\"},{\"id\":\"34\",\"title\":\"** Strevens H, Wide-Swensson D, Torffvit O, Grubb A (2002). \\\"Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy\\\". _Scandinavian Journal of Clinical and Laboratory Investigation_. **62** (2): 141â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1080/003655102753611771](https://doi.org/10.1080%2F003655102753611771). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12004930](https://pubmed.ncbi.nlm.nih.gov/12004930). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [25382382](https://api.semanticscholar.org/CorpusID:25382382).\",\"description\":\"34. **^** Strevens H, Wide-Swensson D, Torffvit O, Grubb A (2002). \\\"Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy\\\". _Scandinavian Journal of Clinical and Laboratory Investigation_. **62** (2): 141â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1080/003655102753611771](https://doi.org/10.1080%2F003655102753611771). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12004930](https://pubmed.ncbi.nlm.nih.gov/12004930). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [25382382](https://api.semanticscholar.org/CorpusID:25382382).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"35\",\"title\":\"** Akbari A, Lepage N, Keely E, Clark HD, Jaffey J, MacKinnon M, Filler G (May 2005). \\\"Cystatin-C and beta trace protein as markers of renal function in pregnancy\\\". _BJOG_. **112** (5): 575â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1471-0528.2004.00492.x](https://doi.org/10.1111%2Fj.1471-0528.2004.00492.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15842279](https://pubmed.ncbi.nlm.nih.gov/15842279). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [1851149](https://api.semanticscholar.org/CorpusID:1851149).\",\"description\":\"35. **^** Akbari A, Lepage N, Keely E, Clark HD, Jaffey J, MacKinnon M, Filler G (May 2005). \\\"Cystatin-C and beta trace protein as markers of renal function in pregnancy\\\". _BJOG_. **112** (5): 575â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1471-0528.2004.00492.x](https://doi.org/10.1111%2Fj.1471-0528.2004.00492.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15842279](https://pubmed.ncbi.nlm.nih.gov/15842279). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [1851149](https://api.semanticscholar.org/CorpusID:1851149).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"36\",\"title\":\"** SjÃ¶strÃ¶m P, Tidman M, Jones I (2005). \\\"Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans\\\". _Scandinavian Journal of Clinical and Laboratory Investigation_. **65** (2): 111â€“24\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1080/00365510510013523](https://doi.org/10.1080%2F00365510510013523). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16025834](https://pubmed.ncbi.nlm.nih.gov/16025834). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [41336736](https://api.semanticscholar.org/CorpusID:41336736).\",\"description\":\"36. **^** SjÃ¶strÃ¶m P, Tidman M, Jones I (2005). \\\"Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans\\\". _Scandinavian Journal of Clinical and Laboratory Investigation_. **65** (2): 111â€“24\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1080/00365510510013523](https://doi.org/10.1080%2F00365510510013523). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16025834](https://pubmed.ncbi.nlm.nih.gov/16025834). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [41336736](https://api.semanticscholar.org/CorpusID:41336736).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"37\",\"title\":\"** Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. (July 2006). [\\\"Chronic kidney disease and mortality risk: a systematic review\\\"](http://jasn.asnjournals.org/cgi/pmidlookup?view=long\u0026pmid=16738019). _Journal of the American Society of Nephrology_. **17** (7): 2034â€“47\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1681/ASN.2005101085](https://doi.org/10.1681%2FASN.2005101085). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16738019](https://pubmed.ncbi.nlm.nih.gov/16738019).\",\"description\":\"37. **^** Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. (July 2006). [\\\"Chronic kidney disease and mortality risk: a systematic review\\\"](http://jasn.asnjournals.org/cgi/pmidlookup?view=long\u0026pmid=16738019). _Journal of the American Society of Nephrology_. **17** (7): 2034â€“47\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1681/ASN.2005101085](https://doi.org/10.1681%2FASN.2005101085). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16738019](https://pubmed.ncbi.nlm.nih.gov/16738019).\",\"url\":\"http://jasn.asnjournals.org/cgi/pmidlookup?view=long\u0026pmid=16738019\",\"favicon\":\"\"},{\"id\":\"38\",\"title\":\"** Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (September 2004). [\\\"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization\\\"](https://doi.org/10.1056%2FNEJMoa041031). _The New England Journal of Medicine_. **351** (13): 1296â€“305\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMoa041031](https://doi.org/10.1056%2FNEJMoa041031). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15385656](https://pubmed.ncbi.nlm.nih.gov/15385656).\",\"description\":\"38. **^** Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (September 2004). [\\\"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization\\\"](https://doi.org/10.1056%2FNEJMoa041031). _The New England Journal of Medicine_. **351** (13): 1296â€“305\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMoa041031](https://doi.org/10.1056%2FNEJMoa041031). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15385656](https://pubmed.ncbi.nlm.nih.gov/15385656).\",\"url\":\"https://doi.org/10.1056%2FNEJMoa041031\",\"favicon\":\"\"},{\"id\":\"39\",\"title\":\"** Zethelius B, Berglund L, SundstrÃ¶m J, Ingelsson E, Basu S, Larsson A, et al. (May 2008). [\\\"Use of multiple biomarkers to improve the prediction of death from cardiovascular causes\\\"](https://doi.org/10.1056%2FNEJMoa0707064). _The New England Journal of Medicine_. **358** (20): 2107â€“16\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMoa0707064](https://doi.org/10.1056%2FNEJMoa0707064). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18480203](https://pubmed.ncbi.nlm.nih.gov/18480203).\",\"description\":\"39. **^** Zethelius B, Berglund L, SundstrÃ¶m J, Ingelsson E, Basu S, Larsson A, et al. (May 2008). [\\\"Use of multiple biomarkers to improve the prediction of death from cardiovascular causes\\\"](https://doi.org/10.1056%2FNEJMoa0707064). _The New England Journal of Medicine_. **358** (20): 2107â€“16\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMoa0707064](https://doi.org/10.1056%2FNEJMoa0707064). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18480203](https://pubmed.ncbi.nlm.nih.gov/18480203).\",\"url\":\"https://doi.org/10.1056%2FNEJMoa0707064\",\"favicon\":\"\"},{\"id\":\"40\",\"title\":\"** Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. (May 2005). [\\\"Cystatin C and the risk of death and cardiovascular events among elderly persons\\\"](https://doi.org/10.1056%2FNEJMoa043161). _The New England Journal of Medicine_. **352** (20): 2049â€“60\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMoa043161](https://doi.org/10.1056%2FNEJMoa043161). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15901858](https://pubmed.ncbi.nlm.nih.gov/15901858).\",\"description\":\"40. **^** Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. (May 2005). [\\\"Cystatin C and the risk of death and cardiovascular events among elderly persons\\\"](https://doi.org/10.1056%2FNEJMoa043161). _The New England Journal of Medicine_. **352** (20): 2049â€“60\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMoa043161](https://doi.org/10.1056%2FNEJMoa043161). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15901858](https://pubmed.ncbi.nlm.nih.gov/15901858).\",\"url\":\"https://doi.org/10.1056%2FNEJMoa043161\",\"favicon\":\"\"},{\"id\":\"41\",\"title\":\"** Ix JH, Shlipak MG, Chertow GM, Whooley MA (January 2007). [\\\"Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study\\\"](http://circ.ahajournals.org/cgi/pmidlookup?view=long\u0026pmid=17190862). _Circulation_. **115** (2): 173â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1161/CIRCULATIONAHA.106.644286](https://doi.org/10.1161%2FCIRCULATIONAHA.106.644286). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2771187](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771187). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17190862](https://pubmed.ncbi.nlm.nih.gov/17190862).\",\"description\":\"41. **^** Ix JH, Shlipak MG, Chertow GM, Whooley MA (January 2007). [\\\"Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study\\\"](http://circ.ahajournals.org/cgi/pmidlookup?view=long\u0026pmid=17190862). _Circulation_. **115** (2): 173â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1161/CIRCULATIONAHA.106.644286](https://doi.org/10.1161%2FCIRCULATIONAHA.106.644286). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2771187](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771187). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17190862](https://pubmed.ncbi.nlm.nih.gov/17190862).\",\"url\":\"http://circ.ahajournals.org/cgi/pmidlookup?view=long\u0026pmid=17190862\",\"favicon\":\"\"},{\"id\":\"42\",\"title\":\"** Deo R, Fyr CL, Fried LF, Newman AB, Harris TB, Angleman S, et al. (January 2008). \\\"Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study\\\". _American Heart Journal_. **155** (1): 62â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.ahj.2007.08.012](https://doi.org/10.1016%2Fj.ahj.2007.08.012). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18082491](https://pubmed.ncbi.nlm.nih.gov/18082491).\",\"description\":\"42. **^** Deo R, Fyr CL, Fried LF, Newman AB, Harris TB, Angleman S, et al. (January 2008). \\\"Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study\\\". _American Heart Journal_. **155** (1): 62â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.ahj.2007.08.012](https://doi.org/10.1016%2Fj.ahj.2007.08.012). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18082491](https://pubmed.ncbi.nlm.nih.gov/18082491).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"43\",\"title\":\"** Koenig W, Twardella D, Brenner H, Rothenbacher D (February 2005). [\\\"Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate\\\"](https://doi.org/10.1373%2Fclinchem.2004.041889). _Clinical Chemistry_. **51** (2): 321â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1373/clinchem.2004.041889](https://doi.org/10.1373%2Fclinchem.2004.041889). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15563478](https://pubmed.ncbi.nlm.nih.gov/15563478).\",\"description\":\"43. **^** Koenig W, Twardella D, Brenner H, Rothenbacher D (February 2005). [\\\"Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate\\\"](https://doi.org/10.1373%2Fclinchem.2004.041889). _Clinical Chemistry_. **51** (2): 321â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1373/clinchem.2004.041889](https://doi.org/10.1373%2Fclinchem.2004.041889). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15563478](https://pubmed.ncbi.nlm.nih.gov/15563478).\",\"url\":\"https://doi.org/10.1373%2Fclinchem.2004.041889\",\"favicon\":\"\"},{\"id\":\"44\",\"title\":\"** Jernberg T, Lindahl B, James S, Larsson A, Hansson LO, Wallentin L (October 2004). [\\\"Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome\\\"](http://circ.ahajournals.org/cgi/pmidlookup?view=long\u0026pmid=15477399). _Circulation_. **110** (16): 2342â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1161/01.CIR.0000145166.44942.E0](https://doi.org/10.1161%2F01.CIR.0000145166.44942.E0). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15477399](https://pubmed.ncbi.nlm.nih.gov/15477399).\",\"description\":\"44. **^** Jernberg T, Lindahl B, James S, Larsson A, Hansson LO, Wallentin L (October 2004). [\\\"Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome\\\"](http://circ.ahajournals.org/cgi/pmidlookup?view=long\u0026pmid=15477399). _Circulation_. **110** (16): 2342â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1161/01.CIR.0000145166.44942.E0](https://doi.org/10.1161%2F01.CIR.0000145166.44942.E0). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15477399](https://pubmed.ncbi.nlm.nih.gov/15477399).\",\"url\":\"http://circ.ahajournals.org/cgi/pmidlookup?view=long\u0026pmid=15477399\",\"favicon\":\"\"},{\"id\":\"45\",\"title\":\"** Luc G, Bard JM, Lesueur C, Arveiler D, Evans A, Amouyel P, et al. (April 2006). [\\\"Plasma cystatin-C and development of coronary heart disease: The PRIME Study\\\"](https://pure.qub.ac.uk/ws/files/496612/Plasma%20cystatin-C%20and%20development%20of%20coronary%20heart%20disease%20-%20The%20PRIME%20Study%20-%20Atherosclerosis%202006%20-%20Evans%20AE%20-%20\\\\(Yarnell%20JW,%20Kee%20F,%20members\\\\).pdf) (PDF). _Atherosclerosis_. **185** (2): 375â€“80\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.atherosclerosis.2005.06.017](https://doi.org/10.1016%2Fj.atherosclerosis.2005.06.017). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16046222](https://pubmed.ncbi.nlm.nih.gov/16046222). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [40221090](https://api.semanticscholar.org/CorpusID:40221090).\",\"description\":\"45. **^** Luc G, Bard JM, Lesueur C, Arveiler D, Evans A, Amouyel P, et al. (April 2006). [\\\"Plasma cystatin-C and development of coronary heart disease: The PRIME Study\\\"](https://pure.qub.ac.uk/ws/files/496612/Plasma%20cystatin-C%20and%20development%20of%20coronary%20heart%20disease%20-%20The%20PRIME%20Study%20-%20Atherosclerosis%202006%20-%20Evans%20AE%20-%20\\\\(Yarnell%20JW,%20Kee%20F,%20members\\\\).pdf) (PDF). _Atherosclerosis_. **185** (2): 375â€“80\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.atherosclerosis.2005.06.017](https://doi.org/10.1016%2Fj.atherosclerosis.2005.06.017). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16046222](https://pubmed.ncbi.nlm.nih.gov/16046222). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [40221090](https://api.semanticscholar.org/CorpusID:40221090).\",\"url\":\"https://pure.qub.ac.uk/ws/files/496612/Plasma%20cystatin-C%20and%20development%20of%20coronary%20heart%20disease%20-%20The%20PRIME%20Study%20-%20Atherosclerosis%202006%20-%20Evans%20AE%20-%20\\\\(Yarnell%20JW,%20Kee%20F,%20members\\\\\",\"favicon\":\"\"},{\"id\":\"46\",\"title\":\"** Servais A, Giral P, Bernard M, Bruckert E, Deray G, Isnard Bagnis C (May 2008). \\\"Is serum cystatin-C a reliable marker for metabolic syndrome?\\\". _The American Journal of Medicine_. **121** (5): 426â€“32\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.amjmed.2008.01.040](https://doi.org/10.1016%2Fj.amjmed.2008.01.040). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18456039](https://pubmed.ncbi.nlm.nih.gov/18456039).\",\"description\":\"46. **^** Servais A, Giral P, Bernard M, Bruckert E, Deray G, Isnard Bagnis C (May 2008). \\\"Is serum cystatin-C a reliable marker for metabolic syndrome?\\\". _The American Journal of Medicine_. **121** (5): 426â€“32\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.amjmed.2008.01.040](https://doi.org/10.1016%2Fj.amjmed.2008.01.040). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18456039](https://pubmed.ncbi.nlm.nih.gov/18456039).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"47\",\"title\":\"** Menon V, Shlipak MG, Wang X, Coresh J, Greene T, Stevens L, et al. (July 2007). [\\\"Cystatin C as a risk factor for outcomes in chronic kidney disease\\\"](http://www.annals.org/cgi/pmidlookup?view=reprint\u0026pmid=17606957). _Annals of Internal Medicine_. **147** (1): 19â€“27\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7326/0003-4819-147-1-200707030-00004](https://doi.org/10.7326%2F0003-4819-147-1-200707030-00004). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17606957](https://pubmed.ncbi.nlm.nih.gov/17606957). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [31964826](https://api.semanticscholar.org/CorpusID:31964826).\",\"description\":\"47. **^** Menon V, Shlipak MG, Wang X, Coresh J, Greene T, Stevens L, et al. (July 2007). [\\\"Cystatin C as a risk factor for outcomes in chronic kidney disease\\\"](http://www.annals.org/cgi/pmidlookup?view=reprint\u0026pmid=17606957). _Annals of Internal Medicine_. **147** (1): 19â€“27\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7326/0003-4819-147-1-200707030-00004](https://doi.org/10.7326%2F0003-4819-147-1-200707030-00004). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17606957](https://pubmed.ncbi.nlm.nih.gov/17606957). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [31964826](https://api.semanticscholar.org/CorpusID:31964826).\",\"url\":\"http://www.annals.org/cgi/pmidlookup?view=reprint\u0026pmid=17606957\",\"favicon\":\"\"},{\"id\":\"48\",\"title\":\"** Sarnak MJ, Katz R, Fried LF, Siscovick D, Kestenbaum B, Seliger S, et al. (January 2008). [\\\"Cystatin C and aging success\\\"](https://archive.today/20080607214016/http://archinte.ama-assn.org/cgi/pmidlookup?view=long\u0026pmid=18227360). _Archives of Internal Medicine_. **168** (2): 147â€“53\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1001/archinternmed.2007.40](https://doi.org/10.1001%2Farchinternmed.2007.40). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2871318](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871318). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18227360](https://pubmed.ncbi.nlm.nih.gov/18227360). Archived from [the original](http://archinte.ama-assn.org/cgi/pmidlookup?view=long\u0026pmid=18227360) on 2008-06-07.\",\"description\":\"48. **^** Sarnak MJ, Katz R, Fried LF, Siscovick D, Kestenbaum B, Seliger S, et al. (January 2008). [\\\"Cystatin C and aging success\\\"](https://archive.today/20080607214016/http://archinte.ama-assn.org/cgi/pmidlookup?view=long\u0026pmid=18227360). _Archives of Internal Medicine_. **168** (2): 147â€“53\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1001/archinternmed.2007.40](https://doi.org/10.1001%2Farchinternmed.2007.40). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2871318](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871318). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18227360](https://pubmed.ncbi.nlm.nih.gov/18227360). Archived from [the original](http://archinte.ama-assn.org/cgi/pmidlookup?view=long\u0026pmid=18227360) on 2008-06-07.\",\"url\":\"https://archive.today/20080607214016/http://archinte.ama-assn.org/cgi/pmidlookup?view=long\u0026pmid=18227360\",\"favicon\":\"\"},{\"id\":\"49\",\"title\":\"** DjoussÃ© L, Kurth T, Gaziano JM (January 2008). [\\\"Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2179893). _American Heart Journal_. **155** (1): 82â€“6\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.ahj.2007.08.023](https://doi.org/10.1016%2Fj.ahj.2007.08.023). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2179893](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2179893). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18082494](https://pubmed.ncbi.nlm.nih.gov/18082494).\",\"description\":\"49. **^** DjoussÃ© L, Kurth T, Gaziano JM (January 2008). [\\\"Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2179893). _American Heart Journal_. **155** (1): 82â€“6\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.ahj.2007.08.023](https://doi.org/10.1016%2Fj.ahj.2007.08.023). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2179893](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2179893). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18082494](https://pubmed.ncbi.nlm.nih.gov/18082494).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2179893\",\"favicon\":\"\"},{\"id\":\"50\",\"title\":\"** O'Hare AM, Newman AB, Katz R, Fried LF, Stehman-Breen CO, Seliger SL, et al. (2005). [\\\"Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study\\\"](https://doi.org/10.1001%2Farchinte.165.22.2666). _Archives of Internal Medicine_. **165** (22): 2666â€“70\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1001/archinte.165.22.2666](https://doi.org/10.1001%2Farchinte.165.22.2666). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16344426](https://pubmed.ncbi.nlm.nih.gov/16344426).\",\"description\":\"50. **^** O'Hare AM, Newman AB, Katz R, Fried LF, Stehman-Breen CO, Seliger SL, et al. (2005). [\\\"Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study\\\"](https://doi.org/10.1001%2Farchinte.165.22.2666). _Archives of Internal Medicine_. **165** (22): 2666â€“70\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1001/archinte.165.22.2666](https://doi.org/10.1001%2Farchinte.165.22.2666). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16344426](https://pubmed.ncbi.nlm.nih.gov/16344426).\",\"url\":\"https://doi.org/10.1001%2Farchinte.165.22.2666\",\"favicon\":\"\"},{\"id\":\"51\",\"title\":\"** Stevens LA, Levey AS (May 2005). \\\"Chronic kidney disease in the elderly--how to assess risk\\\". _The New England Journal of Medicine_. **352** (20): 2122â€“4\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMe058035](https://doi.org/10.1056%2FNEJMe058035). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15901867](https://pubmed.ncbi.nlm.nih.gov/15901867).\",\"description\":\"51. **^** Stevens LA, Levey AS (May 2005). \\\"Chronic kidney disease in the elderly--how to assess risk\\\". _The New England Journal of Medicine_. **352** (20): 2122â€“4\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMe058035](https://doi.org/10.1056%2FNEJMe058035). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15901867](https://pubmed.ncbi.nlm.nih.gov/15901867).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"52\",\"title\":\"** Delanaye P, Cavalier E, Krzesinski JM (February 2008). [\\\"Cystatin C, renal function, and cardiovascular risk\\\"](http://orbi.ulg.ac.be/handle/2268/4787). _Annals of Internal Medicine_. **148** (4): 323. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7326/0003-4819-148-4-200802190-00023](https://doi.org/10.7326%2F0003-4819-148-4-200802190-00023). [hdl](Hdl_\\\\(identifier\\\\) \\\"Hdl \\\\(identifier\\\\)\\\"):[2268/4787](https://hdl.handle.net/2268%2F4787). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18283218](https://pubmed.ncbi.nlm.nih.gov/18283218).\",\"description\":\"52. **^** Delanaye P, Cavalier E, Krzesinski JM (February 2008). [\\\"Cystatin C, renal function, and cardiovascular risk\\\"](http://orbi.ulg.ac.be/handle/2268/4787). _Annals of Internal Medicine_. **148** (4): 323. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7326/0003-4819-148-4-200802190-00023](https://doi.org/10.7326%2F0003-4819-148-4-200802190-00023). [hdl](Hdl_\\\\(identifier\\\\) \\\"Hdl \\\\(identifier\\\\)\\\"):[2268/4787](https://hdl.handle.net/2268%2F4787). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18283218](https://pubmed.ncbi.nlm.nih.gov/18283218).\",\"url\":\"http://orbi.ulg.ac.be/handle/2268/4787\",\"favicon\":\"\"},{\"id\":\"53\",\"title\":\"** Norden AG, Lapsley M, Lee PJ, Pusey CD, Scheinman SJ, Tam FW, et al. (November 2001). [\\\"Glomerular protein sieving and implications for renal failure in Fanconi syndrome\\\"](https://doi.org/10.1046%2Fj.1523-1755.2001.00016.x). _Kidney International_. **60** (5): 1885â€“92\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1046/j.1523-1755.2001.00016.x](https://doi.org/10.1046%2Fj.1523-1755.2001.00016.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11703607](https://pubmed.ncbi.nlm.nih.gov/11703607).\",\"description\":\"53. **^** Norden AG, Lapsley M, Lee PJ, Pusey CD, Scheinman SJ, Tam FW, et al. (November 2001). [\\\"Glomerular protein sieving and implications for renal failure in Fanconi syndrome\\\"](https://doi.org/10.1046%2Fj.1523-1755.2001.00016.x). _Kidney International_. **60** (5): 1885â€“92\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1046/j.1523-1755.2001.00016.x](https://doi.org/10.1046%2Fj.1523-1755.2001.00016.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11703607](https://pubmed.ncbi.nlm.nih.gov/11703607).\",\"url\":\"https://doi.org/10.1046%2Fj.1523-1755.2001.00016.x\",\"favicon\":\"\"},{\"id\":\"54\",\"title\":\"** Tenstad O, Roald AB, Grubb A, Aukland K (August 1996). \\\"Renal handling of radiolabelled human cystatin C in the rat\\\". _Scandinavian Journal of Clinical and Laboratory Investigation_. **56** (5): 409â€“14\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3109/00365519609088795](https://doi.org/10.3109%2F00365519609088795). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8869663](https://pubmed.ncbi.nlm.nih.gov/8869663).\",\"description\":\"54. **^** Tenstad O, Roald AB, Grubb A, Aukland K (August 1996). \\\"Renal handling of radiolabelled human cystatin C in the rat\\\". _Scandinavian Journal of Clinical and Laboratory Investigation_. **56** (5): 409â€“14\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3109/00365519609088795](https://doi.org/10.3109%2F00365519609088795). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8869663](https://pubmed.ncbi.nlm.nih.gov/8869663).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"55\",\"title\":\"** Grubb A, LindstrÃ¶m V, Jonsson M, BÃ¤ck SE, Ã…hlund T, Rippe B, Christensson A (July 2015). [\\\"Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'Shrunken pore syndrome'\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487590). _Scandinavian Journal of Clinical and Laboratory Investigation_. **75** (4): 333â€“40\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3109/00365513.2015.1025427](https://doi.org/10.3109%2F00365513.2015.1025427). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4487590](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487590). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25919022](https://pubmed.ncbi.nlm.nih.gov/25919022).\",\"description\":\"55. **^** Grubb A, LindstrÃ¶m V, Jonsson M, BÃ¤ck SE, Ã…hlund T, Rippe B, Christensson A (July 2015). [\\\"Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'Shrunken pore syndrome'\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487590). _Scandinavian Journal of Clinical and Laboratory Investigation_. **75** (4): 333â€“40\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3109/00365513.2015.1025427](https://doi.org/10.3109%2F00365513.2015.1025427). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4487590](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487590). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25919022](https://pubmed.ncbi.nlm.nih.gov/25919022).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487590\",\"favicon\":\"\"},{\"id\":\"56\",\"title\":\"** Grubb A (June 2020). [\\\"Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options\\\"](https://doi.org/10.1016%2Fj.clinbiochem.2020.06.002). _Clinical Biochemistry_. Online ahead of print: 12â€“20\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.clinbiochem.2020.06.002](https://doi.org/10.1016%2Fj.clinbiochem.2020.06.002). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [32544475](https://pubmed.ncbi.nlm.nih.gov/32544475).\",\"description\":\"56. **^** Grubb A (June 2020). [\\\"Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options\\\"](https://doi.org/10.1016%2Fj.clinbiochem.2020.06.002). _Clinical Biochemistry_. Online ahead of print: 12â€“20\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.clinbiochem.2020.06.002](https://doi.org/10.1016%2Fj.clinbiochem.2020.06.002). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [32544475](https://pubmed.ncbi.nlm.nih.gov/32544475).\",\"url\":\"https://doi.org/10.1016%2Fj.clinbiochem.2020.06.002\",\"favicon\":\"\"},{\"id\":\"57\",\"title\":\"** Levy E, Lopez-Otin C, Ghiso J, Geltner D, Frangione B (May 1989). [\\\"Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189307). _The Journal of Experimental Medicine_. **169** (5): 1771â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1084/jem.169.5.1771](https://doi.org/10.1084%2Fjem.169.5.1771). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2189307](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189307). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [2541223](https://pubmed.ncbi.nlm.nih.gov/2541223).\",\"description\":\"57. **^** Levy E, Lopez-Otin C, Ghiso J, Geltner D, Frangione B (May 1989). [\\\"Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189307). _The Journal of Experimental Medicine_. **169** (5): 1771â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1084/jem.169.5.1771](https://doi.org/10.1084%2Fjem.169.5.1771). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2189307](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189307). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [2541223](https://pubmed.ncbi.nlm.nih.gov/2541223).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189307\",\"favicon\":\"\"},{\"id\":\"58\",\"title\":\"** Levy E, Jaskolski M, Grubb A (January 2006). [\\\"The role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal models\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095742). _Brain Pathology_. **16** (1): 60â€“70\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1750-3639.2006.tb00562.x](https://doi.org/10.1111%2Fj.1750-3639.2006.tb00562.x). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [8095742](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095742). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16612983](https://pubmed.ncbi.nlm.nih.gov/16612983). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [21279341](https://api.semanticscholar.org/CorpusID:21279341).\",\"description\":\"58. **^** Levy E, Jaskolski M, Grubb A (January 2006). [\\\"The role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal models\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095742). _Brain Pathology_. **16** (1): 60â€“70\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1750-3639.2006.tb00562.x](https://doi.org/10.1111%2Fj.1750-3639.2006.tb00562.x). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [8095742](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095742). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16612983](https://pubmed.ncbi.nlm.nih.gov/16612983). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [21279341](https://api.semanticscholar.org/CorpusID:21279341).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095742\",\"favicon\":\"\"},{\"id\":\"59\",\"title\":\"** Janowski R, Kozak M, Janowska E, Grzonka Z, Grubb A, Abrahamson M, et al. (April 2001). [\\\"Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping\\\"](https://lup.lub.lu.se/record/131360). _Nature Structural Biology_. **8** (4): 316â€“320\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/86188](https://doi.org/10.1038%2F86188). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11276250](https://pubmed.ncbi.nlm.nih.gov/11276250). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [28916747](https://api.semanticscholar.org/CorpusID:28916747).\",\"description\":\"59. **^** Janowski R, Kozak M, Janowska E, Grzonka Z, Grubb A, Abrahamson M, et al. (April 2001). [\\\"Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping\\\"](https://lup.lub.lu.se/record/131360). _Nature Structural Biology_. **8** (4): 316â€“320\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/86188](https://doi.org/10.1038%2F86188). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11276250](https://pubmed.ncbi.nlm.nih.gov/11276250). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [28916747](https://api.semanticscholar.org/CorpusID:28916747).\",\"url\":\"https://lup.lub.lu.se/record/131360\",\"favicon\":\"\"},{\"id\":\"60\",\"title\":\"** Janowski R, Kozak M, Abrahamson M, Grubb A, Jaskolski M (Nov 2005). \\\"Glomerular protein sieving and implications for renal failure in Fanconi syndrome\\\". _Proteins_. **61** (3): 570â€“578â€“92. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/prot.20633](https://doi.org/10.1002%2Fprot.20633). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16170782](https://pubmed.ncbi.nlm.nih.gov/16170782). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [633348](https://api.semanticscholar.org/CorpusID:633348).\",\"description\":\"60. **^** Janowski R, Kozak M, Abrahamson M, Grubb A, Jaskolski M (Nov 2005). \\\"Glomerular protein sieving and implications for renal failure in Fanconi syndrome\\\". _Proteins_. **61** (3): 570â€“578â€“92. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/prot.20633](https://doi.org/10.1002%2Fprot.20633). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16170782](https://pubmed.ncbi.nlm.nih.gov/16170782). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [633348](https://api.semanticscholar.org/CorpusID:633348).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"61\",\"title\":\"** Chrabaszczewska M, Sieradzan AK, Rodziewicz-MotowidÅ‚o S, Grubb A, Dobson CM, Kunita JR, Kozak M (Aug 2020). [\\\"Structural characterization of covalently stabilized human cystatin C oligomers\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461555). _International Journal of Molecular Sciences_. **21** (5860): 5860. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3390/ijms21165860](https://doi.org/10.3390%2Fijms21165860). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [7461555](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461555). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [32824145](https://pubmed.ncbi.nlm.nih.gov/32824145).\",\"description\":\"61. **^** Chrabaszczewska M, Sieradzan AK, Rodziewicz-MotowidÅ‚o S, Grubb A, Dobson CM, Kunita JR, Kozak M (Aug 2020). [\\\"Structural characterization of covalently stabilized human cystatin C oligomers\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461555). _International Journal of Molecular Sciences_. **21** (5860): 5860. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3390/ijms21165860](https://doi.org/10.3390%2Fijms21165860). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [7461555](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461555). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [32824145](https://pubmed.ncbi.nlm.nih.gov/32824145).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461555\",\"favicon\":\"\"},{\"id\":\"62\",\"title\":\"** Mi W, Pawlik M, Sastre M, Jung SS, Radvinsky DS, Klein AM, et al. (December 2007). \\\"Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models\\\". _Nature Genetics_. **39** (12): 1440â€“2\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/ng.2007.29](https://doi.org/10.1038%2Fng.2007.29). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18026100](https://pubmed.ncbi.nlm.nih.gov/18026100). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [21332698](https://api.semanticscholar.org/CorpusID:21332698).\",\"description\":\"62. **^** Mi W, Pawlik M, Sastre M, Jung SS, Radvinsky DS, Klein AM, et al. (December 2007). \\\"Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models\\\". _Nature Genetics_. **39** (12): 1440â€“2\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/ng.2007.29](https://doi.org/10.1038%2Fng.2007.29). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18026100](https://pubmed.ncbi.nlm.nih.gov/18026100). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [21332698](https://api.semanticscholar.org/CorpusID:21332698).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"63\",\"title\":\"** Kaeser SA, Herzig MC, Coomaraswamy J, Kilger E, Selenica ML, Winkler DT, et al. (December 2007). \\\"Cystatin C modulates cerebral beta-amyloidosis\\\". _Nature Genetics_. **39** (12): 1437â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/ng.2007.23](https://doi.org/10.1038%2Fng.2007.23). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18026102](https://pubmed.ncbi.nlm.nih.gov/18026102). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [7001526](https://api.semanticscholar.org/CorpusID:7001526).\",\"description\":\"63. **^** Kaeser SA, Herzig MC, Coomaraswamy J, Kilger E, Selenica ML, Winkler DT, et al. (December 2007). \\\"Cystatin C modulates cerebral beta-amyloidosis\\\". _Nature Genetics_. **39** (12): 1437â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/ng.2007.23](https://doi.org/10.1038%2Fng.2007.23). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18026102](https://pubmed.ncbi.nlm.nih.gov/18026102). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [7001526](https://api.semanticscholar.org/CorpusID:7001526).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"64\",\"title\":\"** Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (January 2007). \\\"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database\\\". _Nature Genetics_. **39** (1): 17â€“23\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/ng1934](https://doi.org/10.1038%2Fng1934). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17192785](https://pubmed.ncbi.nlm.nih.gov/17192785). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [452851](https://api.semanticscholar.org/CorpusID:452851).\",\"description\":\"64. **^** Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (January 2007). \\\"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database\\\". _Nature Genetics_. **39** (1): 17â€“23\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/ng1934](https://doi.org/10.1038%2Fng1934). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17192785](https://pubmed.ncbi.nlm.nih.gov/17192785). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [452851](https://api.semanticscholar.org/CorpusID:452851).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"65\",\"title\":\"** Chuo LJ, Sheu WH, Pai MC, Kuo YM (2007). [\\\"Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease\\\"](https://www.karger.com/Article/PDF/000100021). _Dementia and Geriatric Cognitive Disorders_. **23** (4): 251â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1159/000100021](https://doi.org/10.1159%2F000100021). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17310123](https://pubmed.ncbi.nlm.nih.gov/17310123). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [29689590](https://api.semanticscholar.org/CorpusID:29689590).\",\"description\":\"65. **^** Chuo LJ, Sheu WH, Pai MC, Kuo YM (2007). [\\\"Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease\\\"](https://www.karger.com/Article/PDF/000100021). _Dementia and Geriatric Cognitive Disorders_. **23** (4): 251â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1159/000100021](https://doi.org/10.1159%2F000100021). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17310123](https://pubmed.ncbi.nlm.nih.gov/17310123). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [29689590](https://api.semanticscholar.org/CorpusID:29689590).\",\"url\":\"https://www.karger.com/Article/PDF/000100021\",\"favicon\":\"\"},{\"id\":\"66\",\"title\":\"** Del Boccio P, Pieragostino D, Lugaresi A, Di Ioia M, Pavone B, Travaglini D, et al. (August 2007). \\\"Cleavage of cystatin C is not associated with multiple sclerosis\\\". _Annals of Neurology_. **62** (2): 201â€“4, discussion 205. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/ana.20968](https://doi.org/10.1002%2Fana.20968). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17006926](https://pubmed.ncbi.nlm.nih.gov/17006926). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [10687960](https://api.semanticscholar.org/CorpusID:10687960).\",\"description\":\"66. **^** Del Boccio P, Pieragostino D, Lugaresi A, Di Ioia M, Pavone B, Travaglini D, et al. (August 2007). \\\"Cleavage of cystatin C is not associated with multiple sclerosis\\\". _Annals of Neurology_. **62** (2): 201â€“4, discussion 205. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/ana.20968](https://doi.org/10.1002%2Fana.20968). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17006926](https://pubmed.ncbi.nlm.nih.gov/17006926). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [10687960](https://api.semanticscholar.org/CorpusID:10687960).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"67\",\"title\":\"** Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, et al. (November 1999). [\\\"Cystatin C deficiency in human atherosclerosis and aortic aneurysms\\\"](https://dash.harvard.edu/bitstream/handle/1/13506934/Cystatin%20C%20deficiency%20in%20human%20atherosclerosis.pdf?sequence=1) (PDF). _The Journal of Clinical Investigation_. **104** (9): 1191â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1172/JCI7709](https://doi.org/10.1172%2FJCI7709). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [409823](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC409823). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10545518](https://pubmed.ncbi.nlm.nih.gov/10545518).\",\"description\":\"67. **^** Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, et al. (November 1999). [\\\"Cystatin C deficiency in human atherosclerosis and aortic aneurysms\\\"](https://dash.harvard.edu/bitstream/handle/1/13506934/Cystatin%20C%20deficiency%20in%20human%20atherosclerosis.pdf?sequence=1) (PDF). _The Journal of Clinical Investigation_. **104** (9): 1191â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1172/JCI7709](https://doi.org/10.1172%2FJCI7709). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [409823](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC409823). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10545518](https://pubmed.ncbi.nlm.nih.gov/10545518).\",\"url\":\"https://dash.harvard.edu/bitstream/handle/1/13506934/Cystatin%20C%20deficiency%20in%20human%20atherosclerosis.pdf?sequence=1\",\"favicon\":\"\"},{\"id\":\"68\",\"title\":\"** Abisi S, Burnand KG, Waltham M, Humphries J, Taylor PR, Smith A (December 2007). [\\\"Cysteine protease activity in the wall of abdominal aortic aneurysms\\\"](https://doi.org/10.1016%2Fj.jvs.2007.08.015). _Journal of Vascular Surgery_. **46** (6): 1260â€“6\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.jvs.2007.08.015](https://doi.org/10.1016%2Fj.jvs.2007.08.015). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18155003](https://pubmed.ncbi.nlm.nih.gov/18155003).\",\"description\":\"68. **^** Abisi S, Burnand KG, Waltham M, Humphries J, Taylor PR, Smith A (December 2007). [\\\"Cysteine protease activity in the wall of abdominal aortic aneurysms\\\"](https://doi.org/10.1016%2Fj.jvs.2007.08.015). _Journal of Vascular Surgery_. **46** (6): 1260â€“6\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.jvs.2007.08.015](https://doi.org/10.1016%2Fj.jvs.2007.08.015). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18155003](https://pubmed.ncbi.nlm.nih.gov/18155003).\",\"url\":\"https://doi.org/10.1016%2Fj.jvs.2007.08.015\",\"favicon\":\"\"},{\"id\":\"69\",\"title\":\"** Abdul-Hussien H, Soekhoe RG, Weber E, von der ThÃ¼sen JH, Kleemann R, Mulder A, et al. (March 2007). [\\\"Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases\\\"](http://ajp.amjpathol.org/cgi/pmidlookup?view=long\u0026pmid=17322367). _The American Journal of Pathology_. **170** (3): 809â€“17\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2353/ajpath.2007.060522](https://doi.org/10.2353%2Fajpath.2007.060522). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1864891](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1864891). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17322367](https://pubmed.ncbi.nlm.nih.gov/17322367).\",\"description\":\"69. **^** Abdul-Hussien H, Soekhoe RG, Weber E, von der ThÃ¼sen JH, Kleemann R, Mulder A, et al. (March 2007). [\\\"Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases\\\"](http://ajp.amjpathol.org/cgi/pmidlookup?view=long\u0026pmid=17322367). _The American Journal of Pathology_. **170** (3): 809â€“17\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2353/ajpath.2007.060522](https://doi.org/10.2353%2Fajpath.2007.060522). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1864891](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1864891). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17322367](https://pubmed.ncbi.nlm.nih.gov/17322367).\",\"url\":\"http://ajp.amjpathol.org/cgi/pmidlookup?view=long\u0026pmid=17322367\",\"favicon\":\"\"},{\"id\":\"70\",\"title\":\"** Gacko M, Chyczewski L, Chrostek L (1999). \\\"Distribution, activity and concentration of cathepsin B and cystatin C in the wall of aortic aneurysm\\\". _Polish Journal of Pathology_. **50** (2): 83â€“6\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10481531](https://pubmed.ncbi.nlm.nih.gov/10481531).\",\"description\":\"70. **^** Gacko M, Chyczewski L, Chrostek L (1999). \\\"Distribution, activity and concentration of cathepsin B and cystatin C in the wall of aortic aneurysm\\\". _Polish Journal of Pathology_. **50** (2): 83â€“6\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10481531](https://pubmed.ncbi.nlm.nih.gov/10481531).\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"71\",\"title\":\"** Eriksson P, Jones KG, Brown LC, Greenhalgh RM, Hamsten A, Powell JT (January 2004). [\\\"Genetic approach to the role of cysteine proteases in the expansion of abdominal aortic aneurysms\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439999). _The British Journal of Surgery_. **91** (1): 86â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/bjs.4364](https://doi.org/10.1002%2Fbjs.4364). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [11439999](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439999). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [14716800](https://pubmed.ncbi.nlm.nih.gov/14716800). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [45363107](https://api.semanticscholar.org/CorpusID:45363107).\",\"description\":\"71. **^** Eriksson P, Jones KG, Brown LC, Greenhalgh RM, Hamsten A, Powell JT (January 2004). [\\\"Genetic approach to the role of cysteine proteases in the expansion of abdominal aortic aneurysms\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439999). _The British Journal of Surgery_. **91** (1): 86â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/bjs.4364](https://doi.org/10.1002%2Fbjs.4364). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [11439999](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439999). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [14716800](https://pubmed.ncbi.nlm.nih.gov/14716800). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [45363107](https://api.semanticscholar.org/CorpusID:45363107).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439999\",\"favicon\":\"\"},{\"id\":\"72\",\"title\":\"** Lindholt JS, Erlandsen EJ, Henneberg EW (November 2001). [\\\"Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms\\\"](https://doi.org/10.1046%2Fj.0007-1323.2001.01911.x). _The British Journal of Surgery_. **88** (11): 1472â€“5\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1046/j.0007-1323.2001.01911.x](https://doi.org/10.1046%2Fj.0007-1323.2001.01911.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11683743](https://pubmed.ncbi.nlm.nih.gov/11683743). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [42364814](https://api.semanticscholar.org/CorpusID:42364814).\",\"description\":\"72. **^** Lindholt JS, Erlandsen EJ, Henneberg EW (November 2001). [\\\"Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms\\\"](https://doi.org/10.1046%2Fj.0007-1323.2001.01911.x). _The British Journal of Surgery_. **88** (11): 1472â€“5\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1046/j.0007-1323.2001.01911.x](https://doi.org/10.1046%2Fj.0007-1323.2001.01911.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11683743](https://pubmed.ncbi.nlm.nih.gov/11683743). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [42364814](https://api.semanticscholar.org/CorpusID:42364814).\",\"url\":\"https://doi.org/10.1046%2Fj.0007-1323.2001.01911.x\",\"favicon\":\"\"},{\"id\":\"73\",\"title\":\"** Zurdel J, Finckh U, Menzer G, Nitsch RM, Richard G (February 2002). [\\\"CST3 genotype associated with exudative age related macular degeneration\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1771004). _The British Journal of Ophthalmology_. **86** (2): 214â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/bjo.86.2.214](https://doi.org/10.1136%2Fbjo.86.2.214). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1771004](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1771004). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11815350](https://pubmed.ncbi.nlm.nih.gov/11815350).\",\"description\":\"73. **^** Zurdel J, Finckh U, Menzer G, Nitsch RM, Richard G (February 2002). [\\\"CST3 genotype associated with exudative age related macular degeneration\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1771004). _The British Journal of Ophthalmology_. **86** (2): 214â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/bjo.86.2.214](https://doi.org/10.1136%2Fbjo.86.2.214). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1771004](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1771004). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11815350](https://pubmed.ncbi.nlm.nih.gov/11815350).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1771004\",\"favicon\":\"\"},{\"id\":\"74\",\"title\":\"** Im E, Kazlauskas A (March 2007). \\\"The role of cathepsins in ocular physiology and pathology\\\". _Experimental Eye Research_. **84** (3): 383â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.exer.2006.05.017](https://doi.org/10.1016%2Fj.exer.2006.05.017). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16893541](https://pubmed.ncbi.nlm.nih.gov/16893541).\",\"description\":\"74. **^** Im E, Kazlauskas A (March 2007). \\\"The role of cathepsins in ocular physiology and pathology\\\". _Experimental Eye Research_. **84** (3): 383â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.exer.2006.05.017](https://doi.org/10.1016%2Fj.exer.2006.05.017). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16893541](https://pubmed.ncbi.nlm.nih.gov/16893541).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"75\",\"title\":\"** Strojan P, Oblak I, Svetic B, Smid L, Kos J (May 2004). [\\\"Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409457). _British Journal of Cancer_. **90** (10): 1961â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/sj.bjc.6601830](https://doi.org/10.1038%2Fsj.bjc.6601830). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2409457](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409457). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15138478](https://pubmed.ncbi.nlm.nih.gov/15138478).\",\"description\":\"75. **^** Strojan P, Oblak I, Svetic B, Smid L, Kos J (May 2004). [\\\"Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409457). _British Journal of Cancer_. **90** (10): 1961â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/sj.bjc.6601830](https://doi.org/10.1038%2Fsj.bjc.6601830). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2409457](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409457). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15138478](https://pubmed.ncbi.nlm.nih.gov/15138478).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409457\",\"favicon\":\"\"},{\"id\":\"76\",\"title\":\"** Kos J, Krasovec M, Cimerman N, Nielsen HJ, Christensen IJ, BrÃ¼nner N (February 2000). [\\\"Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis\\\"](http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=long\u0026pmid=10690531). _Clinical Cancer Research_. **6** (2): 505â€“11\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10690531](https://pubmed.ncbi.nlm.nih.gov/10690531).\",\"description\":\"76. **^** Kos J, Krasovec M, Cimerman N, Nielsen HJ, Christensen IJ, BrÃ¼nner N (February 2000). [\\\"Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis\\\"](http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=long\u0026pmid=10690531). _Clinical Cancer Research_. **6** (2): 505â€“11\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10690531](https://pubmed.ncbi.nlm.nih.gov/10690531).\",\"url\":\"http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=long\u0026pmid=10690531\",\"favicon\":\"\"},{\"id\":\"77\",\"title\":\"** Strevens H, Wide-Swensson D, Grubb A, Hansen A, Horn T, Ingemarsson I, et al. (September 2003). [\\\"Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies\\\"](https://doi.org/10.1111%2Fj.1471-0528.2003.02051.x). _BJOG_. **110** (9): 825â€“30\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1471-0528.2003.02051.x](https://doi.org/10.1111%2Fj.1471-0528.2003.02051.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [14511964](https://pubmed.ncbi.nlm.nih.gov/14511964). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [26686328](https://api.semanticscholar.org/CorpusID:26686328).\",\"description\":\"77. **^** Strevens H, Wide-Swensson D, Grubb A, Hansen A, Horn T, Ingemarsson I, et al. (September 2003). [\\\"Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies\\\"](https://doi.org/10.1111%2Fj.1471-0528.2003.02051.x). _BJOG_. **110** (9): 825â€“30\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1471-0528.2003.02051.x](https://doi.org/10.1111%2Fj.1471-0528.2003.02051.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [14511964](https://pubmed.ncbi.nlm.nih.gov/14511964). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [26686328](https://api.semanticscholar.org/CorpusID:26686328).\",\"url\":\"https://doi.org/10.1111%2Fj.1471-0528.2003.02051.x\",\"favicon\":\"\"},{\"id\":\"78\",\"title\":\"** Franceschini N, Qiu C, Barrow DA, Williams MA (2008). \\\"Cystatin C and preeclampsia: a case control study\\\". _Renal Failure_. **30** (1): 89â€“95\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1080/08860220701742229](https://doi.org/10.1080%2F08860220701742229). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18197549](https://pubmed.ncbi.nlm.nih.gov/18197549). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [205592849](https://api.semanticscholar.org/CorpusID:205592849).\",\"description\":\"78. **^** Franceschini N, Qiu C, Barrow DA, Williams MA (2008). \\\"Cystatin C and preeclampsia: a case control study\\\". _Renal Failure_. **30** (1): 89â€“95\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1080/08860220701742229](https://doi.org/10.1080%2F08860220701742229). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18197549](https://pubmed.ncbi.nlm.nih.gov/18197549). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [205592849](https://api.semanticscholar.org/CorpusID:205592849).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"79\",\"title\":\"** Kristensen K, Wide-Swensson D, Schmidt C, Blirup-Jensen S, LindstrÃ¶m V, Strevens H, Grubb A (2007). [\\\"Cystatin C, beta-2-microglobulin and beta-trace protein in pre-eclampsia\\\"](https://doi.org/10.1080%2F00016340701318133). _Acta Obstetricia et Gynecologica Scandinavica_. **86** (8): 921â€“6\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1080/00016340701318133](https://doi.org/10.1080%2F00016340701318133). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17653875](https://pubmed.ncbi.nlm.nih.gov/17653875). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [45055267](https://api.semanticscholar.org/CorpusID:45055267).\",\"description\":\"79. **^** Kristensen K, Wide-Swensson D, Schmidt C, Blirup-Jensen S, LindstrÃ¶m V, Strevens H, Grubb A (2007). [\\\"Cystatin C, beta-2-microglobulin and beta-trace protein in pre-eclampsia\\\"](https://doi.org/10.1080%2F00016340701318133). _Acta Obstetricia et Gynecologica Scandinavica_. **86** (8): 921â€“6\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1080/00016340701318133](https://doi.org/10.1080%2F00016340701318133). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17653875](https://pubmed.ncbi.nlm.nih.gov/17653875). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [45055267](https://api.semanticscholar.org/CorpusID:45055267).\",\"url\":\"https://doi.org/10.1080%2F00016340701318133\",\"favicon\":\"\"},{\"id\":\"80\",\"title\":\"** Kristensen K, Larsson I, Hansson SR (March 2007). [\\\"Increased cystatin C expression in the pre-eclamptic placenta\\\"](https://doi.org/10.1093%2Fmolehr%2Fgal111). _Molecular Human Reproduction_. **13** (3): 189â€“95\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/molehr/gal111](https://doi.org/10.1093%2Fmolehr%2Fgal111). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17227816](https://pubmed.ncbi.nlm.nih.gov/17227816).\",\"description\":\"80. **^** Kristensen K, Larsson I, Hansson SR (March 2007). [\\\"Increased cystatin C expression in the pre-eclamptic placenta\\\"](https://doi.org/10.1093%2Fmolehr%2Fgal111). _Molecular Human Reproduction_. **13** (3): 189â€“95\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/molehr/gal111](https://doi.org/10.1093%2Fmolehr%2Fgal111). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17227816](https://pubmed.ncbi.nlm.nih.gov/17227816).\",\"url\":\"https://doi.org/10.1093%2Fmolehr%2Fgal111\",\"favicon\":\"\"},{\"id\":\"81\",\"title\":\"_**a**_ _**b**_ Croda-Todd MT, Soto-Montano XJ, HernÃ¡ndez-Cancino PA, JuÃ¡rez-Aguilar E (September 2007). \\\"Adult cystatin C reference intervals determined by nephelometric immunoassay\\\". _Clinical Biochemistry_. **40** (13â€“14): 1084â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.clinbiochem.2007.05.011](https://doi.org/10.1016%2Fj.clinbiochem.2007.05.011). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17624320](https://pubmed.ncbi.nlm.nih.gov/17624320).\",\"description\":\"81. ^ _**a**_ _**b**_ Croda-Todd MT, Soto-Montano XJ, HernÃ¡ndez-Cancino PA, JuÃ¡rez-Aguilar E (September 2007). \\\"Adult cystatin C reference intervals determined by nephelometric immunoassay\\\". _Clinical Biochemistry_. **40** (13â€“14): 1084â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.clinbiochem.2007.05.011](https://doi.org/10.1016%2Fj.clinbiochem.2007.05.011). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17624320](https://pubmed.ncbi.nlm.nih.gov/17624320).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"82\",\"title\":\"** Lamb EJ, O'Riordan SE, Webb MC, Newman DJ (November 2003). [\\\"Serum cystatin C may be a better marker of renal impairment than creatinine\\\"](https://doi.org/10.1046%2Fj.1532-5415.2003.515244.x). _Journal of the American Geriatrics Society_. **51** (11): 1674, author reply 1674-5. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1046/j.1532-5415.2003.515244.x](https://doi.org/10.1046%2Fj.1532-5415.2003.515244.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [14687406](https://pubmed.ncbi.nlm.nih.gov/14687406). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [34235014](https://api.semanticscholar.org/CorpusID:34235014).\",\"description\":\"82. **^** Lamb EJ, O'Riordan SE, Webb MC, Newman DJ (November 2003). [\\\"Serum cystatin C may be a better marker of renal impairment than creatinine\\\"](https://doi.org/10.1046%2Fj.1532-5415.2003.515244.x). _Journal of the American Geriatrics Society_. **51** (11): 1674, author reply 1674-5. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1046/j.1532-5415.2003.515244.x](https://doi.org/10.1046%2Fj.1532-5415.2003.515244.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [14687406](https://pubmed.ncbi.nlm.nih.gov/14687406). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [34235014](https://api.semanticscholar.org/CorpusID:34235014).\",\"url\":\"https://doi.org/10.1046%2Fj.1532-5415.2003.515244.x\",\"favicon\":\"\"},{\"id\":\"83\",\"title\":\"** Peake M, Whiting M (November 2006). [\\\"Measurement of serum creatinine--current status and future goals\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784008). _The Clinical Biochemist. Reviews_. **27** (4): 173â€“84\\\\. [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1784008](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784008). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17581641](https://pubmed.ncbi.nlm.nih.gov/17581641).\",\"description\":\"83. **^** Peake M, Whiting M (November 2006). [\\\"Measurement of serum creatinine--current status and future goals\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784008). _The Clinical Biochemist. Reviews_. **27** (4): 173â€“84\\\\. [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1784008](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784008). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17581641](https://pubmed.ncbi.nlm.nih.gov/17581641).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784008\",\"favicon\":\"\"},{\"id\":\"84\",\"title\":\"** Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, et al. (January 2006). [\\\"Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program\\\"](https://doi.org/10.1373%2Fclinchem.2005.0525144). _Clinical Chemistry_. **52** (1): 5â€“18\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1373/clinchem.2005.0525144](https://doi.org/10.1373%2Fclinchem.2005.0525144). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16332993](https://pubmed.ncbi.nlm.nih.gov/16332993).\",\"description\":\"84. **^** Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, et al. (January 2006). [\\\"Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program\\\"](https://doi.org/10.1373%2Fclinchem.2005.0525144). _Clinical Chemistry_. **52** (1): 5â€“18\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1373/clinchem.2005.0525144](https://doi.org/10.1373%2Fclinchem.2005.0525144). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16332993](https://pubmed.ncbi.nlm.nih.gov/16332993).\",\"url\":\"https://doi.org/10.1373%2Fclinchem.2005.0525144\",\"favicon\":\"\"},{\"id\":\"85\",\"title\":\"_**a**_ _**b**_ _**c**_ KÃ¶ttgen A, Selvin E, Stevens LA, Levey AS, Van Lente F, Coresh J (March 2008). \\\"Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III)\\\". _American Journal of Kidney Diseases_. **51** (3): 385â€“94\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1053/j.ajkd.2007.11.019](https://doi.org/10.1053%2Fj.ajkd.2007.11.019). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18295054](https://pubmed.ncbi.nlm.nih.gov/18295054).\",\"description\":\"85. ^ _**a**_ _**b**_ _**c**_ KÃ¶ttgen A, Selvin E, Stevens LA, Levey AS, Van Lente F, Coresh J (March 2008). \\\"Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III)\\\". _American Journal of Kidney Diseases_. **51** (3): 385â€“94\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1053/j.ajkd.2007.11.019](https://doi.org/10.1053%2Fj.ajkd.2007.11.019). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18295054](https://pubmed.ncbi.nlm.nih.gov/18295054).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"86\",\"title\":\"_**a**_ _**b**_ Finney H, Newman DJ, Thakkar H, Fell JM, Price CP (January 2000). [\\\"Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1718178). _Archives of Disease in Childhood_. **82** (1): 71â€“5\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/adc.82.1.71](https://doi.org/10.1136%2Fadc.82.1.71). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1718178](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1718178). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10630919](https://pubmed.ncbi.nlm.nih.gov/10630919).\",\"description\":\"86. ^ _**a**_ _**b**_ Finney H, Newman DJ, Thakkar H, Fell JM, Price CP (January 2000). [\\\"Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1718178). _Archives of Disease in Childhood_. **82** (1): 71â€“5\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/adc.82.1.71](https://doi.org/10.1136%2Fadc.82.1.71). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1718178](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1718178). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10630919](https://pubmed.ncbi.nlm.nih.gov/10630919).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1718178\",\"favicon\":\"\"},{\"id\":\"87\",\"title\":\"** Ognibene A, Mannucci E, Caldini A, Terreni A, Brogi M, Bardini G, et al. (June 2006). \\\"Cystatin C reference values and aging\\\". _Clinical Biochemistry_. **39** (6): 658â€“61\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.clinbiochem.2006.03.017](https://doi.org/10.1016%2Fj.clinbiochem.2006.03.017). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16730690](https://pubmed.ncbi.nlm.nih.gov/16730690).\",\"description\":\"87. **^** Ognibene A, Mannucci E, Caldini A, Terreni A, Brogi M, Bardini G, et al. (June 2006). \\\"Cystatin C reference values and aging\\\". _Clinical Biochemistry_. **39** (6): 658â€“61\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.clinbiochem.2006.03.017](https://doi.org/10.1016%2Fj.clinbiochem.2006.03.017). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16730690](https://pubmed.ncbi.nlm.nih.gov/16730690).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"88\",\"title\":\"** Filler G, BÃ¶kenkamp A, Hofmann W, Le Bricon T, MartÃ­nez-BrÃº C, Grubb A (January 2005). \\\"Cystatin C as a marker of GFR--history, indications, and future research\\\". _Clinical Biochemistry_. **38** (1): 1â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.clinbiochem.2004.09.025](https://doi.org/10.1016%2Fj.clinbiochem.2004.09.025). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15607309](https://pubmed.ncbi.nlm.nih.gov/15607309).\",\"description\":\"88. **^** Filler G, BÃ¶kenkamp A, Hofmann W, Le Bricon T, MartÃ­nez-BrÃº C, Grubb A (January 2005). \\\"Cystatin C as a marker of GFR--history, indications, and future research\\\". _Clinical Biochemistry_. **38** (1): 1â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.clinbiochem.2004.09.025](https://doi.org/10.1016%2Fj.clinbiochem.2004.09.025). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15607309](https://pubmed.ncbi.nlm.nih.gov/15607309).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"89\",\"title\":\"** Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, et al. (March 2008). [\\\"Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2390827). _American Journal of Kidney Diseases_. **51** (3): 395â€“406\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1053/j.ajkd.2007.11.018](https://doi.org/10.1053%2Fj.ajkd.2007.11.018). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2390827](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2390827). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18295055](https://pubmed.ncbi.nlm.nih.gov/18295055).\",\"description\":\"89. **^** Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, et al. (March 2008). [\\\"Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2390827). _American Journal of Kidney Diseases_. **51** (3): 395â€“406\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1053/j.ajkd.2007.11.018](https://doi.org/10.1053%2Fj.ajkd.2007.11.018). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2390827](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2390827). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18295055](https://pubmed.ncbi.nlm.nih.gov/18295055).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2390827\",\"favicon\":\"\"},{\"id\":\"90\",\"title\":\"** Shlipak MG (March 2008). \\\"Cystatin C: research priorities targeted to clinical decision making\\\". _American Journal of Kidney Diseases_. **51** (3): 358â€“61\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1053/j.ajkd.2008.01.002](https://doi.org/10.1053%2Fj.ajkd.2008.01.002). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18295049](https://pubmed.ncbi.nlm.nih.gov/18295049).\",\"description\":\"90. **^** Shlipak MG (March 2008). \\\"Cystatin C: research priorities targeted to clinical decision making\\\". _American Journal of Kidney Diseases_. **51** (3): 358â€“61\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1053/j.ajkd.2008.01.002](https://doi.org/10.1053%2Fj.ajkd.2008.01.002). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18295049](https://pubmed.ncbi.nlm.nih.gov/18295049).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"91\",\"title\":\"** Muntner P, Winston J, Uribarri J, Mann D, Fox CS (April 2008). [\\\"Overweight, obesity, and elevated serum cystatin C levels in adults in the United States\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049932). _The American Journal of Medicine_. **121** (4): 341â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.amjmed.2008.01.003](https://doi.org/10.1016%2Fj.amjmed.2008.01.003). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3049932](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049932). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18374694](https://pubmed.ncbi.nlm.nih.gov/18374694).\",\"description\":\"91. **^** Muntner P, Winston J, Uribarri J, Mann D, Fox CS (April 2008). [\\\"Overweight, obesity, and elevated serum cystatin C levels in adults in the United States\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049932). _The American Journal of Medicine_. **121** (4): 341â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.amjmed.2008.01.003](https://doi.org/10.1016%2Fj.amjmed.2008.01.003). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3049932](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049932). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18374694](https://pubmed.ncbi.nlm.nih.gov/18374694).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049932\",\"favicon\":\"\"},{\"id\":\"92\",\"title\":\"** [\\\"Entrez Gene: CST3 cystatin C (amyloid angiopathy and cerebral hemorrhage)\\\"](https://www.ncbi.nlm.nih.gov/gene?Db=gene\u0026Cmd=ShowDetailView\u0026TermToSearch=1471).\",\"description\":\"92. **^** [\\\"Entrez Gene: CST3 cystatin C (amyloid angiopathy and cerebral hemorrhage)\\\"](https://www.ncbi.nlm.nih.gov/gene?Db=gene\u0026Cmd=ShowDetailView\u0026TermToSearch=1471).\",\"url\":\"https://www.ncbi.nlm.nih.gov/gene?Db=gene\u0026Cmd=ShowDetailView\u0026TermToSearch=1471\",\"favicon\":\"\"},{\"id\":\"93\",\"title\":\"** Hwang SJ, Yang Q, Meigs JB, Pearce EN, Fox CS (September 2007). [\\\"A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1995611). _BMC Medical Genetics_. **8** (Suppl 1): S10. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1186/1471-2350-8-S1-S10](https://doi.org/10.1186%2F1471-2350-8-S1-S10). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1995611](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1995611). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17903292](https://pubmed.ncbi.nlm.nih.gov/17903292).\",\"description\":\"93. **^** Hwang SJ, Yang Q, Meigs JB, Pearce EN, Fox CS (September 2007). [\\\"A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1995611). _BMC Medical Genetics_. **8** (Suppl 1): S10. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1186/1471-2350-8-S1-S10](https://doi.org/10.1186%2F1471-2350-8-S1-S10). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1995611](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1995611). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17903292](https://pubmed.ncbi.nlm.nih.gov/17903292).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1995611\",\"favicon\":\"\"},{\"id\":\"94\",\"title\":\"** Janowski R, Kozak M, Jankowska E, Grzonka Z, Grubb A, Abrahamson M, Jaskolski M (April 2001). [\\\"Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping\\\"](http://portal.research.lu.se/ws/files/4833049/624200.pdf) (PDF). _Nature Structural Biology_. **8** (4): 316â€“20\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/86188](https://doi.org/10.1038%2F86188). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11276250](https://pubmed.ncbi.nlm.nih.gov/11276250). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [28916747](https://api.semanticscholar.org/CorpusID:28916747).\",\"description\":\"94. **^** Janowski R, Kozak M, Jankowska E, Grzonka Z, Grubb A, Abrahamson M, Jaskolski M (April 2001). [\\\"Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping\\\"](http://portal.research.lu.se/ws/files/4833049/624200.pdf) (PDF). _Nature Structural Biology_. **8** (4): 316â€“20\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/86188](https://doi.org/10.1038%2F86188). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11276250](https://pubmed.ncbi.nlm.nih.gov/11276250). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [28916747](https://api.semanticscholar.org/CorpusID:28916747).\",\"url\":\"http://portal.research.lu.se/ws/files/4833049/624200.pdf\",\"favicon\":\"\"},{\"id\":\"95\",\"title\":\"_**a**_ _**b**_ Grubb A, LÃ¶fberg H (May 1982). [\\\"Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC346341). _Proceedings of the National Academy of Sciences of the United States of America_. **79** (9): 3024â€“7\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1982PNAS...79.3024G](https://ui.adsabs.harvard.edu/abs/1982PNAS...79.3024G). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1073/pnas.79.9.3024](https://doi.org/10.1073%2Fpnas.79.9.3024). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [346341](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC346341). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [6283552](https://pubmed.ncbi.nlm.nih.gov/6283552).\",\"description\":\"95. ^ _**a**_ _**b**_ Grubb A, LÃ¶fberg H (May 1982). [\\\"Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC346341). _Proceedings of the National Academy of Sciences of the United States of America_. **79** (9): 3024â€“7\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1982PNAS...79.3024G](https://ui.adsabs.harvard.edu/abs/1982PNAS...79.3024G). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1073/pnas.79.9.3024](https://doi.org/10.1073%2Fpnas.79.9.3024). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [346341](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC346341). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [6283552](https://pubmed.ncbi.nlm.nih.gov/6283552).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC346341\",\"favicon\":\"\"},{\"id\":\"96\",\"title\":\"** LÃ¶fberg H, Grubb AO (November 1979). \\\"Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system\\\". _Scandinavian Journal of Clinical and Laboratory Investigation_. **39** (7): 619â€“26\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3109/00365517909108866](https://doi.org/10.3109%2F00365517909108866). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [119302](https://pubmed.ncbi.nlm.nih.gov/119302).\",\"description\":\"96. **^** LÃ¶fberg H, Grubb AO (November 1979). \\\"Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system\\\". _Scandinavian Journal of Clinical and Laboratory Investigation_. **39** (7): 619â€“26\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3109/00365517909108866](https://doi.org/10.3109%2F00365517909108866). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [119302](https://pubmed.ncbi.nlm.nih.gov/119302).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"97\",\"title\":\"** Grubb A, Simonsen O, Sturfelt G, Truedsson L, Thysell H (1985). \\\"Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate\\\". _Acta Medica Scandinavica_. **218** (5): 499â€“503\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.0954-6820.1985.tb08880.x](https://doi.org/10.1111%2Fj.0954-6820.1985.tb08880.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [3911736](https://pubmed.ncbi.nlm.nih.gov/3911736).\",\"description\":\"97. **^** Grubb A, Simonsen O, Sturfelt G, Truedsson L, Thysell H (1985). \\\"Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate\\\". _Acta Medica Scandinavica_. **218** (5): 499â€“503\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.0954-6820.1985.tb08880.x](https://doi.org/10.1111%2Fj.0954-6820.1985.tb08880.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [3911736](https://pubmed.ncbi.nlm.nih.gov/3911736).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"98\",\"title\":\"** Simonsen O, Grubb A, Thysell H (April 1985). \\\"The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate\\\". _Scandinavian Journal of Clinical and Laboratory Investigation_. **45** (2): 97â€“101\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3109/00365518509160980](https://doi.org/10.3109%2F00365518509160980). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [3923607](https://pubmed.ncbi.nlm.nih.gov/3923607).\",\"description\":\"98. **^** Simonsen O, Grubb A, Thysell H (April 1985). \\\"The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate\\\". _Scandinavian Journal of Clinical and Laboratory Investigation_. **45** (2): 97â€“101\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3109/00365518509160980](https://doi.org/10.3109%2F00365518509160980). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [3923607](https://pubmed.ncbi.nlm.nih.gov/3923607).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"99\",\"title\":\"** Shlipak MG, Matsushita K, Ã„rnlÃ¶v J, Inker LA, Katz R, Polkinghorne KR, et al. (September 2013). [\\\"Cystatin C versus creatinine in determining risk based on kidney function\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993094). _The New England Journal of Medicine_. **369** (10): 932â€“43\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMoa1214234](https://doi.org/10.1056%2FNEJMoa1214234). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3993094](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993094). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24004120](https://pubmed.ncbi.nlm.nih.gov/24004120).\",\"description\":\"99. **^** Shlipak MG, Matsushita K, Ã„rnlÃ¶v J, Inker LA, Katz R, Polkinghorne KR, et al. (September 2013). [\\\"Cystatin C versus creatinine in determining risk based on kidney function\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993094). _The New England Journal of Medicine_. **369** (10): 932â€“43\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMoa1214234](https://doi.org/10.1056%2FNEJMoa1214234). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3993094](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993094). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24004120](https://pubmed.ncbi.nlm.nih.gov/24004120).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993094\",\"favicon\":\"\"}],\"images\":[],\"fixedIssues\":[{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"\\\"(formerly **gamma trace** , post-gamma-globulin, or neuroendocrine basic polypeptide),[5]\\\"\",\"explanation\":\"Reference [5] is an archived Alzforum page focused on CST3's role in Alzheimer's disease genetics, which does not discuss or support the historical nomenclature (former names) of cystatin C. The former names are verified in authoritative sources like UniProt and NCBI Gene, but the citation is mismatched and inappropriate.\",\"fixedText\":\"Replace citation [5] with [95] or a more general source like NCBI Gene entry, which lists the synonyms including gamma-trace, post-gamma-globulin, and neuroendocrine basic polypeptide.\",\"evidenceSource\":\"[95] (Grubb \u0026 LÃ¶fberg, 1982, on gamma-trace); UniProt: https://www.uniprot.org/uniprotkb/P01034/entry\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"\\\"Recently, it has been studied for its role in predicting new-onset or deteriorating [cardiovascular disease](Cardiovascular_disease \\\"Cardiovascular disease\\\").\\\"\",\"explanation\":\"The term \\\"recently\\\" is vague and undated, making the claim time-sensitive without context. Studies on cystatin C's role in cardiovascular disease date back to at least 2005 (e.g., ref [40]), and ongoing research continues, but without a timeframe, it lacks precision for an encyclopedic entry.\",\"fixedText\":\"Rephrase to \\\"It has been investigated for its role in predicting...\\\" to remove temporal vagueness, or specify \\\"as of the 2010s and beyond\\\" if needed, citing key reviews.\",\"evidenceSource\":\"Existing refs [16], [39], [40]; no specific \\\"recent\\\" cutoff provided.\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"Infobox gene location (Human): \\\"Start| 23,626,706 [bp][1] End| 23,638,473 [bp][1]\\\"; Ref [1] cites Ensembl release 89 (May 2017).\",\"explanation\":\"The genomic coordinates are slightly outdated; current Ensembl (release 113+, as of 2025) lists end at 23,638,556 bp on GRCh38. While the difference is minor (83 bp), it represents an annotation update, and the reference is over 8 years old, potentially misleading for precise genetic data.\",\"fixedText\":\"Update coordinates to 23,626,706â€“23,638,556 bp and cite current Ensembl or NCBI; however, since infobox will be removed per guidelines, this resolves in rewrite.\",\"evidenceSource\":\"Ensembl: https://www.ensembl.org/id/ENSG00000101439.9; NCBI Gene: https://www.ncbi.nlm.nih.gov/gene/1471\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"N/A (overall section lacks mention of recent guidelines)\",\"explanation\":\"The section omits key recent developments, such as the 2024 KDIGO guidelines recommending cystatin C for more accurate GFR estimation in specific populations (e.g., obesity, cancer, pregnancy), enhancing its clinical role beyond general kidney function biomarker status.\",\"fixedText\":\"Add a concise sentence in the kidney biomarker description: \\\"The 2024 KDIGO guidelines recommend its use alongside creatinine for improved GFR estimation in certain clinical scenarios, such as obesity or malignancy.\\\"\",\"evidenceSource\":\"[](https://kdigo.org/guidelines/ckd-evaluation-and-management/); Recent reviews: https://www.ccjm.org/content/92/9/546 (Sep 2025)\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"The UK's National Institute for Health and Care Excellence (NICE) guideline for the assessment and management of CKD in adults concluded that using serum cystatin C to estimate GFR is more specific for important disease outcomes than use of serum creatinine, and may reduce overdiagnosis in patients with a borderline diagnosis, reducing unnecessary appointments, patient worries, and the overall burden of CKD in the population.[18]\",\"explanation\":\"The cited reference [18] refers to the 2014 NICE guideline (CG182). The updated NICE guideline NG203 (published 2021, last reviewed August 2025) does not mention cystatin C or make similar recommendations, indicating a potential change in emphasis. This presents an outdated view of current UK guidelines without temporal context, which could mislead on current clinical practice.\",\"fixedText\":\"Specify the guideline as the 2014 version and note that the 2021 update (NG203) does not address cystatin C. Add information on more recent international guidelines like KDIGO 2024 that promote cystatin C use.\",\"evidenceSource\":\"[](https://www.nice.org.uk/guidance/ng203)\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"\",\"explanation\":\"The section lacks mention of recent developments in CKD guidelines as of 2024-2025, such as the KDIGO 2024 Clinical Practice Guideline, which recommends using cystatin C in combination with creatinine for more accurate eGFR estimation when available, emphasizing its role in routine assessment. This gap affects completeness on current medical consensus.\",\"fixedText\":\"Add a sentence or paragraph in the Kidney function subsection summarizing the KDIGO 2024 recommendation, citing the source, to reflect up-to-date guidelines.\",\"evidenceSource\":\"[](https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline-Executive-Summary.pdf)\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"\\\"It is a more expensive test than serum creatinine (around $2 or $3, compared to $0.02 to $0.15)\\\"\",\"explanation\":\"These costs are outdated (from 2003-2006 citations) and do not reflect current (2025) laboratory pricing. Actual costs for cystatin C tests range from $50â€“150, while serum creatinine is $10â€“50, still more expensive but the specific figures mislead on accessibility and relative expense.\",\"fixedText\":\"Update costs to approximate current ranges: \\\"typically $50â€“150, compared to $10â€“50 for serum creatinine\\\", with new citation to recent lab pricing sources.\",\"evidenceSource\":\"Web search: MDsave ($6â€“53 for creatinine), FindLabTest ($28â€“61 for creatinine), LifeExtension ($99 for cystatin C)\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"\\\"Across different studies, the mean reference interval ... was between 0.52 and 0.98 mg/L. For women, the average reference interval is 0.52 to 0.90 mg/L with a mean of 0.71 mg/L. For men, the average reference interval is 0.56 to 0.98 mg/L with a mean of 0.77 mg/L.[81]\\\"\",\"explanation\":\"Reference [81] is a 2007 study on Mexican adults; broader and more recent ranges (e.g., Mayo Clinic 2025: 0.63â€“1.03 mg/L for ages 18â€“49, 0.67â€“1.21 mg/L for â‰¥50) differ, potentially leading to misinterpretation of normal values.\",\"fixedText\":\"Replace with updated ranges from authoritative lab (e.g., Mayo Clinic), noting age/sex variations, and cite recent source.\",\"evidenceSource\":\"[web:21] Mayo Clinic Laboratories: CYSTATIN C reference values\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"\\\"In a large study from the United States National Health and Nutrition Examination Survey, the reference interval ... was between 0.57 and 1.12 mg/L.\\\"\",\"explanation\":\"NHANES III data (1988â€“1994, analyzed 2008) is outdated; no recent NHANES updates cited, and cystatin C assays have been standardized (IFCC reference material since ~2010), altering values.\",\"fixedText\":\"Specify as historical data from NHANES III (1988â€“1994) or update/remove if superseded by recent population studies.\",\"evidenceSource\":\"[web:38] GFR Estimation After Cystatin C Reference Material Change (2020)\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"\\\"the cut-off values of cystatin C for CKD for a 60-year-old white women would be 1.12 mg/L and 1.27 mg/L in a black man (a 13% increase). For serum creatinine values adjusted with the MDRD equation, these values would be 0.95 mg/dL to 1.46 mg/dL (a 54% increase).[90]\\\"\",\"explanation\":\"CKD is defined by eGFR \u0026lt;60 mL/min/1.73mÂ² (KDIGO), not direct cystatin C/creatinine cut-offs. MDRD equation is obsolete (replaced by CKD-EPI 2021 without race); race-based adjustments are no longer recommended, misstating current practice.\",\"fixedText\":\"Remove race-specific example; clarify CKD diagnosis uses eGFR equations (e.g., CKD-EPI cystatin C), cite current guidelines.\",\"evidenceSource\":\"NKF/KDIGO guidelines (2024): eGFR-based CKD staging; CKD-EPI 2021 removes race [web:51]\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"No specific text; entire section lacks updates.\",\"explanation\":\"Section omits key developments: IFCC standardization of cystatin C assays (affecting values), KDIGO 2024 recommendation for cystatin C in confirming eGFR when creatinine is unreliable, and race-free eGFR equations (CKD-EPI 2021/2024).\",\"fixedText\":\"Add paragraph on current measurement standards and role in eGFR, with citations to KDIGO/NKF.\",\"evidenceSource\":\"[web:51] KDIGO 2024 CKD Guideline; [web:38] on standardization\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"\\\"Based on a threshold level of 1.09 mg/L ... the prevalence of increased levels of cystatin C in the United States was 9.6% ... In Americans aged 60 and 80 and older, serum cystatin is increased in 41% and more than 50%.[85]\\\"\",\"explanation\":\"Threshold and prevalence from 2008 analysis of old NHANES data; no update, and with standardized assays, values/prevalence may differ. Lacks recency for \\\"United States\\\" claims.\",\"fixedText\":\"Note as based on historical NHANES III data; if possible, add recent prevalence if available, or remove if not critical.\",\"evidenceSource\":\"[web:20] Updated reference intervals (2025)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Cystatin C was first described as 'gamma-trace' in 1961 as a trace protein together with other ones (such as beta-trace) in the [cerebrospinal fluid](Cerebrospinal_fluid \\\"Cerebrospinal fluid\\\") and in the [urine](Urine \\\"Urine\\\") of people with [kidney failure](Kidney_failure \\\"Kidney failure\\\").[95]\",\"explanation\":\"The citation [95] is a 1982 paper on the amino acid sequence of gamma-trace and does not mention or support the 1961 discovery. The 1961 discovery by J. Clausen was specifically in cerebrospinal fluid (CSF), not urine; the association with urine in kidney failure patients was noted later (e.g., in subsequent studies).\",\"fixedText\":\"Remove [95] from this claim. Correct to specify discovery in CSF only. Add citation to Clausen (1961). Rephrase to: \\\"Cystatin C was first described as 'gamma-trace' in 1961 by J. Clausen as a trace protein in normal cerebrospinal fluid not found in serum.[](https://doi.org/10.3181/00379727-107-26569)\\\"\",\"evidenceSource\":\"Clausen J (1961). \\\"Proteins in Normal Cerebrospinal Fluid Not Found in Serum\\\". Proc Soc Exp Biol Med. 107(1):125-8. doi:10.3181/00379727-107-26569. PMID: 13704715.[](https://doi.org/10.3181/00379727-107-26569)\"},{\"criticality\":\"Critical\",\"issueType\":\"Mechanism/Specification Error\",\"problematicText\":\"... in the [cerebrospinal fluid](Cerebrospinal_fluid \\\"Cerebrospinal fluid\\\") and in the [urine](Urine \\\"Urine\\\") of people with [kidney failure](Kidney_failure \\\"Kidney failure\\\").[95]\",\"explanation\":\"The 1961 description by Clausen focused on proteins in normal CSF, not in urine of kidney failure patients. Gamma-trace was later observed in urine of patients with renal issues, but attributing urine to the initial 1961 discovery misstates the historical context and scope of the original finding.\",\"fixedText\":\"Remove reference to urine and kidney failure from the 1961 description. Move kidney failure observation to the sentence about Grubb and Lofberg [96], as it fits there.\",\"evidenceSource\":\"Clausen J (1961). Proc Soc Exp Biol Med. 107:125-8. Later observations: e.g., Grubb \u0026 Lofberg (1979) noted elevated levels in renal failure plasma.[](https://doi.org/10.3181/00379727-107-26569)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Use of serum creatinine and cystatin C was found very effective in accurately reflecting the GFR in a study reported in the July 5, 2012, issue of the New England Journal of Medicine.[99]\",\"explanation\":\"The cited [99] is a September 5, 2013, NEJM paper (Shlipak et al.) comparing cystatin C and creatinine for risk prediction based on kidney function, not primarily for estimating GFR accuracy. The described study matches a different 2012 paper (Inker et al., July 5, 2012) on estimating GFR using both markers. Wrong date and mismatched reference.\",\"fixedText\":\"Correct the date to July 5, 2012. Replace [99] with new citation to Inker et al. (2012). Rephrase slightly for accuracy: \\\"A 2012 study in the New England Journal of Medicine found that equations using serum creatinine and cystatin C provided more accurate estimates of GFR than creatinine alone.[](https://doi.org/10.1056/NEJMoa1114248)\\\"\",\"evidenceSource\":\"Inker LA et al. (2012). \\\"Estimating Glomerular Filtration Rate from Blood Creatinine and Cystatin C\\\". N Engl J Med. 367(1):20-9. doi:10.1056/NEJMoa1114248. [99] is Shlipak et al. (2013).[](https://doi.org/10.1056/NEJMoa1114248)\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"[Entire section lacks mention of renaming to cystatin C]\",\"explanation\":\"The history section omits key development: gamma-trace was renamed cystatin C in 1984 upon recognition of its protease inhibitor function, bridging early discovery to modern use. This gap leaves the historical progression incomplete, especially since the article focuses on its medical role.\",\"fixedText\":\"Add sentence: \\\"In 1984, it was renamed cystatin C due to its similarity to other cystatin protease inhibitors.[](https://doi.org/10.1016/0006-291X(84)91300-20)\\\" after the amino acid sequence mention.\",\"evidenceSource\":\"Isemura S et al. (1984). \\\"The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors\\\". Biochem Biophys Res Commun. 119(2):797-804. doi:10.1016/0006-291X(84)91300-20.[](https://doi.org/10.1016/0006-291X(84)91300-20)\"}],\"slug\":\"Cystatin_C\",\"title\":\"Cystatin C\",\"content\":\"$1f\",\"description\":\"Cystatin C\\n\\nCystatin C or cystatin 3 (formerly gamma trace, post-gamma-globulin, or neuroendocrine basic polypeptide), a protein encoded by the CST3 gene, is mainly used as a biomarker of kidney...\",\"metadata\":{\"categories\":[\"CysC\",\"Cystatin-C\"],\"lastModified\":\"1761553828\",\"contentLength\":\"17207\",\"version\":\"1.0\",\"lastEditor\":\"system\",\"language\":\"en\",\"isRedirect\":false,\"redirectTarget\":\"\",\"isWithheld\":false},\"stats\":{\"totalViews\":\"34050\",\"recentViews\":\"34050\",\"dailyAvgViews\":1135,\"qualityScore\":1,\"lastViewed\":\"1761887278\"},\"linkedPages\":null},\"found\":true},\"dataUpdateCount\":1,\"dataUpdatedAt\":1761887278809,\"error\":null,\"errorUpdateCount\":0,\"errorUpdatedAt\":0,\"fetchFailureCount\":0,\"fetchFailureReason\":null,\"fetchMeta\":null,\"isInvalidated\":false,\"status\":\"success\",\"fetchStatus\":\"idle\"},\"queryKey\":[\"page\",\"Cystatin_C\"],\"queryHash\":\"[\\\"page\\\",\\\"Cystatin_C\\\"]\"}]},\"children\":\"$L20\"}]\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"c:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"Cystatin C\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"Cystatin C or cystatin 3 (formerly gamma trace, post-gamma-globulin, or neuroendocrine basic polypeptide), a protein encoded by the CST3 gene, is mainly used as a biomarker of kidney function.[95] It has been investigated for its role in predicting new-onset or deteriorating cardiovascular disease. It has also been implicated in brain disorders involving amyloid (a specific type of protein deposition), such as Alzheimer's disease. In humans, all cells with a nucleus (cell core containing the...\"}],[\"$\",\"meta\",\"2\",{\"name\":\"author\",\"content\":\"system\"}],[\"$\",\"link\",\"3\",{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"meta\",\"4\",{\"name\":\"keywords\",\"content\":\"CysC, Cystatin-C\"}],[\"$\",\"meta\",\"5\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"6\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"link\",\"7\",{\"rel\":\"canonical\",\"href\":\"https://grokipedia.com/page/Cystatin_C\"}],[\"$\",\"meta\",\"8\",{\"property\":\"og:title\",\"content\":\"Cystatin C\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:description\",\"content\":\"Cystatin C or cystatin 3 (formerly gamma trace, post-gamma-globulin, or neuroendocrine basic polypeptide), a protein encoded by the CST3 gene, is mainly used as a biomarker of kidney function.[95] It has been investigated for its role in predicting new-onset or deteriorating cardiovascular disease. It has also been implicated in brain disorders involving amyloid (a specific type of protein deposition), such as Alzheimer's disease. In humans, all cells with a nucleus (cell core containing the...\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:url\",\"content\":\"https://grokipedia.com/page/Cystatin_C\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:locale\",\"content\":\"en\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",\"16\",{\"property\":\"og:image:alt\",\"content\":\"Cystatin C\"}],[\"$\",\"meta\",\"17\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"18\",{\"property\":\"article:modified_time\",\"content\":\"1970-01-21T09:19:13.828Z\"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",\"20\",{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",\"21\",{\"name\":\"twitter:title\",\"content\":\"Cystatin C\"}],[\"$\",\"meta\",\"22\",{\"name\":\"twitter:description\",\"content\":\"Cystatin C or cystatin 3 (formerly gamma trace, post-gamma-globulin, or neuroendocrine basic polypeptide), a protein encoded by the CST3 gene, is mainly used as a biomarker of kidney function.[95] It has been investigated for its role in predicting new-onset or deteriorating cardiovascular disease. It has also been implicated in brain disorders involving amyloid (a specific type of protein deposition), such as Alzheimer's disease. In humans, all cells with a nucleus (cell core containing the...\"}],[\"$\",\"meta\",\"23\",{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"link\",\"24\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"$L21\",\"25\",{}]],\"error\":null,\"digest\":\"$undefined\"}\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"11:\"$c:metadata\"\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"22:I[61172,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"PageEditorProvider\"]\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"23:I[63493,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="ZDEzYWZhZTAtMmNmMS00NTc3LWFmNmUtODI4YTFiNWQzNWI4">self.__next_f.push([1,"20:[\"$\",\"$L22\",null,{\"children\":[\"$\",\"$L23\",null,{\"slug\":\"Cystatin_C\"}]}]\n"])</script></body></html>